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 i 
Abstract 
 
Due to the difficulties involved in assessing dermal exposure of bioactive agents, it is 
necessary to identify less toxic, surrogate compounds in vitro, which can be used to 
predict dermal absorption of bioactive agents in vivo. It is also important to 
understand factors influencing dermal absorption of chemicals for the purposes of 
risk assessment for exposure to civilians, as many studies tend to focus on 
occupational or military exposure. These studies were aimed at identifying potential 
surrogate compounds for dermal absorption of bioactive agents in vitro using flow 
through and static cell diffusion systems, and also to generate novel data on the 
effects of application vehicle on chemical absorption following low level exposure. 
For protection and risk assessment purposes, the influence of ‘everyday’ clothing, 
and skin surface decontamination on dermal chemical absorption was also assessed.  
 
The model compounds (caffeine and benzoic acid), and the surrogate compounds 
(chlorpyrifos, dichlorvos and phorate) were generally found to be poor marker 
chemicals for comparison with HD absorption through human and pig skin in vitro. 
However, benzoic acid absorption from a finite dose in IPA more closely matched the 
absorption profile of HD applied as a finite dose in IPA.  Dichlorvos absorption was 
greatest from all vehicles compared with chlorpyrifos and HD absorption in vitro. 
Dermal absorption of chlorpyrifos was enhanced when applied in PG compared with 
absorption from IPA or IPM.  No differences were observed between absorption of 
neat HD and HD in IPA in terms of percentage of applied dose absorbed at 24 hours. 
Absorption of HD through full thickness pig skin more closely matched absorption 
through full thickness human skin, split thickness pig skin overestimated absorption 
of HD in vitro in comparison.  
 
‘Everyday’ clothing (cotton shirt) significantly reduced absorption of dichlorvos, 
chlorpyrifos and HD through human skin. Chemicals were applied to clothed skin in 
IPA to mimic finite exposure, and left in contact for 30 minutes (dichlorvos), 4 hours 
(chlorpyrifos), and 1 hour (HD). For all chemicals, removal of clothing followed by 
immediate skin surface decontamination with 0.5% (v/v) soap solution further 
reduced absorption compared with removal of clothing alone. Despite these 
differences not being significant, in terms or civilian exposure, it would be 
recommended to remove clothing and decontaminate as early as possible post-
exposure to minimise the potential for dermal absorption and localised toxicity within 
the skin.  
 
In conclusion, the organophosphate compounds used in these studies (chlorpyrifos 
and dichlorvos) could potentially be useful surrogates for organophosphate agents 
such as VX or sarin, however, further work is needed to make these comparisons. 
The vehicle in which a chemical is applied to the skin can have a profound effect on 
dermal absorption, and this knowledge is important for risk assessment for exposure 
to a range of chemicals. Cotton shirt material significantly reduced dermal absorption 
of all chemicals used compared with 24 hour exposure. Despite this clothing not 
being designed for protective purposes, this may have a significant impact for 
reducing dermal absorption and toxicity in vivo as a result of chemical exposure. 
Further investigation is needed to assess absorption of a wider range of chemicals 
and application vehicles for risk assessment purposes, and to identify chemicals that 
more closely mimic dermal absorption of bioactive agents in vitro for extrapolation to 
in vivo exposure scenarios 
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1.Introduction 
2 
1. Introduction 
 
1.1: Structure of Skin 
The average adult male has a skin surface area of approximately 1.8-2.2m2, 
although these figures are variable depending on a number of factors, such as 
an individual’s height and weight. The skin has many different functions, 
primarily as a barrier to prevent loss of water, nutrients and essential 
compounds from the body. However, the skin also operates in a protective 
capacity to limit absorption. As a result of this, the skin plays a pivotal role as 
a barrier to the potential absorption of hazardous compounds into the body 
(Grandjean, 1990). One of the main factors in enabling the skin to limit 
absorption is its relatively small surface area. In comparison, organs which 
have evolved to efficiently facilitate absorption, such as the lungs 
(approximately 150m2) and the gastrointestinal tract (approximately 200m2) 
have much larger surface areas (Chilcott and Price, 2008). However, the role 
of skin as a protective barrier is not exclusive to chemicals. It also provides 
physical, immunological and pathogen protection, as well as limiting 
absorption of UV radiation (Menon, 2002).  
 
The skin also plays a significant role in thermoregulation and maintaining the 
core temperature of the body. The skin has also been shown to contain some 
metabolising enzymes (Merk et al. 1996, Jewell et al. 2007, and Traynor et al. 
2008). However, the levels of metabolising enzymes in the skin are generally 
regarded to be low in comparison to the liver, the main site of metabolism 
(Williams, 2008).    
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Structurally, the skin can be divided into three main layers. These are the 
epidermis, the dermis and the hypodermis (figure 1.1). The outermost skin 
layer, the epidermis, can be further subdivided on the basis of cellular 
differentiation.   This, along with the dermis provides the structural 
components. The hypodermis comprises mainly of adipose and connective 
tissue. 
 
 
 
 
 
 
 
 
 
Fig.1.1 structure of a typical skin section (adapted from ‘human physiology: fifth edition’ (Fox, 
1996) 
 
 
1.1.1: Epidermis 
The epidermis is the outermost layer of the skin, and is made up of multiple 
layers of stratified squamous epithelial cells. These layers of epithelium can 
be further subdivided into four distinctive layers (from outermost to 
innermost); the stratum corneum, stratum granulosum, stratum spinosum 
and the stratum basale, which can be distinguished by the differentiation of 
the cells present in the epidermis. Approximately 80-95% of cells in the 
1.Introduction 
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epidermis are keratinocytes, with the remainder of cells in this layer of skin 
being made up of melanocytes (involved in pigment formation), Langerhans 
cells (involved in immunological function), and Merkel cells (involved in 
sensory perception) (Monteiro-Riviere, 1996; Menon, 2002). 
 
The innermost layer of the epidermis is the stratum basale. This is a single 
layer of epidermal stem cells occupying the basement membrane of the skin 
and is anatomically attached to the stratum by hemidesmosomes (rivet-like 
structures in the stratum basale). The cells of the stratum basale differentiate 
into epithelial cells which are linked to adjacent cells by desmosomes 
(specialised protein structures involved primarily in cell to cell adhesion). 
Cells constantly undergo apical migration from the stratum basale to produce 
the remaining layers of the epidermis.  
 
The stratum spinosum is characterised by a spiny appearance 
microscopically due to the abundance of desmosomal connections within 
this layer. The stratum spinosum has a profusion of lamellar bodies, which 
are a major component in the synthesis of epidermal lamellar lipids including 
ceramides, fatty acids and cholesterol (Wertz and Downing, 1989). This 
helps to provide the skin with its ‘water-proof’ feature. There is also a greater 
amount of keratin filaments in the stratum spinosum compared with the basal 
layer of the skin.  
 
The stratum granulosum is so called due to its grainy appearance. Here, the 
epidermal cells take on a flatter appearance compared with the more basal 
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layers, and also contains keratohyalin granules, which gives rise to the 
grainy appearance of this skin layer. Keratohyalin granules contain filaggrin 
(stored as profilaggrin, a 400kDa phosphorylated protein consisting of 10-12 
repeats of filaggrin). This facilitates bundling of keratin later on during cell 
differentiation. Filaggrin is essential in the formation, structural integrity and 
barrier function of the upper layer of the epidermis, the stratum corneum. 
Filaggrin is synthesised in the cytoplasm and is stored in keratohyalin 
granules. During terminal cell differentiation, profilaggrin is proteolytically 
cleaved into multiple copies of the 37kDa filaggrin protein (Dale et al. 1985, 
Gan et al. 1990). Filaggrin binds to keratin fibres causing it to bundle into 
highly insoluble macrofibrils. It is this aggregation of protein fibres that 
causes the collapse of the cytoskeleton, which results in the compaction of 
keratinocytes to form corneocytes found in the stratum corneum (Chilcott 
and Price, 2008). An increase in lamellar bodies is also seen in the stratum 
granulosum, with lipids derived from these lamellar bodies being secreted 
into extracellular spaces as the cells differentiate into corneocytes. 
 
The stratum corneum is the outermost layer of the epidermis, and is made 
up of approximately 15-20 layers (this varies depending on anatomical 
location) of flattened, keratinised, dead cells known as corneocytes. These 
cells are surrounded by lipids that occupy the intercellular spaces. The 
structure of the stratum corneum is often referred to as resembling a ‘brick 
and mortar’ arrangement ((figure 1.2), Williams and Elias 1993), and is 
credited with being the body’s main barrier against percutaneous absorption 
of xenobiotic compounds, as well as helping to keep the body hydrated by 
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preventing water loss from the skin surface. The epidermis contains no blood 
vessels and so it relies on diffusion of nutrients from the dermis in order to 
be maintained. Cells in the epidermis migrate upwards from the stratum 
basale and undergo considerable differentiation. During this process, 
considerable amounts of protein and lipid (especially ceramides, a class of 
polar lipids) are synthesised in the stratum spinosum and stratum 
granulosum.  The polar lipids are extruded into the extracellular spaces in 
the upper layer of the stratum granulosum. The final stage of differentiation 
is formation of the corneocytes, non-viable cells, devoid of nucleus and 
organelles, filled with highly cross linked keratin bundles, and surrounded by 
a thickened cell membrane, known as the cornified cell envelope. The 
corneocytes are eventually lost from the upper layers of the stratum 
corneum, a process termed desquamation, in which the corneocytes are 
continuously being ‘sloughed off’ and replaced with cells from the underlying 
skin layers.  This maintains the stratum corneum at a constant thickness. In 
the cells of the upper stratum corneum, filaggrin is proteolysed into a 
complex mixture of hygroscopic chemicals, including amino acids and 
derivatives. This chemical mixture is termed the ‘skin natural moisturising 
factor’ (NMF). This plays a role in determining the level of stratum corneum 
hydration.  
 
1.1.2: Dermis 
The dermis is the largest layer within the skin structure and is situated 
directly below the epidermis. This layer is made up of dense connective 
tissue situated within an extracellular matrix, consisting of collagen, elastin 
1.Introduction 
7 
and proteoglycans. The dermis is highly vascular, containing networks of 
blood vessels, capillaries, lymphatic systems and nerve fibres. These 
systems are necessary in order to support the various glandular structures 
found within the dermis, including sweat glands, sebaceous glands and hair 
follicles. These structures are referred to as appendages, and penetrate 
through the dermis and into the stratum corneum to form pores on the skin 
surface.  The uppermost layer of the dermis is named the papillary layer. It is 
this section of the skin that contains blood vessels and nerve fibres that 
provide nutrients to the avascular epidermis. The lower layer, although 
indiscernible from the upper layer, is termed the reticular layer. This contains 
an abundance of thick, densely packed collagen fibres and connective tissue 
(Montiero-Riviere, 2004). 
 
1.1.3: Appendages 
The term ‘appendages’ refers to the glandular structures, such as hair 
follicles, sweat glands and sebaceous glands that are present within the 
dermis. These pass from the dermis, through the epidermis and the stratum 
corneum to form pores on the skin surface. The appendageal route can 
provide an alternative route of absorption through the skin to those 
demonstrated in figure 1.2. This is particularly important for chemicals which 
may be to large in structure to penetrate the stratum corneum under normal 
circumstances (Montiero-Riviere, 2004).   
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1.1.4: Dermal absorption and penetration 
It is important to study the dermal absorption and penetration of chemicals 
for a number of reasons. Humans come into contact with a wide variety of 
chemicals on a daily basis, whether it is through topically applied drugs, 
cosmetics, household products or through occupational, environmental or 
accidental exposure to chemicals. It is therefore vitally important to 
understand the permeation of chemicals through the skin. Chemicals that 
come into contact with human skin have the potential to be dermally 
absorbed, and so they also have the potential to cause local or systemic 
toxicity effects. Therefore, by investigating the dermal absorption of a series 
of chemicals with differing physicochemical properties, the absorption of 
these chemicals through skin will be better understood and this data can 
then be used for developing risk assessment strategies that may help to 
minimise the effects of exposure to hazardous compounds. 
 
1.1.5: The function of skin as a barrier to absorption 
As mentioned previously, the stratum corneum provides the main barrier to 
dermal absorption of chemicals which come into contact with the skin. 
Although the skin is a barrier to penetration of xenobiotic compounds, it is by 
no means infallible in this role, due to the fact that most chemicals are able 
to penetrate into the skin to some degree. The stratum corneum is not 
impermeable, but it does function to limit the penetration and absorption or 
the vast majority of compounds.  
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The two predominant components of the stratum corneum are the 
corneocytes and the intercellular lamellar lipids. It is thought that the 
intercellular lamellar lipids give then skin its permeability by creating a 
porous route between the corneocytes through which compounds can be 
absorbed (Elias and Friend, 1975, Wertz, 2004).  
  
1.2: Routes of dermal absorption 
Percutaneous absorption is largely considered to be a passive diffusion 
process, with the stratum corneum involved in limiting the rate of absorption 
of xenobiotic compounds. However, most compounds can penetrate the 
stratum corneum to some extent (depending on their physicochemical 
properties). There are several routes by which molecules can pass through 
the stratum corneum and into the viable epidermis (and hence potentially 
reach the systemic circulation); these are termed the intercellular, 
transcellular and the appendageal routes (figure 1.2). 
The intercellular route, which involves passage of compounds through the 
lipid matrix between corneocytes in the stratum corneum, is widely 
considered to be the principal route of percutaneous absorption of most 
xenobiotic compounds (Bodde et al. 1991, Kitson and Thewalt, 2000). 
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intercellular appendageal transcellular
 
Fig 1.2.  Routes of transcellular, appendageal and intercellular penetration. 
 
 
Transcellular absorption occurs when a compound passes through both the 
corneocytes and the lipid matrix within the stratum corneum. The 
significance of this route of absorption is unclear because passage of 
chemicals through multiple layers of corneocytes and intercellular lipids is a 
thermodynamically and kinetically unfavourable process (Flynn, 1990). 
Appendageal absorption involves passage through the appendages, such as 
hair follicles and sweat glands; therefore bypassing absorption through the 
stratum corneum (Maibach et al. 1971). However, this route of absorption is 
considered to be of less significance for the absorption of chemicals with a 
lower molecular weight, partially due to the fact that appendages are 
relatively sparse, and cover approximately 11cm2 (Monteiro-Riviere, 1996) of 
human skin. Chemicals with a low molecular weight are more likely to be 
absorbed through the skin via the other alternative absorption routes.  
 
Little is known regarding the exact route of absorption specific to individual 
chemicals, although experiments have been undertaken to attempt isolation 
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of the appendageal route (Grams and Bouwstra, 2002, Barry, 2002).  The 
approach employed by Barry, 2002, was a novel ‘sandwich’ technique to 
isolate the appendageal route. Here, two stratum corneum layers were 
‘sandwiched’ together, leading to a blockage of the appendages through 
both stratum corneum layers. Therefore, it could be assumed that if 
absorption of a compound was restricted through the stratum corneum 
‘sandwich’, then the appendageal route could be deemed of importance in 
terms of dermal absorption of a particular compound.  
 
1.3: Kinetics of dermal absorption 
Diffusion can be defined as the process by which molecules move from an 
area of high concentration to an area of low concentration due to random 
molecular movement. Diffusion kinetics can be applied to dermal absorption 
using Fick’s law of diffusion for absorption across a membrane at steady 
state.  
J = kp dC 
 
This equation is used to determine the rate of absorption at a steady state 
(J) of a compound passing through the skin, per unit area, per hour (e.g. 
µg/cm2/h). Where Kp corresponds to the permeation coefficient of a given 
chemical across the skin and dC refers to the concentration difference 
across the skin membrane (Grandjean, 1990). A maximum absorption rate is 
achieved when the system reaches a steady state of absorption. The term 
‘steady state absorption rate’ (or steady state flux), refers to a situation 
where the concentration of a chemical on the skin surface and beneath the 
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skin surface are in a state of equilibrium, and also when the rate of 
absorption remains constant over time. In order for steady state absorption 
to be truly achieved, the chemical penetrant must be applied to the skin 
surface at an infinite concentration, so that the concentration on the skin 
surface does not become depleted sufficiently over time and therefore 
reduce the rate of absorption. 
 
The permeability coefficient (Kp) (expressed as cm/hour) is characterised by 
the ratio of the ‘flux’ or maximum absorption rate and the concentration of 
the test compound (Kp=flux/C). It provides a quantitative estimate of the rate 
of absorption across the skin. This is a useful indicator for the rate of 
absorption, particularly when comparing different concentrations of the 
chemical of interest. This means that the permeability coefficient is 
independent of the concentration of chemical applied to the skin surface. 
This can only be calculated accurately when the chemical applied to the skin 
surface at an infinite dose and when the system is at steady state (USEPA, 
1992). 
 
Lag time is defined as the time it takes in hours for a chemical to reach a 
steady state of absorption. The lag time for a particular chemical can be 
determined by extrapolating a line of best fit through the linear section of a 
cumulative absorption graph to the x-axis. The point where the line of best fit 
intercepts the x-axis is the lag time (fig. 1.3). This is a theoretical value 
derived from in vitro dermal absorption studies and therefore does not truly 
reflect the time it takes for a compound to be absorbed through the skin. 
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However, identifying lag time is a useful indicator for comparing dermal 
absorption of different compounds with differing properties.   
 
The maximum rate of absorption (flux) can be also be determined from a 
cumulative absorption profile; with the gradient of the line of best fit of the 
linear phase (steady state) being relative to the maximum rate of absorption. 
The linear phase corresponds to the steady state of absorption, when the 
concentration of a chemical on the skin surface and below the skin surface is 
in equilibrium.  
 
 
Fig.1.3. Diagrammatical representation of steady state absorption, maximum absorption rate 
and lag time 
 
It is important to understand that diffusion of compounds across the stratum 
corneum is driven by a thermodynamic gradient and is not determined solely 
by a concentration gradient. Diffusion through the skin does have a degree 
of reliance on the concentration of which a substance is applied to the skin 
surface, as the more molecules of a substance there is on the skin surface, 
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the greater the probability that molecules will diffuse from an area of high to 
low concentration over time. However, it is also important to take into 
consideration interactions between molecules (when diffusing between the 
application vehicle and the stratum corneum). The term ‘fugacity’ can be 
used to describe the outcome of these molecular interactions. Fugacity can 
be defined as the tendency of a molecule to move from one environment to 
another. This is important to consider with respect to dermal absorption, for 
instance, because a lipophilic molecule dissolved in a hydrophilic vehicle will 
exhibit a greater fugacity for the lipids of the stratum corneum than a 
hydrophilic molecule would if dissolved in the same vehicle. In some 
instances, the thermodynamic gradient can be the opposite of the 
concentration gradient, an example of this is hexachlorobenzene in octanol: 
water (Chilcott and price, 2008). The maximum thermodynamic activity of a 
molecule occurs when it is dissolved to saturation in a particular application 
vehicle. Theoretically, the thermodynamic activity of a particular molecule 
should be the same, regardless of application vehicle provided it is in a 
saturated solution. However, the thermodynamic activity of a molecule at the 
same concentration in two vehicles (but not saturated), will be different. 
Thermodynamic activity and concentration are only ever approximately equal 
when using very dilute concentrations.   
 
The theoretical principles of diffusion mentioned above have been used to 
create mathematical models for the purpose of predicting dermal absorption 
of chemicals based on their physicochemical properties (Flynn, 1990a, Potts 
and Guy, 1992, van der Merwe, 2006). These mathematical models are 
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known as quantitative structure-activity relationships (QSARS). QSARs are 
usually formed upon the correlation of the physicochemical properties of the 
chemical of interest (such as molecular weight, permeability coefficients and 
solubility), and the vehicle in which the compound is applied to the skin 
surface.  The Flynn dataset compiled in 1990 (Flynn 1990a), gave 
information on 97 permeability coefficients for 94 different compounds 
through in vitro human skin, however, the data were compiled from 15 
different laboratories. This meant that the data contained a high degree of 
experimental error due to inter-laboratory variation in experimental 
procedure. Flynn used simple algorithms for low and high molecular 
compounds, assuming that hydrophilic compounds had low skin 
permeability, and that lipophilic compounds had high skin permeability. It 
was also stated that octanol: water partition coefficient dependent QSARs 
could be used to predict skin absorption of high and low molecular weight 
compounds. The dataset presented by Flynn has led to vast amounts of 
research being conducted into generating models for prediction of dermal 
absorption, most of which has been extensively reviewed in the literature 
(Moss et al. 2002, Vecchia and Bunge, 2002, Godin and Touitou, 2007) 
 
1.4: Factors influencing dermal absorption 
There are a number of factors that can affect skin absorption of chemicals.  
These may relate to the skin membrane through which a chemical may be 
absorbed (biological factors) or to the penetrating chemical or its vehicle for 
application to the skin surface (physicochemical factors). 
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1.4.1: Biological factors affecting dermal absorption 
Biological factors relate to the variability seen in the structure of the skin. 
Differences in the influence of biological factors can be seen intra or inter-
individually, as well as between different species. The main biological factors 
that influence dermal absorption include the anatomical location of the skin, 
gender, age, skin damage/disease and also species.  
 
1.4.1.1: Anatomical location of the skin 
It is important to consider anatomical location when investigating dermal 
absorption because different areas of the body have different permeabilities 
(Maibach et al. 1971). Areas of the body where the stratum corneum is 
thickest, such as the palms of the hands (400µm) and soles of the feet 
(600µm) will be far less permeable to xenobiotic compounds than an area of 
the body where the stratum corneum is much thinner, such as the scrotum 
(5µm) (Scheuplein and Blank, 1971). Exposure of scrotal skin to organic 
solvents has shown a fifty-fold increase in permeability when compared to 
areas with thicker skin (Boman and Maibach, 2000). An investigation into 
absorption of sunscreen lotion has also identified that absorption is 
approximately four times greater when applied to the face compared with 
absorption when applied to the back (Benson et al. 2005). For the purposes 
of in vitro skin diffusion studies, excised human breast or abdomen skin are 
most commonly used due to the reduced variability in permeation when 
using skin samples from these sites (Southwell et al. 1984).  
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Not only does skin thickness vary from one anatomical location to another, 
but there is also variation in the composition and amount of lipids present in 
the stratum corneum, which may also contribute to variations in permeability 
between anatomical locations (Lampe et al. 1983).  Stratum corneum lipid 
composition has also been shown to differ, not only intra-individually, but 
also inter-individually. High ceramide to cholesterol ratios were observed in 
the wrists area, which coincided with a high level of trans-epidermal water 
loss. However, no correlation between ceramide levels and barrier function 
were found (Norlen et al. 1999).  
 
1.4.1.2: Gender differences 
It has also been seen that differences in the gender can affect dermal 
absorption. A study carried out by Jacobi et al. 2005, investigating the 
differences in the physiology of the stratum corneum through tape stripping 
showed that variations in structure, permeability and protein composition of 
the stratum corneum exist between genders.  
 
1.4.1.3: Skin damage 
Percutaneous absorption of compounds can also be greatly affected by 
damage to the skin. This can be as a result of physical trauma (e.g. open 
wounds), chemical insult (in which the arrangement of stratum corneum 
lipids is perturbed), irritation, or as a result of skin diseases. Skin diseases 
can either increase or decrease dermal absorption depending on how a 
particular disease affects the structure of the skin. It has been suggested 
that slight skin damage (caused by pre-exposure with sodium lauryl 
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sulphate), can significantly affect the absorption rate, lag time, and total 
penetration of a variety of chemicals, particularly with more hydrophilic 
compounds (Nielsen, 2005).  
 
1.4.1.4: Species differences 
The thickness of the stratum corneum differs greatly between commonly 
studied mammalian species. For instance, the dorsal stratum corneum is 3 
times thicker in humans than it is in rats (Monteiro-Riviere et al. 1990), 
meaning that absorption of compounds will be greater through rat skin than 
through human skin. This is one of the reasons why investigating dermal 
absorption through rat skin in vitro as a model for human exposure to 
particular compounds can lead to an overestimation of absorption. 
Absorption of demeton-s-methyl has also been shown to be two fold greater 
through pig ear skin compared with human skin in vitro (Vallet et al. 2007). 
However, when VX (0-ethyl-S-[2(di-isopropylamino) ethyl] methyl 
phosphonothioate) was applied to human, pig and guinea pig skin in vitro, no 
statistically significant differences in absorption were found between human 
and pig skin. However, absorption through guinea pig skin was seen to be 
seven fold higher than through human skin (Dalton et al. 2006).  Despite 
various differences in absorption between species, pig skin is generally 
regarded to be the most suitable animal model for human skin absorption 
(Simon and Maibach, 2000).  
 
Another factor causing variation in absorption between different species is 
hair follicle density. For example, dorsal skin of the rat and mouse has 289 
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and 658 follicles/cm2 respectively. However, human back skin has only 11 
follicles per cm2 (Bronaugh et al. 1982). In this study, hairless ‘nude’ mice 
with an approximate hair follicle density of 75 per cm2 were shown to have a 
reduced rate of absorption compared to normal mice. The appendageal 
route of absorption through the skin is likely to contribute much more 
significantly to the penetration of a compound through rodent skin than it will 
through human skin, due to the fact that rodents have far more hair follicles 
than humans. Again, this could lead to an overestimate of penetration if 
using rat skin samples to model for how a compound will penetrate through 
human skin.   Differences in hair follicle density may also contribute to 
differences in permeability between anatomical sites, but this is controversial 
because areas of skin with high follicle density, such as the human forehead 
and mandible, also have reduced stratum corneum thickness.  
 
1.4.2: Physicochemical factors affecting dermal absorption 
There are also a number of physicochemical factors that can influence 
percutaneous absorption in addition to factors of biological skin structure. 
The main physicochemical factors that can affect the degree to which a 
compound is dermally absorbed include the lipophilicity of the compound of 
interest, molecular weight, the vehicle of application to the skin and also the 
type of dose applied. 
 
1.4.2.1: Lipophilicity of a penetrant 
Lipophilicity is a major factor determining the dermal penetration of a 
particular compound. The lipophilicity of a compound is expressed as Log P 
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(the logarithm to base ten of the partition coefficient between octanol and 
water). The higher the log P value, the more lipophilic the chemical is. The 
majority of compounds lie within the log P range of -4 to 7. For example, the 
log P of water is -1.38, caffeine is 0.07, benzoic acid is 1.83 and testosterone 
is 3.32. Compounds with a Log P above 3 are considered lipophilic. 
Lipophilicity affects dermal absorption because a more lipophilic substance 
will readily partition into the stratum corneum, but cannot pass easily through 
the skin into systemic circulation due to the aqueous nature of the viable 
epidermis. The more lipophilic a compound is, the less likely it is to have the 
ability to partition into the epidermis. In contrast to this, absorption of 
hydrophilic compounds is limited by the lipophilicity of the stratum corneum; 
however, once a hydrophilic compound has penetrated through this, it will 
partition readily into the epidermis and into systemic circulation (Bronaugh, 
2004).  
 
1.4.2.2: Molecular weight of a penetrant 
The molecular weight of a compound will also impact upon its ability to 
penetrate through the skin. Smaller molecules will pass through the skin 
much more rapidly than compounds that have a higher molecular weight. 
Routes of absorption also have different levels of importance depending on 
molecular weight; for instance, the appendageal route is more important for 
the absorption of larger molecules than for smaller molecules (Scheuplein, 
1965). It is generally considered that chemicals with a molecular weight of 
greater than 500Da do not penetrate the skin under ‘normal’ circumstances 
(Bos and Meinardi, 2000). Despite this, there is some evidence that larger 
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molecules, such as cyclosporin A (1203Da), which is traditionally a poorly 
penetrating compound, can have its absorption significantly enhanced by 
introducing polar side chains in the form of a prodrug. This despite the fact 
that by adding polar side chains, the molecular weight of cyclosporin is 
increased (Billich et al. 2005).  
 
1.4.2.3: Solvent vehicle for application of a penetrant 
Percutaneous absorption of a compound can be influenced by the solvent 
vehicle in which it is applied to the skin surface. The absorption of a 
compound into the skin may be impeded if it is more soluble in the vehicle it 
is applied in than the stratum corneum (Jacobi et al. 2006). Contrary to this, 
if a compound is less soluble in its application vehicle than the stratum 
corneum, then the compound is more likely to penetrate into the stratum 
corneum. 
 
 As percutaneous absorption is a passive process, the rate of absorption will 
have some dependence on the concentration gradient across the stratum 
corneum, though the absolute concentration in the donor solution is less 
important than the thermodynamic activity.  This depends on the solubility of 
the penetrant in the application vehicle.  The rate of percutaneous absorption 
is maximal when the penetrant in the donor chamber is saturated in its 
application vehicle (because thermodynamic activity is maximal). Hence, a 
lipophilic chemical dissolved in an aqueous vehicle will be absorbed more 
rapidly than at the same concentration from a more lipophilic solvent.  
Furthermore, some solvent vehicles are able to act as penetration enhancers 
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(Bach and Lippold, 1998, Williams and Barry, 2004, Duracher et al. 2009), 
either by perturbing the arrangement of stratum corneum lipids, or by 
entering the stratum corneum and creating a reservoir for dissolution of the 
penetrant. Therefore, it is important to take into consideration the effect a 
solvent vehicle will have on the dermal absorption compounds.  
 
1.4.2.4: Dose of a penetrant 
Finally, the dose applied to the skin can have a significant influence on 
dermal absorption. Compounds can either be applied to the skin as a finite 
or infinite dose. An infinite dose involves applying the penetrant as a 
saturated solution, in a large volume to the skin surface (usually 1ml/cm2) so 
that the maximum rate of absorption of the compound at steady state can be 
reached, and the chemical continues to penetrate at the same rate 
throughout the duration of skin contact. Theoretically, the rate of absorption 
does not decrease following application of an infinite dose because the 
surface dose does not get depleted significantly with time. Determination of 
the maximum absorption rate and permeability coefficient of compounds is 
considered to be important when considering risk assessment for exposure 
(Howes et al. 1996, OECD, 2004). Infinite dosing to obtain maximum 
absorption rates and permeability coefficients of a variety of compounds is 
also important for the purpose of modelling exposure, for instance, when 
looking at QSAR predictions for dermal exposure. 
 
A finite dose is a lower concentration or volume applied to the skin (we use 
10µl/cm2). Following application of a finite dose, absorption may not reach a 
steady state because the application dose is usually significantly depleted 
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over time (Franz, 1978). Finite doses mimic occupational or accidental 
exposure to chemicals, and so they are most relevant when investigating 
how chemicals will be dermally absorbed in a typical exposure scenario. 
However, when assessing the suitability of a topically applied 
pharmaceutical product, an infinite dose may be more suitable to identify the 
maximum absorption rate of a compound (OECD, 2004).   
 
1.5: Use of skin in vitro to predict dermal absorption 
Assessing dermal absorption in vitro is often the only feasible method for 
ethically obtain important dermal absorption data relevant to human 
exposure (Bronaugh, 2004). This is of particular importance when 
considering the dermal absorption of highly toxic compounds, which cannot 
be administered to human volunteers in vivo. Excised sections of skin 
obtained from surgical procedures, such as mammoplasty and 
abdominoplasty, are commonly used for the purposes of in vitro dermal 
absorption (Harrison et al. 1984, Bronaugh et al. 1986, Howes et al. 1996, 
Wester et al. 2000, Wilkinson and Williams, 2002, Schreiber et al. 2005, 
Miller and Kasting, 2010). The use of excised human skin is seen as the 
‘gold standard’ for comparing in vitro absorption data with human in vivo data 
(Howes et al .1996).  
 
Absorption studies in vitro have been shown to predict the in vivo absorption 
of a variety of compounds. However, penetration of a compound may be 
altered by blood flow, or inflammatory responses to the compound applied to 
the skin surface in vivo, however, these systems do not exist when using 
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excised skin in vitro, meaning that the absorption of some chemicals may not 
be accurately predicted (OECD, 2004, Williams, 2006).  
 
1.5.1: Diffusion Cells 
Studies using skin mounted in diffusion cells are the most common method 
for in vitro determination of percutaneous penetration. This system is used in 
order to mimic the in vivo absorption and penetration of chemicals through 
the skin as closely as possible. The main principle is that a section of ex vivo 
skin can be mounted, stratum corneum facing up, above a receptor chamber 
containing a receptor fluid. Test compounds can then be applied to the skin 
surface. The compound can penetrate through the skin, and be recovered in 
the receptor fluid beneath the skin and the rate of penetration can then be 
determined.  
 
Two main types of diffusion cell are used to measure in vitro percutaneous 
absorption; the static diffusion cell and the flow through diffusion cell. The 
original diffusion cells were static cells (Franz, 1975). These were so called 
because the cell consists of a receptor chamber, containing a fixed volume 
of receptor fluid, which remains in contact with the underside of the skin. In 
static cells, the receptor fluid is sampled by the removal of aliquots of the 
receptor fluid within the chamber at given time points to assess penetration, 
and replaced with the same quantity of fresh receptor fluid. Commonly used 
receptor fluids include aqueous saline or a mixture of ethanol and water.  
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 The flow through diffusion cell (Bronaugh and Stewart, 1985) is an 
alternative system for measuring percutaneous absorption. The principle 
behind the flow through system is that the receptor fluid is constantly being 
removed from the receptor fluid chamber and replenished with fresh receptor 
fluid by an automatic peristaltic pump at a constant rate. When this system is 
used in conjunction with an automatic fraction collector, aliquots of receptor 
fluid can be collected at regular intervals, therefore eliminating the need for 
manual sampling of receptor fluids. 
 
One advantage of the constant replenishment of receptor fluid beneath the 
skin surface in the flow through diffusion system is that the skin is continually 
being provided with fresh nutrient. This helps to maintain the viability of the 
skin for the duration of the experiment. Another advantage of the flow 
through system can be seen when using compounds that are known to 
penetrate rapidly are applied to the skin. If a fast penetrating compound is 
applied to the skin surface in a static cell, the chemical may penetrate 
through the skin so rapidly that a sufficiently large amount of the chemical 
may accumulate in the receptor chamber and reduce the concentration 
gradient across the epidermis. This effectively reduces further partitioning of 
the test substance into the skin and results in an underestimation of 
penetration (Bronaugh, 2004). However, the static diffusion cell system is 
still a very useful method for measuring absorption, particularly with 
chemicals that penetrate the skin poorly. This is because the receptor fluids 
can be collected at longer intervals in order to concentrate up the amount of 
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chemical within the receptor fluids so that it can be more easily detected. 
This is especially useful if ‘cold’ analysis methods are being implemented.  
 
The receptor fluids most commonly used in the flow through diffusion system 
are saline, buffer, or a culture medium containing nutrients. This receptor 
fluid is typically aqueous, and so partitioning of more lipophilic compounds 
can be limited depending on their solubility in the receptor fluid phase. To 
overcome the issue of the solubility of lipophilic chemicals limiting 
percutaneous dermal absorption, receptor fluids can be supplemented with 
2% (w/v) bovine serum albumin (BSA) (Surber et al. 1991, Dick et al. 1996). 
This helps to facilitate absorption of more lipophilic compounds through the 
skin and gives rates of penetration that more closely match those seen in 
vivo (Bronaugh, 2004). The use of 50% ethanol in water has also been used 
to facilitate absorption of more lipophilic compounds into the receptor fluid 
(Scott et al. 1987). However, ethanol: water has been shown to increase the 
permeability of skin to the penetration of water, and so it has been 
suggested that more physiological solutions, such as culture medium or 
saline are more favourable for diffusion studies (Wilkinson and Williams, 
2002).  
 
There are many variations on the flow through diffusion cell introduced by 
Bronaugh and Stewart, however, the fundamental design remains the same. 
One particular variation (used in the flow through studies of this thesis), is 
the Scott-Dick flow through diffusion cell (figure 1.4). In this system, it is 
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possible to run 15 diffusion cells in parallel, compared with only 7 cells in the 
Bronaugh and Stewart system.  
 
 
Fig.1.4. Schematic diagram of a Scott-Dick flow through diffusion cell (Wakefield, 2006) 
 
The Flow through diffusion cell shown in figure 1.4 is designed so that the 
donor chamber can be un-occluded and exposed to ambient conditions 
similar to those that would be expected in vivo, or, the skin can be occluded 
after application of a test compound, for instance, in order to mimic the 
effects that clothing may have on dermal absorption. A collection chamber 
containing a carbon filter can be used to collect material which may 
evaporate from the skin surface over time. This is of particular importance 
when a volatile substance is being tested (Jewell et al. 2000). The flow 
through diffusion cells used for the purposes of investigations in this thesis 
were made from polytetralfluoroethylene (PTFE - Teflon), which is resistant 
to binding of compounds applied to the skin surface, which could affect 
dermal absorption (Bronaugh et al. 2001).   
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Upon termination of an in vitro dermal absorption study, the stratum corneum 
can be removed from the skin so that the amount of chemical within the 
stratum corneum can be determined separately to the viable epidermis. 
Chemicals remaning within the stratum corneum have been considered to be 
systemically unavailable due to the constant turnover of cells from basal skin 
layers upwards helping to remove chemicals from the skin by ‘sloughing-off’ 
of skin cells (Bronaugh, 2004). However, OECD guidelines on dermal 
absorption state that any test chemical remaning within the skin, including 
both the stratum corneum and the viable epidermis, should be considered 
systemically available until experimentally proven otherwise (OECD, 2004).  
 
1.5.2: Skin Preparation 
In vitro skin studies have been carried out using various skin preparations, 
including full thickness skin, split thickness skin (dermatomed skin) or 
epidermal membranes. The use of different skin thicknesses may produce 
differing absorption, depending on the test compound. For example, in vitro 
studies using full thickness skin sections have the ability to underestimate 
the absorption of a particular chemical into receptor fluid, particularly for 
more lipophilic chemicals, as these may become retained in the dermis 
(Bronaugh, 2000, Bronaugh, 2004). When a chemical penetrates the 
epidermis in vivo, it is systemically available due to the dense vasculature 
within the dermis. However, when full thickness skin is being used in vitro, 
the compound has to pass through both the epidermis and the dermis in 
order to reach the receptor fluid. Essentially, this means that a compound 
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has to penetrate further in vitro than it does in vivo to be considered 
systemically available.  
 
The alternative method to using full thickness skin is to use dermatomed skin 
preparations or epidermal membranes. The process of dermatoming 
involves shaving a layer of skin (we use a depth of approximately 330µm), 
which separates the stratum corneum and the viable epidermis from the 
majority of the dermis. This enables the in vitro system for measuring dermal 
absorption to more closely model the situation in vivo (Hawkins and 
Reifenrath, 1986, USEPA, 1992, Bronaugh, 2004, OECD, 2004).  
Investigations have shown that there are no significant differences in dermal 
absorption between full thickness and dermatomed skin when using highly 
water soluble compounds (Dick and Scott, 1992, Moser et al. 2001).  Further 
to this, no significant differences have been identified between full thickness 
and dermatomed skin with regard to the dermal penetration of caffeine 
(hydrophilic), whereas penetration of testosterone (lipophilic) was found to 
be 10 fold higher through dermatomed skin compared with full thickness skin 
(Wilkinson et al. 2006). Studies using other non-lipophilic chemicals, such as 
glycol ethers, ethoxyethanol and butoxyethanol have also demonstrated 
increased penetration through dermatomed skin compared with full thickness 
skin (Wilkinson and Williams, 2002, Wilkinson et al. 2006). This suggests 
that the lipophilicity is a highly important aspect to consider when assessing 
dermal penetration of chemicals.  
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1.5.3: Measurement of dermal barrier integrity 
Prior to the start of a dermal penetration study, stratum corneum integrity 
should be checked once the skin has been prepared and placed in a 
diffusion cell to ensure that the skin hasn’t sustained any damage during 
preparation. This is important to consider, because any damage to the skin 
could lead to increased penetration of a chemical through the skin. This is in 
coordination with OECD guidelines (OECD, 2004).    
 
The method of membrane integrity measurement used for the purpose of the 
studies conducted in this project was electrical resistance across the stratum 
corneum. However, there are other methods that can be implemented, 
including trans-epidermal water loss (TEWL) measurements, and 
penetration of tritiated water (3H).  
 
Measurement of electrical resistance (kΩ) to an alternating (AC) current 
across the skin can be measured by attaching an AC impedance meter to 
electrodes that protrude from the outer walls of the donor and receiver 
chambers of the flow through diffusion cell. Prior to measurement of 
electrical resistance, physiological saline solution is applied to the skin 
surface, with the same saline solution in the receptor chamber. Following 
equilibration for 30-60 minutes, the electrical resistance between the donor 
and receptor chambers is determined. The general consensus is that skin is 
considered to be undamaged when the resistance is greater than 20kΩ 
(Diembeck et al. 1999, OECD, 2004).  
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TEWL involves measuring water loss from the stratum corneum (Oestmann 
et al. 1993). The theory behind this method is that damaged skin will give 
rise to increased TEWL due to reduced barrier integrity compared with skin 
that is healthy and intact (Nangia et al. 1998). TEWL is measured by placing 
two vapour pressure sensitive electrodes parallel to the skin surface. The 
vapour pressure gradient above the skin is then converted to water loss from 
across the stratum corneum (g/m2/h) (Levin and Maibach, 2005). A rate 
between 4 and 10g/m2/h is considered to be a normal rate of trans-epidermal 
water loss; however, this can potentially increase by up to 30 times if the 
stratum corneum is badly damaged (Charbonnier et al. 2004). The use of 
TEWL as a barrier integrity measurement has been questioned, as no 
correlation was identified between basal transepidermal water loss rates and 
the permeability of human epidermal membranes to tritiated water or sulphur 
mustard (Chilcott et al. 2002a). However, in contrast to the findings by 
Chilcott et al, TEWL has been shown to linearly correlate with tritiated water 
flux through full thickness pig skin in vitro (Elmahjoubi et al. 2009). Other 
recent studies have also suggested that TEWL is a useful indicator of skin 
barrier in vitro and in vivo (Tsai et al. 2003, Fluhr et al. 2006, Elkeeb et al. 
2010). 
 
Another method for assessing dermal membrane integrity is to determine the 
penetration of tritiated water through the skin (Heylings et al. 2001). The 
penetration of tritiated water can be determined prior to the application of the 
test chemical to the skin surface. However, one negative aspect of using this 
method is that skin sections in vitro decrease in viability over time, and so 
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the skin may deteriorate as a result of testing the penetration of the 
reference chemical (tritiated water) before being able to measure absorption 
of a test chemical. Due to this, it is possible that using a reference penetrant 
such as tritiated water may lead to an overestimate of penetration of a test 
chemical (Nangia et al. 1998, OECD, 2004). To overcome this problem, it is 
possible to apply tritiated water to the skin concurrently with, for example, a 
14C-labelled test chemical. Therefore, barrier function and penetration of the 
test compound can theoretically be measured simultaneously. However, this 
can only be implemented if the concentration of tritiated water is low enough 
to have no effect on the thermodynamic activity of the test compound 
(OECD, 2004).  
 
1.5.4: In vitro stratum corneum tape-stripping 
Tape stripping of the stratum corneum is a technique that can be carried out 
upon termination of a diffusion cell study. This method allows quantitation of 
the amount of the test compound remaining within the stratum corneum at 
the end of the exposure period, independently of the viable epidermis, 
dermis and basal skin layers.  
 
Tape stripping involves applying a section of adhesive tape to the skin 
surface with gentle pressure, and subsequently removing it. Sequential tape 
strips are taken to remove successive layers of the stratum corneum. This 
can be a useful technique, because individual tape strips can be analysed to 
identify the amount of the test compound present in each layer of the stratum 
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corneum. The human stratum corneum is 10-20µm thick and requires 
approximately 15 tape strips to remove in vitro.   
 
Despite the useful aspects of this method, its main limitation is the variability 
in the amount of corneocytes removed with each tape strip. Therefore, the 
number of cells removed may not be proportional to the amount of tape 
strips taken, and so the amount of corneocytes removed with each tape strip 
is likely to vary between skin samples.  
 
Other factors which may also affect the amount of corneocytes being 
removed with sequential tape strips include the level of skin hydration, 
anatomical site and inter-individual variations in skin composition (Marttin et 
al.1996). The composition of the stratum corneum itself can also inhibit the 
accuracy of tape stripping. The stratum corneum has ‘furrows’ running 
across the surface, meaning that tape strips may not take cells from the 
same layer, because the cells from the base of these furrows will not be 
taken at the same time as those that are on the ‘peaks’ of the furrow (van 
der Molen et al. 1997).  
 
1.6: Test Compounds 
This project has focused on investigating the dermal absorption of 
compounds that can potentially be used to model absorption of a wider 
range of chemicals in real life scenarios. The compounds used for these in 
vitro studies were, benzoic acid, caffeine, testosterone, methyl paraben, 
chlorpyrifos and dichlorvos. Dermal absorption of sulphur mustard (HD) and 
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phorate were also investigated in order to compare absorption profiles of 
model compounds with more toxic substances.  
 
1.6.1: Model compounds for dermal absorption 
It is extremely useful when undertaking dermal absorption studies to identify 
the absorption profile of chemicals whose dermal absorption profiles are 
already well established. One of the major factors affecting dermal 
absorption is the physicochemical properties of the chemical being tested, 
and so assessing the penetration of chemicals with differing physicochemical 
properties; which also have well defined absorption profiles based on a wide 
range of studies will generate confidence in the data generated from 
absorption studies testing chemicals where knowledge of penetration is 
lacking. This is especially important if the data is being obtained using new 
equipment or different methods to ones used to generate the pre-existing 
data to which you are trying to compare. OECD guidelines also stipulate that 
in order to demonstrate the reliability of a test system for predicting dermal 
absorption, results for known test compounds should be in accordance with 
published literature (OECD, 2004).    
 
Some compounds have become traditionally recognised as markers for 
assessing dermal penetration. These compounds include caffeine, 
testosterone, benzoic acid and methyl paraben, which have been used 
predominantly due to their differing physicochemical properties (van de 
Sandt et al. 2004, Wilkinson et al. 2006).  
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1.6.2: Caffeine 
Caffeine (1, 3, 7 trimethylxanthine) is a xanthine alkaloid that is commonly 
found in everyday beverages such as tea and coffee. It is found in the 
beans, leaves and fruits of a variety of plants and is well known as a central 
nervous system stimulant in humans. Caffeine exerts its effect as a stimulant 
as it is a non selective antagonist of adenosine. Caffeine is similar in 
structure to adenosine, and so it blocks adenosine receptors and prevents 
adenosine from binding and eliciting its effects. Adenosine is important in 
energy transfer processes (as adenosine triphosphate (ATP) and adenosine 
diphosphate (ADP) and, under normal circumstances, decreases firing of 
cholinergic, dopaminergic, glutaminergic, and noradrenergic receptors. 
However, by binding to adenosine receptors, caffeine causes increased 
firing of these neurones, which leads to excessive stimulation as a result of 
caffeine intake (Daly and Fredholm, 1998).  
 
Caffeine is a hydrophilic (Log p = -0.07) compound that has a moderate 
molecular weight (194.19). It has been used in a range of dermal absorption 
studies due to its physicochemical properties, where it has been compared 
with a variety of compounds with differing properties (Bronaugh and Franz, 
1986, Greaves et al. 2002, van de Sandt et al. 2004, Wilkinson et al. 2006, 
Akomeah et al, 2007). Caffeine does not readily partition into the stratum 
corneum when in contact with the skin, predominantly due to the hydrophilic 
nature of caffeine, and the lipophilic nature of the stratum corneum. Despite 
this, once caffeine has penetrated the stratum corneum, it will readily 
partition into the more hydrophilic layers of the skin; the viable epidermis and 
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dermis. From here, caffeine can become systemically available. The stratum 
corneum is the main barrier to caffeine absorption and is therefore the rate 
limiting step for penetration (Kitson and Thewalt, 2000). 
  
 
Fig.1.5. the structure of caffeine 
 
A range of in vitro studies have been undertaken to assess the penetration 
of caffeine through excised sections of skin taken from a number of different 
species, including rat, pig, mouse and human ((breast and abdomen), 
Reifenrath et al. 1984, Bronaugh and Franz, 1986, Monti et al. 2001, 
Akomeah et al. 2004, Wilkinson et al. 2006, Duracher et al. 2009)). A multi-
centre experiment involving 9 independent European laboratories was 
undertaken to assess inter and intra-laboratory variations in dermal 
absorption of model penetrants, including caffeine, through human skin in 
vitro. The total amount of caffeine found to be absorbed through human skin 
after 24 hour exposure (averaged over 9 laboratories) was 24.5 ± 11.6% of 
the applied dose (van de Sandt et al. 2004).  
 
1.6.3: Benzoic acid 
Benzoic acid has also been used as a model penetrant in a number of 
dermal absorption studies, utilising excised skin from a variety of different 
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species including human and rat skin (Reifenrath et al. 1991, Yoshida et al. 
2000, van de Sandt et al. 2004, JB Nielsen et al. 2009). 
 
It is the simplest carboxylic acid containing a carboxyl group bonded directly 
to a benzene ring (figure1.6). It is a weak acid, commercially produced by 
partial oxidation of toluene with oxygen and its salts are commonly used as a 
food preservative. Benzoic acid differs from caffeine as it has a relatively low 
molecular weight (122.12) and is also a more lipophilic chemical (log p = 
1.87). 
 
Fig.1.6. the structure of benzoic acid 
 
Due to benzoic acid being a moderately lipophilic compound, it is more likely 
that it will partition more readily from the skin surface into the stratum 
corneum. However, once it has penetrated into the stratum corneum, it will 
be unable to partition as readily into the viable epidermis and dermis where it 
would become systemically available. The ability of benzoic acid to penetrate 
the skin faster than more hydrophilic compounds such as caffeine was 
demonstrated by Nielsen et al. 2009. Caffeine was found to have a lag time 
of approximately 7 hours when applied to human skin as a 4mg/ml dose, 
however, the same concentration of benzoic acid produced a lag time of only 
1.5 hours. This study also demonstrated that almost double the amount of 
benzoic acid was found to be recovered from within the skin after 24 hour 
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exposure compared with caffeine. However, nearly 5 times as much benzoic 
acid was recovered in the receptor fluid after 24 hour exposure.  
 
1.7: Chemicals of Interest – Surrogate compounds 
Dichlorvos and chlorpyrifos were chosen due to their differing 
physicochemical properties, allowing a range of exposure scenarios to be 
investigated. These chemicals were chosen as a surrogate for nerve agent 
exposure because they are both organophosphates and have a similar 
mechanism of action to highly toxic nerve agents such as VX and sarin.  
 
1.7.1: Chlorpyrifos 
Chlorpyrifos (O, O-diethyl-O-(3, 5, 6-trichloro-2-pyridyl) phosphothioate) is a 
non systemic toxic organophosphate insecticide which is commonly used in 
for agricultural purposes in a number of countries, including the USA. It is a 
lipophilic compound (log P = 4.96), and also has a relatively high molecular 
weight (MW =350.59). Chlorpyrifos is in a P=S form (inactive as an 
anticholinesterase). This means that it has to undergo oxidative 
desulphuration via cytochrome P450 (CYP450) enzymes; predominantly 
through CYPs 2B6, 3A4, 2D6, and 3A5 in the liver to convert into its oxon 
(P=O) form in order to elicit its more potent toxic effects as an 
anticholinesterase (Mutch et al. 2006).   
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Fig.1.7. the structure of chlorpyrifos 
 
 
Due to its physicochemical properties, it has been suggested that 
chlorpyrifos can partition into the stratum corneum in vitro, and create a 
‘reservoir’ of penetrated chlorpyrifos that can be released over a long period 
of time. It has also been shown that the solvent vehicle in which chlorpyrifos 
is delivered can have a significant impact on its rate of dermal penetration 
(Griffin et al. 2000).  
 
Like many other organophosphate compounds and nerve agents, the acute 
toxic effects of chlorpyrifos exposure are primarily due to inhibition of the 
enzyme acetylcholinesterase.  This enzyme is responsible for breaking down 
the neurotransmitter acetylcholine, into inactive metabolites, choline and 
acetate at the synaptic cleft of the neuromuscular junction. Therefore, 
inhibition of acetylcholinesterase results in an excessive accumulation of 
active acetylcholine in the synapse and at the neuromuscular junction. This 
leads to over stimulation and potential paralysis of muscarinic and nicotinic 
receptors. Severe intoxication can potentially lead to death, usually as a 
result of respiratory failure.  
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1.7.2: Dichlorvos 
Dichlorvos (2, 2-dichlorovinyl dimethyl phosphate), like chlorpyrifos, is an 
organophosphate compound that is widely used in agriculture as a pesticide. 
This compound was selected because, unlike chlorpyrifos, it is in a P=O 
form, meaning it does not require metabolism to elicit its toxic effects. 
Dichlorvos also has a mechanism of action similar to that of nerve agents. 
 
Dichlorvos has different physicochemical properties to chlorpyrifos, and so 
are both interesting compounds to compare and contrast for the purposes of 
identifying different exposure profiles for in vitro absorption studies.  
Dichlorvos differs from chlorpyrifos in a number of ways. As already 
mentioned, dichlorvos is an oxon (P=O), and therefore does not require 
metabolism by cytochrome P450 enzymes to exert toxicity.  
 
Fig. 1.8. the structure of Dichlorvos 
 
Dichlorvos is also less lipophilic than chlorpyrifos (log P = 1.47), and also 
has a lower molecular weight (MW = 220.98). Therefore, it is likely that 
dichlorvos will not partition into the stratum corneum as readily as 
chlorpyrifos, however, it is more likely to enter into systemic circulation once 
it has penetrated through the epidermis where it will have a greater affinity 
for the more hydrophilic sections of the skin.  
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To my knowledge, there are few published studies regarding the dermal 
penetration and distribution of dichlorvos in vivo or in vitro. However, the 
toxicity of dichlorvos applied to rat skin in vivo has been previously 
investigated (Luty et al. 1998). In this study, histopathological changes were 
found in lungs, lymph glands, thymus, liver, heart and kidneys of rats 
exposed to dichlorvos for 4 hours a day for 4 weeks at concentrations of 
37.5mg/kg (1/2 LD50),   or 7.5mg/kg (1/10 LD50). This shows that dichlorvos 
can penetrate the skin barrier, however, no information was provided on the 
fate of dichlorvos within the skin itself. The fact that dichlorvos has been 
found to be dermally absorbed suggests that it is a highly important 
compound to study in terms of dermal exposure. The data generated for this 
thesis will provide useful, novel information on the dermal absorption and 
distribution of dichlorvos through human skin in vitro.  
 
1.7.3: Phorate 
Phorate (O, O-diethyl S-ethylthiomethyl phosphorodithioate), is a highly toxic 
organophosphate insecticide. It is a lipophilic chemical (Log p = 3.56) with a 
moderately high molecular weight (260.38) and a very low vapour pressure 
(0.000638 mmHg at 25˚C).  
 
 
Fig.1.9. Structure of Phorate 
 
It would be reasonable to assume that phorate would readily partition into 
the stratum corneum due to its lipophilicity. Despite this potential for rapid 
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penetration into the upper skin layers, it is likely that penetration into the 
viable epidermis and dermis would be slow, as phorate will have a greater 
fugacity for the lipophilic sections of the skin than for the more hydrophilic 
basal skin layers. Therefore, the viable epidermis and dermis are likely to be 
the rate limiting barrier for systemic absorption.  
 
At present, and to my knowledge, no studies have been undertaken to 
investigate the dermal absorption and distribution of phorate in vitro or in 
vivo. Due to the fact that little is known about dermal absorption of phorate, 
and that it is a lipophilic liquid (similar to HD), this was chosen as a chemical 
to investigate to compare with dermal absorption of HD, as well as 
absorption of lipophilic solids such as chlorpyrifos.  
 
1.8: Bioactive agent 
 
1.8.1: Sulphur Mustard (HD) 
Sulphur mustard (2, 2’-dichloroethyl sulphide) is a potent vesicating agent 
that causes blistering of the skin and mucous membranes. It was first used 
as a chemical warfare agent by Germany in the First World War against 
French troops at the Ypres, Belgium in 1917. Subsequently, HD has been 
reportedly used in more than 10 conflicts, including the Iran-Iraq conflicts of 
the 1980’s (Saladi et al. 2005). HD may be absorbed through respiration, 
dermal contact, or through the outer membrane of the eye. It can also be 
absorbed through the GI tract if ingested. HD is a lipophilic chemical (Log p 
= 2.4) with a molecular weight of 159.08. HD also has a low vapour pressure 
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(0.1059), meaning it is a poorly volatile compound which remains in contact 
with the skin for a long time after deposition 
.  
 
Fig.1.10. the structure of sulphur mustard (HD) 
 
 
Due to HD being a lipophilic compound, it preferentially enters the lipophilic 
stratum corneum but is slow to penetrate further into the more hydrophilic 
epidermis and dermis. It has been shown that HD forms a ‘reservoir’ within 
epidermal membranes following dermal exposure in human (in vivo and in 
vitro, and pig skin (Smith et al. 1919, Hattersley et al. 2008). Smith et al. 
1919 showed that, despite rapid absorption of HD into the skin, it was 
possible to extract HD from within the skin by washing with a low-volatility 
solvent followed by washing with soap and water up to 10-15 minutes after 
exposure. This suggested that a large proportion of the dose remained on or 
near the skin surface. The study by Hattersley et al. 2008 confirmed the 
presence of a skin reservoir up to 24 hours after HD exposure to 
dermatomed human and pig skin (0.5mm thickness). The effectiveness of 
solvents to extract the available dose from on, or near the skin surface was 
also demonstrated (using acetonitrile).  
 
The primary toxic effects of HD are localised as a result of its 
physicochemical properties. It has been estimated that 4.5µg/cm2 of HD 
vapour and 20µg/cm2 is sufficient to cause severe blistering of the skin 
surface (Chilcott et al. 2001). This suggests that the mechanism by which 
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HD acts as an incapacitating agent is far more important to understand than 
the ability of HD to cause death. This was further demonstrated by the fact 
that only 2% of soldiers exposed during World War I were killed as a result of 
direct exposure to HD (Maynard et al. 1991).  
 
Previous studies have investigated absorption of HD through human skin in 
vivo and in vitro (Smith et al. 1919, Chilcott et al. 2001, Hattersley et al. 
2008), decontamination of HD from pig ear skin and human skin (Chilcott et 
al. 2001), and also the effect of barrier creams on absorption of HD through 
human skin in vitro, and through pig skin in vitro and in vivo (Chilcott et al. 
2007).  
 
Decontamination of HD from heat separated human skin was found to be 
most effective using fuller’s earth when compared to ambergard or BDH 
granules. However, decontamination of pig ear skin was marginally more 
effective using ambergard when compared with fuller’s earth. Chilcott et al. 
2001 suggested that pig skin may not be a suitable model for 
decontamination of human skin exposed to HD.  
 
Barrier creams have been shown to be effective at preventing, or reducing 
the localised effects of HD on the skin, both in human (in vitro), and in pig (in 
vitro and in vivo). Novel perfluorinated barrier creams in particular, gave up 
to an 18 fold reduction in absorption rate through human skin in vitro, and 
reduced the amount of HD penetrating the skin by 95% (Chilcott et al. 2002). 
Similar results using perfluorinated barrier creams were obtained using pig 
skin in vivo and in vitro (Chilcott et al. 2007). 
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These studies have generally been undertaken from a military perspective in 
terms of the potential of HD as a chemical warfare agent and how to prevent 
or reduce the effects of HD in contact with military personnel. From a 
modelling perspective, methyl salicylate has similar physicochemical 
properties to HD, in terms of molecular weight, vapour pressure and water 
solubility. This has been shown to be a good model for HD absorption in vitro 
through the isolated perfused porcine skin flap, with HD having approximately 
a 1.5 to 2 fold higher absorption rate than methyl salicylate (log p – 2.55, 
molecular weight – 152.15)  (Riviere et al. 2001). 
 
1.9: Current knowledge of dermal chemical absorption from civilian 
perspectives  
 
Few studies have been conducted specifically investigating the dermal 
absorption of chlorpyrifos and the effects of different application vehicles on 
absorption rates in vitro; however, one particular study (Griffin et al. 2000) has 
investigated the effect that donor vehicles (ethanol and commercial 
concentrate) have on the dermal absorption of chlorpyrifos. This study 
indicated that the solvent vehicle used can affect percutaneous absorption of 
pesticides, with absorption from ethanol being slower than from a commercial 
concentrate. Some in vivo studies have also been carried out using human 
volunteers in order to investigate dermal absorption by identifying urinary 
metabolites produced as a result of chlorpyrifos absorption (Mueling et al. 
2005, Griffin et al. 1999). The main urinary metabolite produced from the 
metabolism of chlorpyrifos is 3, 5, 6 trichloropyridinol (TCP). This is mainly 
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carried out by CYP3A4, CYP2D6 and CYP2C19.  Studies using 
lymphoblastoma cells expressing human cytochrome p450 isoforms 
(CYP450) have identified CYP1A2, 2B6, 2C9*1, 2C19 and 3A4 as being the 
main isoforms that are involved in metabolism of chlorpyrifos (Tang et al. 
2001). The metabolism of chlorpyrifos has also been investigated using 
human hepatocytes (Choi et al. 2006). This study has suggested that the liver 
could play an important role in detoxifying chlorpyrifos, as no chlorpyrifos-
oxon was found in the hepatocytes treated with chlorpyrifos and chlorpyrifos-
oxon.  
 
In contrast to modelling civilian scenarios of chemical exposure, some 
studies have been conducted at the defence science and technology 
laboratories (DSTL) using similar approaches to those being implemented in 
this project in order to investigate the dermal absorption of chemicals such 
as VX (Dalton et al. 2006) and HD (Chilcott et al. 2001). The latter of the two 
studies investigated HD absorption, and decontamination procedures for HD 
exposure in both human and pig skin. This showed that pig skin is a good 
model for dermal absorption in humans, but is a relatively poor model for 
testing decontamination systems. The dermal route of absorption is of 
particular importance for sulphur mustard exposure as this induces local skin 
lesions when in contact with the skin.  
 
At present, little or no information exists regarding the dermal absorption of 
chemicals that is specific to environmental exposure of members of the 
public. The majority of studies relate to occupational exposure or to military 
personnel. Much of the available data on dermal absorption of chemical 
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compounds focuses on military exposure to nerve agents and occupational 
exposure to pesticides. The public may be exposed to an accidental release 
of a chemical in the form of a spray or vapour, which may have the potential 
to deposit on the skin surface. This type of exposure scenario can be 
mimicked using a finite dose applied to skin in diffusion cell studies. 
Therefore, it is important to investigate dermal penetration of chemicals from 
a civilian perspective, because it is known that organophosphate compounds 
can penetrate the skin and enter systemic circulation, and so it is important 
to be able to model how significant this route is when compared to other 
routes of exposure, such as inhalation.  
 
Both in vivo and in vitro studies using rodent, pig and human volunteers 
have been carried to investigate the percutaneous penetration of a range of 
different pesticides; however, few studies put their results into a civilian 
context. Absorption of carbamate pesticides, such carbofuran, carbosulfan 
and furathiocarb have been studied with rat skin using static diffusion cell 
systems (Liu et al. 2003) in order to assess the usefulness of in vitro rat skin 
studies for predicting dermal absorption of pesticides. This study showed 
that the amount of pesticide penetrating the skin increased with dose and 
water solubility, although rat skin is not a particularly good model for human 
exposure.  
 
Studies investigating the effect of donor vehicle on in vitro percutaneous 
penetration have been carried out using methyl parathion (Sartorelli et al. 
1997), and lindane, an organochlorine insecticide, both in both in vivo and in 
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vitro (Dick et al. 1997a, Dick et al. 1997b). In the study by Sartorelli et al., it 
was found that significantly higher dermal penetration of methyl parathion 
occurred from a commercial concentrate than from an equivalent dose in 
acetone. The lowest percentage of absorption of lindane through skin was 
also found to be from an acetone vehicle. This may be due to the fact that 
acetone is a highly volatile chemical (vapour pressure 232 mm Hg @ 25˚C), 
and so the dose vehicle may evaporate before the compound of interest has 
the opportunity to penetrate the skin surface.  
 
The effects of donor vehicle on the in vitro dermal absorption of 
epoxiconazole, fenpropimorph and metsulfuron-methyl (all fungicides) 
through human skin have also been investigated (Aust et al. 2007). This 
study showed that absorption profiles from different vehicles (ethanol: water 
and commercial concentrate) were quite similar, with absorption of 
fenpropimorph being greatest, and absorption from metsulfuron-methyl being 
lowest from both donor vehicles.  
 
Some in vivo and in vitro studies investigating dermal absorption of 
Malathion, (another phosphorothioate insecticide) have been carried out 
which are of relevance to civilian scenarios. Firstly, the rate of Malathion 
absorption through skin in vivo has been determined (Boutsiouki et al. 2001). 
In this study, microdialysis was used to assess the dermal penetration of 
Malathion, whilst the effect of local blood flow on systemic uptake of 
Malathion was also investigated. The results from this study showed that 
Malathion can be dermally absorbed, and also that increasing local blood 
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flow can increase systemic uptake. Therefore, cooling of the skin locally to 
where contact is made with the chemical can reduce systemic uptake.  
Another study has investigated in vitro dermal absorption of Malathion from 
cotton fabrics (Wester et al. 1996). This study showed that dermal 
absorption from wetted cotton (to simulate sweating) increased in 
comparison to absorption from dry cotton. The effect of clothing on the 
absorption of chemicals through the skin is an important consideration when 
investigating the effects of chemical exposure in the civilian sector.   
 
1.10: Aims of the study 
The overall aim of this project was to investigate the dermal absorption of a 
range of chemicals (caffeine, benzoic acid, dichlorvos and chlorpyrifos) with 
different physicochemical properties in a variety of vehicles (IPA, IPM and 
PG) in order to assess factors affecting dermal absorption in vitro. The 
absorption profiles of these chemicals can then be ranked against the 
absorption profile of a ‘bioactive agent’ (HD) to identify whether the 
chemicals used in these studies could potentially be used to predict the 
outcomes of exposure to highly toxic chemicals in vivo.  Low dose 
concentrations were used to mimic low level exposure of civilians who may 
be exposed to chemicals on the periphery of an accidental or deliberate 
chemical release. To continue the assessment of risk for chemical exposure 
to civilians, the influence of ‘everyday’ clothing (cotton shirt material) was 
also investigated for the purpose of reducing dermal absorption of chemicals 
in contact with the skin, as the majority of published data are concerned with 
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assessing the protective nature of personal protective equipment and 
clothing designed specifically to protect the skin from chemical exposure.      
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2: General methods 
 
2.1: The flow-through diffusion cell system 
In this system, female human breast skin from mammoplasty was placed 
on the receptor chamber of a PTFE (Teflon) flow through diffusion cell 
(adapted from a Scott-Dick flow through diffusion cell) with the stratum 
corneum facing up so that a test chemical could be applied to the skin 
surface. The skin samples are secured in place by attaching the donor 
chamber to the receptor chamber using threaded nuts. The application 
area for these cells is 0.64 cm2. Prior to the skin being secured in place, 
each skin sample was dermatomed to produce a skin section 
approximately 320µm in depth, containing the stratum corneum, the entire 
viable epidermis, and the upper dermis.  Once the skin samples were 
clamped to the diffusion cell, a receptor media (Minimum Essential Medium 
Eagle (MEM) (supplemented with 2% (w/v) bovine serum albumin (BSA) for 
lipophilic chemicals only) was pumped continuously beneath the skin 
through an electric peristaltic pump (at a flow rate of approximately 
1.5ml/hour) with continuous stirring using magnetic followers placed in the 
receptor fluid chambers, and collected in individual collection tubes with an 
autosampler every hour for 24 hours.  
 
Prior to the application of the test compound to the skin surface, the 
integrity of the skin was assessed by measuring the electrical resistance to 
an alternating current across the skin sample. A solution of 0.9% (w/v) 
saline was applied to the skin surface and left to equilibrate for 30 minutes 
before measurement. As a general rule, the skin was considered to be 
undamaged if the resistance measured was greater than 40kΩ. Cells in 
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which resistance was found to be below 40kΩ were still included in the 
actual experiment, but not used for the purposes of analysis.  The saline 
solution was then removed so the dose could be applied to the surface of 
the skin.  
 
For in vitro dermal diffusion studies, it is possible to use one of two dosing 
regimes; these are infinite dose or finite dose. Infinite dosing involves 
application of a large volume of a chemical at a high concentration so that 
the dose concentration on the skin surface does not deplete significantly 
over time, whereas finite dosing involves application of a small volume of 
chemical to the skin surface to more closely mimic exposure in vivo 
(specific details on dosing for each study is stated in each results chapter).  
 
For some studies where volatile vehicles were used, attachments were 
placed above the donor chamber containing a carbon filter, in order to trap 
any evaporated dose. This ensured maximal recovery of the applied dose 
material for a more accurate mass balance study.   
 
For flow-through diffusion studies undertaken to assess the ability of 
‘everyday’ clothing (cotton shirt) to reduce absorption of organophosphates, 
the clothing was held in place above the skin surface by using the donor 
chamber attachment more commonly used to contain carbon filters to trap 
volatile chemicals. By screwing the donor chamber attachment over the 
cotton shirt material (1cm2), a 1mm air gap (approximate) was created 
between the skin surface and the clothing. This was done deliberately to 
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mimic how clothing fits in ‘real life’, as usually clothing is not completely 
skin-tight. Once the clothing had been screwed into place, the dose 
(10µl/cm2) was applied to the clothing, which resulted in the clothing 
‘sticking’ to the skin surface briefly while the dose spread out over the 
clothing. Upon removal of the clothing, the donor chamber attachment was 
removed, and the clothing was placed in a large scintillation vial containing 
10ml of scintillation fluid. This was left for at least 36 hours to allow the 
chemical to be desorbed.    
 
At the end of the experiment, the collection tubes containing receptor fluid 
samples taken hourly were capped and frozen. Tissue swabs using 
aqueous teepol (3% v/v) were used to wash both the skin surface/donor 
chamber (to measure the amount of test compound remaining unabsorbed) 
and the receptor fluid chamber in triplicate. Tape strips were also taken in 
order to separate the stratum corneum from the rest of the skin sample to 
identify how much of the applied compound remained in the stratum 
corneum, which could potentially act as a reservoir for further systemic 
penetration over longer periods of time. Usually no more than 15 tape strips 
were taken before the stratum corneum completely separated from the rest 
of the epidermis. Once the tape strips had been taken, the remaining skin 
sample was added to 2ml of 1.5mol/L potassium hydroxide in ethanol: 
water (4:1 v/v) in a scintillation vial and left overnight to digest (providing 
the compound was radiolabelled). 
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If the compound applied to the skin was radiolabelled, samples from the 
receptor fluids, tissue swabs, carbon filters, skin digests and tape strips 
were added to 10ml scintillation fluid (Optiphase HiSafe 3, Perkin Elmer) 
and radioactivity measured on a liquid scintillation counter (Packard Tri-
Carb 2100TR liquid scintillation analyser). If the compound was not 
radiolabelled (dichlorvos and phorate), then the samples collected were 
analysed using gas chromatography-mass spectrometry (GC-MS). 
 
2.1.2: Scintillation counting and data interpretation 
Samples obtained from studies using 14C labelled chemicals were analysed 
using a scintillation counter. The liquid scintillation counter measures 
ionising radiation emitted from samples placed within the counter. The 
samples produced in each study were added to a liquid scintillation 
‘cocktail’ containing benzene and scintillant additives. Beta particles 
emitted from each sample transfer their energy to solvent particles within 
the scintillation fluid, which in turn transfer energy to the scintillant 
molecules. It is these molecules which become ‘excited’ and disperse the 
energy created by fluorescing.   
 
The data produced by the liquid scintillation counter is interpreted as 
disintegrations per minute (DPM). The DPM corresponds to the number of 
atoms that have decayed in one minute. The DPM measured in the sample 
can be converted into an absolute amount of the test compound of interest 
with respect to the specific activity and the applied dose, since the specific 
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activity relates to the number of decays per second, per amount of 
substance.  
 
The average DPM of 5 dose solutions was taken to be the amount of test 
compound applied to each skin surface, with the total amount recovered 
being relative to this average dose for each individual diffusion cell. Each 
receptor fluid sample was measured in whole and added to 10ml 
scintillation fluid to avoid the potential for quenching (loss of fluorescence). 
This can occur if too much radiolabelled sample is added to a volume of 
scintillation fluid leading to reduced efficiency of the scintillation fluid 
(dilution quenching). The DPM obtained from each receptor fluid sample 
was converted into a percentage of the total dose applied and then plotted 
as a cumulative absorption curve against time. From this cumulative 
absorption profile, it was possible to calculate the maximum absorption rate 
(from the linear portion of the curve) and also the lag time. The DPM 
remaining on the skin surface, within tape strips, in the skin membranes 
and absorbed in the receptor fluid over 24hrs were measured as a 
percentage of the applied dose to determine the dose distribution in all 
compartments.   
 
2.1.3: Chemicals used in flow through diffusion studies 
Isopropanol (propan-2-ol) 99.8% (purchased from Fisher Scientific). 
Isopropyl myristate Purum,>98% (Sigma-Aldrich) 
Propylene glycol, Puriss >99.5% (Sigma-Aldrich) 
4-14C Testosterone in ethanol (specific activity 1.98MBq/mmol), (NEN, 
Boston, MA)  
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1-methyl-14C Caffeine, specific activity 1.9GBq/mmol (Perkin Elmer Life 
Sciences, Boston, MA)  
14C Benzoic acid (>95% purity) purchased from Sigma Aldrich 
14C Chlorpyrifos (pyridine-2 6-14C), specific activity 370-740MBq/mmol, was 
purchased from American Radiolabelled Chemicals Inc.   
Dichlorvos (1g), purchased from Greyhound Chromatography and Allied 
Chemicals, Birkenhead.  
Deuterated dichlorvos (dimethyl - D6), was purchased from Chem Service 
Inc, West Chester, PA, USA.  
 
Receptor fluid was made up of MEM (Sigma-Aldrich) at a concentration of 
9.6g/l in sterilised water. Sodium hydrogen carbonate (NaHCO3) (Sigma-
Aldrich) was also added to a final concentration of 2.2g/l, along with 
Gentamycin (Sigma Aldrich), at a concentration of 200µg/l. When using 
particularly lipophilic compounds such as chlorpyrifos, BSA was added to 
the receptor fluid at 2% w/v. The pH of the media was adjusted to 7.4 using 
1M hydrochloric acid (Fisher Scientific).  
 
Potassium hydroxide (Sigma-Aldrich) added to 4:1 ethanol: water (v/v) at a 
concentration of 1.5M was used to solubilise skin samples prior to addition 
of scintillation fluid ready for scintillation counting. Teepol (purchased from 
VWR International) was used at a concentration of 0.5% in warm water to 
remove excess dose from the skin surface and also for the receptor 
chamber swabs. The scintillation fluid used was Optiphase ‘HiSafe III’ 
(purchased from Fisher Scientific).   
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2.2: Static cell diffusion experiments  
Static diffusion cell studies were carried out at dstl, and accounted for all of 
the studies conducted using sulphur mustard and phorate. Static cells are 
widely used to predict in vivo outcomes for dermal absorption of a variety of 
different chemical compounds.  
 
Static diffusion cell experiments were conducted in order to identify the dermal 
absorption profile of sulphur mustard (HD) through full thickness human skin 
compared with absorption through full and split thickness pig abdomen skin. 
Also, an investigation was undertaken to identify the 24-hour dermal 
absorption profile of phorate through split thickness pig abdomen skin. 
 
2.2.1: Chemicals used in static diffusion studies 
Sulphur Mustard (synthesised by Dstl).  
Phorate 0.1g (purchased from QMX laboratories). 
Deuterated phorate D10 (O, O-diethyl –d10) (QMX Laboratories)  
Ethanol, 99.5% absolute (Sigma-Aldrich) 
HPLC grade Methanol (Sigma-Aldrich) 
Isopropanol (propan-2-ol) (Fisher Scientific)  
Soluene 350 (Perkin Elmer)  
‘Ultima gold’ Scintillation fluid (Perkin Elmer) 
 
The receptor fluid used in these studies was made by mixing ethanol with 
water (50:50 v/v). Each receptor fluid chamber was filled with 5ml of pre-
warmed receptor fluid. Each time an aliquot (20µl) was taken from the 
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receptor fluid during the course of the experiment, it was replaced with the 
equivalent amount of fresh receptor fluid.  
 
Skin samples were digested in 20ml of soluene (an organic based 
solubilisation fluid formulated with toluene) for at least 72 hours, or until the 
skin was completely dissolved. Aliquots from the skin digests were taken 
(20µl) and added to scintillation fluid (5ml) ready for analysis. Cotton wool 
swabs of the skin surface were soaked in 20ml of isopropanol (IPA) for at 
least 72 hours, 20µl aliquots of these were also added to 5ml scintillation fluid 
for analysis.   
 
2.2.2: Human breast skin preparation 
Human breast skin samples were obtained from four skin donors (Biopredic 
International) and used in experiments conducted at Dstl – Porton Down. Prior 
to studies being commenced, all human skin samples were prepared by 
removing any excess subcutaneous fat and blood from the skin before being 
cut into sections using scalpel blades and frozen at -80°C in aluminium foil 
ready for immediate use in each experiment. All human breast tissue was 
used as full thickness for the purpose of static diffusion experiments. 
 
 2.2.3: Pig skin sample preparation 
Five domestic female pigs (5 week old, weanling pigs, supplied by Dstl) were 
sacrificed and the abdomen skin removed from each in order to be used in the 
remaining three static diffusion studies to be conducted at Dstl.  The skin from 
each pig abdomen was cut into sections and prepared as full or split 
thickness. The split thickness skin was dermatomed using a hand-held, gas 
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powered dermatome to approximately 500 microns in thickness. This 
thickness was used in order to prevent leakage of receptor fluid through to the 
stratum corneum due to the hair follicle depth in pig skin. The skin was then 
wrapped in aluminium foil and stored at -80°C separately until needed for 
each experiment. The remaining skin was prepared by removing excess fat 
and muscle tissue from the subcutaneous section of the skin. The skin was 
also shaved using electric hair clippers in order to reduce the amount of hair 
to which the applied compound could stick to and prevent skin contact. The 
skin was then wrapped in aluminium foil and frozen under the same conditions 
as the dermatomed skin.  
 
2.2.4: Experimental procedure 
Prior to the start of each experiment, skin samples were removed from the 
freezer and allowed to defrost naturally at room temperature. Static diffusion 
cells made from glass (5ml receptor chamber, 2.54cm2 receptor chamber 
surface area) were used in each experiment. Skin samples were carefully 
placed stratum corneum side up, directly above the receptor chamber, and 
then clamped firmly in place with the donor chamber compartment. Once the 
skin was held in place, the receptor chamber was filled with 50:50 v/v ethanol: 
water using a syringe and the volume of each receptor fluid chamber was 
recorded separately to account for any differences between individual cells. 
The diffusion cells were set up on heated plates set to 32 ± 1°C within a fume 
cupboard. Each heated plate (4 in total, incorporating 6 static cells each) was 
mounted on a magnetic stirring plate. Magnetic stirrers were placed in each 
receptor fluid chamber and the skin samples were then left overnight in the 
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static cells to equilibrate. On the morning of the experiment, the receptor fluid 
in each receptor fluid was replaced with fresh ethanol: water that had been 
pre-warmed in the water bath at 37°C.  
 
The test compound of interest was applied to the skin surface and left in 
contact for the necessary amount of time required for the experiment (24 
hours or 1 hour). At the initial time of application of the test compound to the 
skin, a 20µl sub-sample of the receptor fluid was taken, placed into individual 
10ml scintillation fluid vials, and replaced with 20µl of fresh media. This 
process was repeated at 30 minutes after application of the test compound, 
and then hourly for the first 6 hours of the experiment. Following on from this, 
sub-samples of media were then taken at 20, 22 and 24 hours after the test 
compound was administered to the skin surface.  
 
For the purposes of the clothing studies, the cotton shirt material was cut into 
squares to fit the application area (2.54cm2). Prior to the clothing being placed 
over the skin, a 1mm x 1mm stainless steel washer was placed on the skin 
surface to provide a 1mm air gap between the clothing and the skin surface. 
The clothing was placed on top of the washer before the dose (20µl) was 
applied to the clothing. Once the dose had been administered, a stainless 
steel weight was placed over the top of the clothing in order to keep it in place 
above the skin surface. Upon removal of the clothing after 1 hour exposure, 
the stainless steel weight was removed and swabbed with 5% soap solution to 
remove any dose that may have made contact with the weight. The clothing 
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was placed in a glass wheaton vial containing 20ml of HPLC grade methanol, 
and left to be desorbed for at least 24 hours.  
 
After the final aliquot of receptor fluid was taken at 24 hours after application, 
the experimental procedure was terminated. This involved swabbing the skin 
surface with cotton wool soaked in 5% soap solution, and then repeating this 
step with dry cotton wool to remove any remaining dose from the skin surface. 
The two swabs taken for each skin sample were then put into 20ml glass 
wheaton vials and 20ml of HPLC grade methanol was added to each vial to 
allow the dose recovered on the swabs to be desorbed. The remaining skin 
from each static cell was also put into individual 20ml glass wheaton vials, 
with 20ml of soluene added to each. The cotton wool swabs and skin samples 
were then left for at least 72 hours until the skin had dissolved. Following this 
period, 20µl samples from each glass wheaton vial were added to labelled 
scintillation fluid vials filled with 10ml of ‘ultima gold’ scintillation fluid (Perkin 
Elmer). 
 
2.3: Gas chromatography-mass spectrometry (GC-MS) 
GC-MS is a method that can be implemented to identify and quantitate 
substances within a test sample. The gas chromatograph implements a 
capillary column, which separates molecules within a sample as they travel 
along the column following injection through a high temperature sample 
injector. The separated molecules take different amounts of time to be eluted 
from the GC column; this is called the retention time. As a result of these 
molecules having different retention times due to their different molecular 
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properties, the mass spectrometer (MS) can capture, ionise and detect each 
molecule separately. 
 
The ionisation method used to analyse samples of dichlorvos obtained from 
dermal penetration studies was electron impact ionisation (EI). In this method, 
sample molecules collide with high energy electrons at high speed. These 
collisions cause the sample molecules to become fragmented and ionised. 
These fragments are then detected based on their mass to charge ratio. 
Results obtained were analysed by selected ion monitoring (SIM). This 
method of analysis involves selecting the most abundant fragments from a 
compound of interest to monitor. This is advantageous over a full scan of all 
fragments, because SIM reduces the detection limit by only looking for 
selected ions. This also allows more scans per second to take place and 
reduce the analysis time. To make sure that the fragments being detected 
were the correct ones, samples of dichlorvos were spiked with a known 
concentration of deuterated (D-6) dichlorvos as an internal standard. By 
identifying the ion fragments from the deuterated dichlorvos, it was possible to 
compare the ion ratios from the dichlorvos in each sample against a known 
reference standard.  
The GC-MS conditions used to analyse samples of dichlorvos was as follows: 
Column: 30m x 0.25mm x 0.25ìm Rtx-5 
GC Conditions: 
Injector Temp: 220˚C 
Oven Temp Programme: 
50˚C hold 1 min: 30˚C/min to 250˚C hold 1min 
Mass Spec Conditions: 
Mass Spec: DSQ II Single Quadrupole 
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Operating Mode: Electron Impact Ionisation - EI, Selected Ion Monitoring 
SIM Ions: 
Dichlorvos: 220, 185, 109 
Dichlorvos D-6: 226, 191, 115 
 
2.3.1: Sample preparation 
1ml aliquots of each receptor fluid sample were taken, to which 10µl of 
internal standard (deuterated dichlorvos (d6) was added at a concentration of 
20ng/ml. Ethyl acetate (1ml) was then added to each individual sample and 
shaken vigorously for 10 seconds. Each sample was then thoroughly vortexed 
for 30 seconds and centrifuged at 1500rpm for 5 minutes. The supernatant 
was then removed from each sample and added to a glass vial ready for 
injection on the GC-MS. For the skin samples, each section of skin was cut 
into small pieces and homogenised in 1ml of ethyl acetate. Skin surface 
swabs were soaked in 2ml of water for 24 hours and vortexed thoroughly for 
30 seconds. Tissues were then squeezed to remove any excess fluid. The 
excess fluid was then added to 1ml of ethyl acetate and the same procedure 
as mentioned above for the receptor fluid samples was carried out.  Standards 
were produced to run on the GC-MS prior to analysis of the samples, ranging 
in concentration from 200ng/ml to 1ng/ml. All samples collected were diluted 
accordingly to fit within this range for analysis. An example of a dichlorvos 
calibration standard curve is shown in figure 2.1. 
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Fig 2.1. Dichlorvos calibration standard curve obtained from GC-MS analysis 
 
The sample standards generated were analysed on the GC-MS prior to 
experimental samples analysis. Once the experimental samples had been 
analysed, it was then possible to extrapolate the results to the standard curve 
of known concentrations of dichlorvos (shown in figure 2.1). This made it 
possible to ascertain the concentration of dichlorvos in each experimental 
sample. In some cases, samples required dilution to fit to into the standard 
curve range, and in these cases, the result from the GC-MS were multiplied 
up to give the total concentration present in the whole sample recovered. 
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Figure 2.2. Dichlorvos SIM peak following GC-MS analysis
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2.4: Liquid Chromatography- tandem mass Spectrometry (LC-MS-MS) 
 
LC-MS-MS was used to analyse receptor fluid samples containing phorate 
obtained at Dstl. LC-MS-MS was implemented due to the complex nature of 
the samples being processed in order to identify ion fragments from the 
sample.  
 
Liquid chromatography – tandem mass spectrometry was carried out on a 
ThermoFinnigan TSQ Quantum triple quadrupole instrument fitted with a 
Surveyor LC pump and autosampler. The mass spectrometer was operated in 
selected reaction monitoring (srm) mode with electrospray ionisation. 
Chromatography was performed on an ACE 3 C8, 50 x 2.1 mm, 3µm, column 
with a mobile phase consisting of 0.02 M ammonium formate in water / 
methanol 25:75 at a flow rate of 0.2 ml/min. The column was maintained at 
ambient temperature. 
 
Electrospray ionisation conditions were as follows: spray voltage 3 kV, 
capillary temperature 300 °C, sheath gas (nitrogen)  50 (arbitrary units), 
auxiliary gas (nitrogen) 15 (arbitrary units). The mass spectrometer was set up 
to monitor the srm transitions m/z 261.1 → 75.2 for phorate and m/z 271.1 → 
75.2 for d10-phorate, 0.2 sec each. Scan width was 0.5Da, collision energy 18 
eV and collision gas (argon) pressure 1.0 mTorr. Instrument tuning was 
optimised on m/z 261 from phorate. 
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2.4.1: Receptor fluid samples (Phorate) 
 
Receptor fluid samples consisted of 20µl of receptor fluid (ethanol / water 
50:50 v/v) collected in glass autosampler vials. To the receptor fluid sample, 
20µl of d10-phorate internal standard solution (0.5ng/µl in ethanol / water 
50:50 v/v) was added and made up to 0.5ml by addition of 460µl of ethanol / 
water 50:50 (v/v). Samples were analysed by LC-MS-MS with electrospray 
ionisation, with each sample being injected in triplicate. Quantitation of ions 
was performed against calibration curves constructed from analysis of 
standard solutions of phorate prepared as for samples. Calibrations were 
linear over the ranges 0.02 to 1ng/µl (R2 0.997) and 0.1 to 25ng/µl (R2 0.999). 
The higher mass range calibration was used for quantitation of samples with 
concentrations exceeding 1ng/µl determined from the lower range calibration. 
 
2.4.2: Skin surface decontamination samples in IPA 
 
 Skin surface decontamination swabs (cotton wool desorbed in IPA) were 
diluted with ethanol / water 50:50 (v/v) to bring the concentration within the 
calibration range. Final dilutions contained d10-phorate internal standard at a 
concentration of 10ng/ml. Samples were analysed by LC-MS-MS with 
electrospray ionisation, each sample being injected in duplicate. Quantitation 
was performed against standard solutions of phorate, containing 10ng/ml of 
internal standard, over the range 0.5 to 100ng/ml (R2 0.999). 
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2.4.3: Skin samples in soluene 
 
100µl of each skin digest sample was transferred to a 10ml Pyrex screw-
capped tube and 1.9ml of ethanol / water 50:50 (v/v) was added. The tube 
was centrifuged at 5000xg for 10 min and 100µl of supernatant transferred to 
a glass autosampler vial. 100 µl of d10-phorate solution (1µg/ml) and 800µl of 
ethanol / water 50:50 (v/v) were added. Samples were analysed by LC-MS-
MS with electrospray ionisation.  
 
2.5: Statistical Analysis 
Data obtained for dermal absorption and distribution of chemicals were 
expressed as mean ± sem. Mass balance data were expressed as the 
percentage of the total applied chlorpyrifos dose found at each test site 
(receptor fluid, skin digest (penetrated dose), tape strip (stratum corneum), 
unabsorbed (skin surface) and carbon filter).   Comparison of means was 
performed using one-way ANOVA followed by Tukey’s posthoc test for 
multiple comparisons using SPSS (SPSS Ltd). Significance was defined as 
p<0.05.
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3: Dermal absorption of model compounds in vitro  
 
3.1: Introduction 
Due to the high toxicity of many organophosphate compounds and chemical 
warfare agents that individuals may become exposed to as a result of 
accidental or deliberate release into the atmosphere, it is important to 
investigate the dermal absorption of less harmful compounds which may 
potentially be useful as surrogate or marker compounds for exposure to more 
harmful compounds based on their varying physicochemical properties.  The 
approach was to investigate dermal absorption of model chemicals and to 
then relate these to surrogate chemicals of interest, and to then finally relate 
both model and surrogate chemicals to absorption of bioactive agents.  
 
The compounds chosen in these initial studies to investigate the dermal 
absorption from infinite and finite saturated doses were caffeine and benzoic 
acid. As mentioned in sections 1.5.2 and 1.5.3 of chapter 1 respectively. 
Caffeine and benzoic acid have been used in the laboratories at Newcastle 
University (van der Sandt et al. 2004, Wilkinson et al. 2006) as marker 
compounds for investigating intra and inter-laboratory differences, as well as 
intra, and inter-individual differences when using in vitro absorption 
techniques. As a result of this, the absorption profiles of these compounds are 
already well established, and so these were ideal model compounds to use in 
these studies, and also to ensure that the in vitro diffusion methods being 
implemented throughout this project were capable of producing reliable data. 
Generating data on dermal absorption of model compounds also makes it 
easier to rank the chemicals of interest (surrogates and bioactive agents). 
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Caffeine and benzoic acid have different physicochemical properties. Caffeine 
is a hydrophilic (Log p = -0.07) compound with a moderate molecular weight 
(194.19). Benzoic acid however, is a lipophilic compound (Log p = 1.87), with 
a relatively low molecular weight (122.12).  As molecular weight and 
lipophilicity are major factors that can affect dermal penetration, studying 
these two compounds could highlight any potential differences in absorption 
that could be caused by differences in chemical properties.  
 
In parallel to investigating the influence of chemical property on dermal 
absorption, the effect of different application vehicles was also investigated. 
The application vehicles chosen were isopropanol (IPA), and propylene glycol 
(PG). IPA is an amphipathic solvent (Log p = 0.05) with a high vapour 
pressure (45.4mmHg at 25˚C) and will volatilise rapidly from the skin surface. 
This makes it a useful solvent to use in dermal penetration studies, as it can 
potentially more closely mimic ‘real life’ exposure to droplets of chemicals 
released into the atmosphere as a spray or a vapour. In contrast, PG is a 
hydrophilic solvent (Log p = -0.92) and has a low vapour pressure 
(0.129mmHg at 25˚C). Due to its low volatility, PG is likely to remain in contact 
with the skin for longer than IPA when applied to the skin surface. Also, PG 
has been reported to be a penetration enhancer (Williams and Barry, 2004, 
Duracher et al. 2009). The mechanism for penetration enhancement by PG is 
thought to be that PG enters the stratum corneum and modifies lipid and 
protein structures within the skin, resulting in reduced barrier integrity of the 
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stratum corneum. This is known as the ‘lipid protein partitioning theory’. 
(Barry, 1988, Bach and Lippold, 1998, Barry, 2001).  
 
3.2: Aims 
The purpose of these studies was to identify the finite and infinite dose dermal 
absorption profiles of caffeine and benzoic acid through dermatomed human 
breast skin. This was carried out with the aim of producing data to allow 
ranking of surrogate and bioactive agents to be tested after generating dermal 
absorption data of model compounds.  
 
3.3: Results  
 
3.3.1: 24 hour exposure of dermatomed human breast skin to an infinite 
dose of 14 C caffeine, using IPA and PG as vehicles 
 
Methods 
For the purpose of this study, 11 flow-through diffusion cells were used 
containing dermatomed human breast skin samples from two skin donors. 
Caffeine was applied to the skin in 2 different vehicles, with 5 cells exposed to 
caffeine as a saturated solution  in IPA (10mg/ml), and 6 cells exposed to 
caffeine as  saturated solution in PG (12mg/ml). The dose applied was infinite, 
with 1ml/cm2 of the dose applied to the skin surface. The exposed area of skin 
measured 0.64cm2 in the flow-through diffusion cell, so 640µl of caffeine in 
IPA or PG was applied to the skin surface. Doses were left in contact with the 
skin for 24 hours before termination of the study. Receptor fluid samples and 
the remaining dose on the skin surface was analysed by scintillation counting. 
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Results 
The cumulative absorption profile of caffeine from an infinite dose applied to 
dermatomed human breast skin for both IPA and PG vehicles is shown in 
figure 3.1. It can be seen that the absorption profiles from IPA and PG differ, 
with the profile of caffeine absorbed from the PG vehicle remaining linear 
throughout the 24 hour exposure period. Caffeine applied in IPA was slower to 
penetrate through the skin initially when compared with absorption from PG. 
Despite this, and because absorption of caffeine from PG was greater up until 
21 hours after exposure, the total amount of caffeine absorbed from the IPA 
vehicle was greater after 24 hour exposure (523 ± 225.5µg/cm2) compared 
with absorption from PG (446 ± 38.6µg/cm2). However, there was no 
statistically significant difference in total absorption between the two vehicles 
due to wide interindividual variability (following 1-way ANOVA analysis).  
 
As caffeine was applied as an infinite, saturated dose in both vehicles, it was 
possible to calculate the maximum absorption (flux) rate of caffeine from IPA 
and PG. The maximum flux was highest when caffeine was applied in IPA 
(49.7 ± 20.5µg/cm2/h, 19-24 hours), compared with 18.8 ± 3.4µg/cm2/h from 
PG (1-24 hours). Despite absorption being greatest from the IPA vehicle, the 
lag time was shorter for caffeine absorption from the PG vehicle (1.7 ± 1.1 
hours) compared with absorption from the IPA vehicle (12 ± 2.6 hours) (shown 
in table 1).  
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Fig.3.1. 24 hour cumulative absorption profile of an infinite dose of 14C caffeine. 
Values for caffeine applied in IPA are mean ± SEM of 5 cells (2 donors). Values for caffeine 
applied in PG are mean ± SEM of 6 cells (2 donors). Skin sections were mounted in flow 
through cells with an exposed area of 0.64cm2. Caffeine in IPA was applied to the skin 
surface as a saturated dose (1ml/cm2) at a concentration of 10mg/ml.  Caffeine in PG was 
also applied as an infinite dose, at a concentration of 12mg/ml. Each 640µl (1ml/cm2) dose 
in both IPA and PG contained approximately 1x105 dpm. 
 
 
 
 
Dose 
Flux 
(µg/cm2/h) 
Kp x 10-3 
(cm/h) 
Lag Time 
(h) 
Linear 
range 
Caffeine in IPA (infinite 
dose) 49.7 ± 20.5* 42.7 ± 19.1 12.1 ± 2.6* 19-24 
Caffeine in PG (infinite 
dose) 18.8 ± 3.4 16.8 ± 8.3 1.7 ± 1.1 1-24 
 
Table 1. Steady state absorption rates, partition coefficients and lag times of 
caffeine applied to the skin surface as infinite doses in IPA and PG. values are 
means ± SEM. A single asterisk denotes a significant difference between vehicles (p<0.05 
with one way ANOVA).  
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Fig.3.2. Dose distribution of 14C caffeine applied as an infinite dose to 
dermatomed human breast skin. Values are mean ± SEM of 5 cells (2 donors) for IPA, 
and values for PG are mean ± SEM of 6 cells (2 donors). The absorbed dose accounts for 
the total amount recovered in the receptor fluid after 24hr exposure. The unabsorbed dose 
was recovered by swabbing the skin surface with alternate wet (0.5% soap solution) and dry 
tissue pieces (3 wet and 3 dry swabs). The total is the sum of the absorbed and unabsorbed 
recoveries.  
 
 
 
The distribution profile of caffeine applied as a saturated, infinite dose in IPA 
or PG (figure.3.2), shows that the amount of caffeine absorbed from either 
vehicle accounted for only a small proportion of the dose applied to the skin 
surface. From the IPA vehicle, 5.2 ± 2.1% of the dose of caffeine was 
absorbed, whereas 2.5 ± 0.6% of the dose from PG was absorbed. The 
majority of the applied dose remained on the skin surface after 24 hour 
exposure (81.8 ± 22.5% from IPA and 86.8 ± 3.2% from PG respectively).  
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3.3.2: 24 hour exposure of dermatomed human breast skin to a finite 
dose of 14C caffeine using IPA and PG as vehicles 
 
Methods 
For this study, 12 flow-through diffusion cells were used, with 6 cells dosed 
with caffeine saturated in IPA (10mg/ml), and 6 cells dosed with caffeine 
saturated in PG (12mg/ml). A dose volume of 10µl/cm2 was used to give a 
finite exposure. The dose was kept in contact with the skin surface for 24 
hours, before terminal procedures were carried out for dose distribution 
analysis by scintillation counting. 
 
Results 
The absorption profile of caffeine applied in IPA and PG vehicles as a 
saturated finite dose can be seen in figure 3.3. The absorption profiles differ 
more greatly between vehicles than for the infinite dose study. The absorption 
rate from IPA was initially very fast, but decreased after 3-4 hours, whereas 
absorption from PG was initially slower, and continued to increase up to 24 
hours after exposure despite finite dosing. The difference in absorption was 
reflected in the maximum flux rates, with 3.3 ± 0.9µg/cm2/h  absorbed from 
IPA and 0.3 ± 0.1µg/cm2/h from PG respectively (table 2). Despite the 
absorption profiles of caffeine differing between vehicles, the total amount 
absorbed from both vehicles after 24 hour exposure were similar, with 16.3 ± 
2.7µg/cm2 being absorbed from IPA and 16.1 ± 4.3µg/cm2 from the PG 
vehicle respectively.  
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From the distribution profile shown in figure 3.4, it can be seen that the 
distribution of caffeine applied in both IPA and PG is comparable following 24 
hour exposure. Similarly to the distribution from the infinite dose study in 
shown in figure 3.2, the majority of the applied dose from both vehicles was 
remaining on the skin surface after 24 hour exposure (69.8 ± 3.6% from IPA 
and 70.6 ± 6.7% from PG respectively). Slightly more of the applied dose was 
found within the skin from the PG dose (4.9 ± 1.8%) compared with IPA (3.4 ± 
0.7), although this was not statistically significant following 1-way ANOVA.  A 
small proportion (2 ± 0.3%) of the applied dose was also found remaining in 
the stratum corneum (tape strips) from both vehicles. 
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Figure.3.3. 24 hour cumulative absorption profile of a finite dose of 14C 
caffeine. Values for caffeine applied as a finite dose in IPA are mean ±SEM for 6 cells (2 
donors), and 6 cells (2 donors) for caffeine applied as a finite dose in PG. 14C caffeine 
(containing approximately 1x105 DPM) was applied to the skin surface in a finite dose 
(10µl/cm2) at a concentration of 10mg/ml in IPA and 12mg/ml in PG. 
 
 
 
 
 
Dose 
Flux 
(µg/cm2/h) 
Kp x 10-3 
(cm/h) Lag Time (h) Linear range 
Caffeine in IPA (finite 
dose) 3.3 ± 0.9* 2.7 ± 1.1 0.8 ± 0.3 1-3 
Caffeine in PG (finite 
dose) 0.3 ± 0.1 3.2 ± 1.0 4.1 ± 1.5* 4-16 
 
Table 2. Steady state absorption rates, partition coefficients and lag times of 
caffeine applied to the skin surface as a finite dose in IPA and PG. values are 
means ± SEM. A single asterisk next to a figure denotes that it is significantly different from 
the remaining figure in the same column (p<0.05 with one way ANOVA).  
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Fig.3.4. Dose distribution of 14C caffeine applied as a finite dose to dermatomed 
human breast skin. Values are mean ± SEM of 6 cells (2 donors) for IPA, and values for 
PG are mean ± SEM of 6 cells (2 donors). The absorbed dose accounts for the total amount 
recovered in the receptor fluid after 24hr exposure. The skin digest represents the amount 
recovered from the viable epidermis and dermis after tape-stripping. The unabsorbed dose 
was recovered by swabbing the skin surface with alternate wet (0.5% soap solution) and dry 
tissue pieces (3 wet and 3 dry swabs). Charcoal filters were placed above the skin surface 
to trap any volatilised dose. Tape strips (no more than 15 per cell) were taken to remove the 
stratum corneum for assessment as a separate compartment to the remaining skin.  The 
total is the sum of the absorbed and unabsorbed recoveries.  
 
 
 
 
 
 
3.3.3: 24 hour exposure of dermatomed human breast skin to an infinite 
dose of 14C benzoic acid, using IPA and PG as vehicles 
 
 
Methods 
For this study, 13 flow-through diffusion cells were used, with 6 cells dosed 
with benzoic acid in IPA (35mg/ml) and 7 cells were dosed with benzoic acid 
in PG (24mg/ml). The volume applied to the skin surface was 1ml/cm2 to give 
an infinite dose exposure. Each dose was left in contact with the skin for 24 
hours before terminal procedures were carried out to analyse the distribution 
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of benzoic acid (receptor fluids and unabsorbed dose) by scintillation 
counting. 
 
Results 
The cumulative absorption profile of benzoic acid applied as a saturated 
infinite dose in 2 vehicles (IPA and PG) is shown in figure 3.5. Absorption of 
benzoic acid from IPA was fast from 3 to 5 hours of exposure before tailing off 
up to 24 hours, despite infinite dosing. However, absorption from PG gave a 
more classical infinite dose profile, with absorption continuing at an 
approximately linear rate throughout the 24 hour exposure period.   
 
Despite the fact that absorption after 24 hours was greater from PG than from 
IPA (1.8 ± 0.7mg/cm2 and 0.7 ± 0.1mg/cm2 respectively), the lag time was 
much shorter from IPA (2.3h ± 0.9) than from PG (9.1h ± 2.1), and the 
apparent maximum absorption rate was approximately 1.5 times greater from 
IPA (180.6 ± 60.8µg/cm2/h) than from PG (120.8 ± 40.3µg/cm2/h).  
 
The distribution analysis shown in figure 3.6 also indicates the differences in 
the amount of benzoic acid absorbed from both vehicles after 24 hour 
exposure. However, it can also be seen that, similarly to the distribution of 
caffeine after 24 hour exposure, the vast majority of the applied dose was 
remaining on the skin surface (88.5 ± 18.9% from IPA and 83.4 ± 12.3% from 
PG).  
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Figure.3.5. 24 hour cumulative absorption profile of an infinite dose of 14C 
benzoic acid. Values for benzoic acid applied as an infinite dose in IPA are mean ±SEM 
for 6 cells (2 donors), and 7 cells (2 donors) for benzoic acid applied as a finite dose in PG. 
14C benzoic acid (containing approximately 1x105 DPM) was applied to the skin surface in 
an infinite dose (1ml/cm2) at a concentration of 35mg/ml in IPA and 24mg/ml in PG. 
 
 
 
Dose 
Flux 
(µg/cm2/h) 
Kp x 10-3 
(cm/h) 
Lag Time 
(h) 
Linear 
range 
Benzoic acid in IPA 
(infinite dose) 180.6 ± 60.8 181.4 ± 50.5 2.3 ± 0.9 3-6 
Benzoic acid in PG (infinite 
dose) 120.8 ± 40.3 118.1 ± 30.2 9.1 ± 2.1* 14-24 
 
Table 3. Steady state absorption rates, partition coefficients and lag times of 
benzoic acid applied to the skin surface as an infinite dose in IPA and PG. 
values are means ± SEM. A single asterisk next to a figure denotes a significant difference 
from the remaining figure in the same column (p<0.05 with one way ANOVA).  
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Fig.3.6. Dose distribution of 14C benzoic acid applied as an infinite dose to 
dermatomed human breast skin. Values are mean ± SEM of 6 cells (2 donors) for IPA, 
and values for PG are mean ± SEM of 7 cells (2 donors). The absorbed dose accounts for 
the total amount recovered in the receptor fluid after 24hr exposure. The unabsorbed dose 
was recovered by swabbing the skin surface with alternate wet (0.5% soap solution) and dry 
tissue pieces (3 wet and 3 dry swabs). The total is the sum of the absorbed and unabsorbed 
recoveries.  
 
 
 
 
 
3.3.4: 24 hour exposure of dermatomed human breast skin to a finite 
dose of 14 C-labelled benzoic acid, using IPA and PG as vehicles 
 
 
Methods 
For this study, 11 flow-through diffusion cells were used. A total of 6 cells 
were dosed with benzoic acid in IPA (35mg/ml), and 5 cells were dosed with 
benzoic acid in PG (24mg/ml). Skin samples were taken from 2 individual 
donors, and the volume of dose applied to the skin surface was 10µl/cm2 to 
give a finite exposure. Each dose was left in contact with the skin surface for 
24 hours before terminal procedures were carried out to identify the dose 
distribution.  
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Results 
Figure 3.7 shows the cumulative absorption profile of benzoic acid applied as 
a finite dose in either IPA or PG vehicles. The finite dose absorption profile 
from the IPA vehicle followed a similar pattern to the absorption profile of the 
infinite dose of benzoic acid in IPA (figure.3.5). Absorption from IPA was 
initially fast over the first 3-4 hours before tailing off rapidly to 24 hours after 
exposure. There was no apparent lag time for absorption from IPA. The 
absorption profile of benzoic acid in PG was however, very different, with 
absorption initially being slow, before reaching steady state absorption after 8 
hours of exposure, however, absorption then tailed off rapidly after 15 hours. 
The apparent lag time for benzoic acid in PG was 5.3 ± 1.4 hours. Despite the 
absorption profiles of benzoic acid being very different between IPA and PG, 
the absolute amounts absorbed after 24 hours was very similar from both 
vehicles (112 ± 23.1µg/cm2 from IPA, and 108 ± 10.7µg/cm2 from PG 
respectively). However, in terms of percentage of dose applied to the skin 
surface (figure.3.8), a greater amount was absorbed from the PG vehicle 
(45.5 ± 7.1%) compared with absorption from the IPA vehicle (32.3 ± 6.6%). 
 
 Figure 3.8 shows that a large proportion of the applied dose of benzoic acid 
remained on the skin surface after 24 hour exposure from both vehicles (56.1 
± 7.4% from IPA and 41.1 ± 5.1% from PG). Approximately 3 times more of 
the applied dose of benzoic acid was found within the skin after 24 hour 
exposure to the PG vehicle than from IPA (1.1 ± 0.2% from IPA and 3.6 ± 
0.8% from PG) (p=>0.05 following 1-way ANOVA); however, similar amounts 
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were recovered from the stratum corneum tape strips from both vehicles after 
24 hours (1.7 ± 0.5% from IPA and 1.1 ± 0.3 % from PG). 
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Figure.3.7. 24 hour cumulative absorption profile of a finite dose of 14C benzoic 
acid. Values for benzoic acid applied as a finite dose in IPA are mean ±SEM for 6 cells (2 
donors), and 5 cells (2 donors) for benzoic acid applied as a finite dose in PG. 14C benzoic 
acid (containing approximately 1x105 DPM) was applied to the skin surface in a finite dose 
(10µl/cm2) at a concentration of 35mg/ml in IPA and 24mg/ml in PG. 
 
 
 
 
Dose 
Flux 
(µg/cm2/h) 
Kp x 10-3 
(cm/h) 
Lag Time 
(h) 
Linear 
range 
Benzoic acid in IPA (finite 
dose) 18.5 ± 5.6 17.2 ± 4.3 0 0-2 
Benzoic acid in PG (finite 
dose) 16.6 ± 4.8 13.3 ± 2.6 5.3 ± 1.4* 8-15 
 
Table 4. Steady state absorption rates, partition coefficients and lag times of 
benzoic acid applied to the skin surface as a finite dose in IPA and PG. Values 
are means ± SEM. A single asterisk next to a figure denotes a statistically significant 
difference from the remaning figure in the same column (p<0.05 with one way ANOVA).  
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Fig.3.8. Dose distribution of 14C benzoic acid applied as a finite dose to 
dermatomed human breast skin. Values are mean ± SEM of 6 cells (2 donors) for IPA, 
and values for PG are mean ± SEM of 5 cells (2 donors). The absorbed dose accounts for 
the total amount recovered in the receptor fluid after 24hr exposure. The skin digest 
represents the amount recovered from the viable epidermis and dermis after tape-stripping. 
The unabsorbed dose was recovered by swabbing the skin surface with alternate wet (0.5% 
soap solution) and dry tissue pieces (3 wet and 3 dry swabs). Charcoal filters were placed 
above the skin surface to trap any volatilised dose. Tape strips (no more than 15 per cell) 
were taken to remove the stratum corneum for assessment as a separate compartment to 
the remaining skin.  The total is the sum of the absorbed and unabsorbed recoveries.  
 
 
 
 
3.4: Discussion 
 
The infinite and finite dose absorption profiles of caffeine and benzoic acid, 
as expected, were different between application vehicles. The absorption of 
caffeine applied as a saturated dose in IPA or PG continued to increase up 
to 24 hours after exposure. This is consistent with a conventional infinite 
dose absorption curve, as the concentration on the skin surface theoretically 
remains constant throughout the exposure period. The amount of caffeine 
absorbed after 24 hours from both infinite and finite doses was small when 
compared with the amount applied on the skin surface, and the majority of 
the dose remained on the skin surface after 24 hour exposure for both IPA 
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and PG. It is probable that this was due to caffeine being a hydrophilic 
compound, and so penetration into the lipophilic stratum corneum and the 
upper layers of the skin was limited. As PG is also a hydrophilic solvent with 
a very low vapour pressure, caffeine would have a greater thermodynamic 
activity within the PG vehicle than in the stratum corneum lipids. As a result 
of this, caffeine was more likely to remain partitioned within the PG vehicle 
rather than penetrate into the upper layers of the skin.  
 
Caffeine absorption from a finite dose in PG continued to increase after a 24 
hour exposure period, which was unusual as absorption from a finite dose 
usually tails off as the applied dose becomes depleted (as seen for caffeine 
in IPA, figure 3.3). It is thought that the dose applied in PG may have 
maintained contact with the skin surface for longer than the dose in IPA due 
to the low volatility of PG. This may have enabled the dose to penetrate 
more slowly and steadily from the vehicle into the skin and maintain a steady 
state of absorption throughout exposure.  
 
The cumulative absorption profile of benzoic acid applied as an infinite dose 
in IPA (figure 3.5) was unusual as it resembled what would be expected from 
a finite dose. It is thought that this may have been caused by evaporation of 
volatile IPA. Evaporation of IPA from the skin surface left a solid residue of 
benzoic acid on the skin surface, which was less able to penetrate through 
the skin. This explains the high recovery from the skin surface (88.5 ± 18.9% 
of applied dose figure 3.6), despite the loss of IPA from the skin surface. 
Because of the volatility of IPA, it was impossible to ascertain a ‘true’ 
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maximum absorption rate for benzoic acid applied to the skin surface in IPA, 
as a steady state of absorption was not achieved during the 24 hour 
exposure time. Absorption of benzoic acid applied as an infinite dose in PG 
followed a more conventional infinite dose profile. As mentioned previously, 
PG has a low vapour pressure and so remained on the skin surface for the 
duration of the study.  
 
A greater amount of benzoic acid was absorbed through the skin than 
caffeine from both vehicles when applied as a finite dose (figure 3.8). This 
could be explained by the physicochemical properties of benzoic acid and its 
interaction with the solvent vehicles in which it was applied to the skin 
surface. Benzoic acid is lipophilic (log p = 1.87), and so is likely to penetrate 
through the skin more readily than the hydrophilic caffeine. However, 
application of benzoic acid to the skin surface in a hydrophilic solvent, such 
as PG, was likely to drive benzoic acid through the skin, as the compound 
has a greater thermodynamic activity in the lipids of the stratum corneum 
than it does in the application vehicle. Only a small proportion of the applied 
finite dose in IPA and PG vehicles was recovered from within the skin (skin 
digests and tape strips – figure 3.8). This suggests that there would be little 
opportunity for further absorption of benzoic acid beyond the 24 hour 
exposure time, as the majority of the applied dose remained on the skin 
surface.  
 
 
 
  
 
 
 
 
 
 
Chapter 4 
 
Dermal absorption of dichlorvos, 
chlorpyrifos and phorate 
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4. Dermal absorption of dichlorvos, chlorpyrifos and phorate 
 
4.1: Introduction 
An aim of this project was to define dermal absorption of nerve agents. 
However there are inherent difficulties and risk associated in working with 
these agents on our laboratories. Therefore studies were conducted with 
surrogate organophosphate molecules.  Chlorpyrifos, dichlorvos and phorate 
were selected due to their differing physicochemical properties, with 
chlorpyrifos being a lipophilic solid (log p = 4.96), dichlorvos a moderately 
lipophilic liquid (log p = 1.47) and phorate is a lipophilic liquid (log p = 3.56). 
Dichlorvos is a stable oxon, with chlorpyrifos and phorate both being 
thiophosphates. These compounds were selected, not only to compare with 
the absorption profiles of model compounds, but to allow extrapolation from 
the surrogate compounds to the absorption of the more harmful nerve agents 
compounds that individuals may become accidentally or deliberately exposed 
to in the environment following a release.  
 
The study of chlorpyrifos, dichlorvos and phorate in terms of in vitro dermal 
absorption and distribution has been limited. At present, only one study has 
been conducted to assess chlorpyrifos absorption through skin in vitro (Griffin 
et al. 2000), where chlorpyrifos was applied to human skin at a high 
concentration (18.28mg/ml) from a commercial mixture, and also dissolved in 
ethanol. In vivo studies have previously been conducted investigating the 
kinetics of urinary elimination of chlorpyrifos applied to the skin (Griffin et al. 
1999, Meuling et al. 2005), and recently, to investigate chlorpyrifos exposure 
in Egyptian cotton field workers (Farahat, et al. 2010). As chlorpyrifos is still 
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a widely used organophosphate pesticide in some poorer countries, it has 
been extensively investigated from an agricultural exposure perspective 
(Cattani et al. 2001, Geer et al. 2004, Abdel-Rasoul et al. 2008). As a result of 
this, chlorpyrifos was selected to investigate in these studies as it has 
relevance, not only as a surrogate compound, but also as a harmful chemical 
in its own right.  
 
To my knowledge, there is little information in the published literature 
regarding the dermal absorption and distribution of dichlorvos in vitro. This 
makes it an interesting chemical to use in dermal absorption studies. Despite 
the lack of in vitro dermal exposure data, dichlorvos toxicity has been widely 
studied and reviewed (Tungul et al. 1991, Luty et al. 1998, Booth et al. 2007) 
as a result of being used extensively used as an agricultural insecticide.  
 
Also, little is known regarding the dermal absorption and distribution of 
phorate. It is still used as a pesticide in many countries and so the possibility 
of civilians coming into contact with phorate is quite high. Due to the fact that 
phorate is still used in agriculture, methods for fast detection of serum 
organophosphates levels as a result of occupational exposure have been 
implemented using a number of different organophosphates, including 
phorate (Singh and Dogra, 2009).  
 
The same solvent vehicles used in chapter 3 were chosen for application of 
chlorpyrifos and dichlorvos to the skin surface. However, in addition, isopropyl 
myristate (IPM) was also included as a third application vehicle. IPM is a 
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highly lipophilic solvent (log p = 7.17) with a low vapour pressure (<1mmHg at 
25˚C). IPM was used because it has been shown to have similar properties to 
the lipids of the stratum corneum, and so is less likely to disrupt the barrier 
integrity of the skin. Other solvent vehicles, such as PG can enhance 
penetration of a chemical by altering the lipid structure of the stratum 
corneum, and so using IPM allowed investigation of organophosphate 
absorption without damaging the stratum corneum. Using IPM also allowed a 
wider range of exposure scenarios for both organophosphates to be 
investigated. Initial studies were undertaken to generate data on infinite dose 
exposures of dichlorvos in IPA, IPM and PG. To do this, dose concentrations 
of 10mg/ml and 1mg/ml were used.   The dose concentrations used in the 
finite dose studies for chlorpyrifos (500ng/cm2) and dichlorvos (5µg/cm2) were 
selected so that low level exposures to these compounds could be assessed. 
It is estimated that a dose of 300-400mg/kg of body weight is necessary for 
severe toxic effects of chlorpyrifos to be seen in humans (FAO/WHO, 2000). 
The 500ng/cm2 dose applied to the skin in these studies would be unlikely to 
result in such high level exposure as this, particularly as absorption would be 
unlikely to reach 100%, and so the dose used can be termed as low level 
exposure. Three vehicles (IPA, IPM and PG) were used to identify the effect 
of application vehicle on dermal absorption, in terms of the effect of the 
vehicle itself, but also as a result of interaction with the compounds of interest.  
 
Dichlorvos was applied to the skin surface at a higher concentration than 
chlorpyrifos to allow for detection by GC-MS. Despite the higher 
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concentration, the dose concentration was still significantly below the limit of 
dose application (5mg/cm2) suggested by OECD guideline 428 (OECD, 2004).  
In a separate study carried out at dstl, finite doses of phorate were applied to 
excised domestic pig abdomen skin as a neat solution (23mg/cell), and diluted 
in IPA (25µg/cell). The neat dose of phorate was used because there is little 
published data regarding dermal absorption of phorate, and so a high dose 
was applied to some cells to provide a worst case scenario for exposure. 
Phorate was also applied to the skin as a finite dose in IPA. This was chosen 
as a vehicle due to the volatility of IPA. This meant following application of a 
finite dose the solvent would evaporate from the skin surface quickly, and 
more closely mimic exposure to droplets or a vapour of phorate.  
 
4.2: Aims  
The aim of these studies was to generate novel data on the dermal absorption 
and distribution of chlorpyrifos and dichlorvos exposed to human breast skin 
samples for 24 hours. Chlorpyrifos and dichlorvos are still widely used in 
agriculture, and so these are also important to investigate in their own right, as 
well as using them to predict how bioactive agents with similar 
physicochemical properties will behave when in contact with the skin. 
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4.3: Results 
 
4.3.1: 24 hour exposure of dermatomed human breast skin to an infinite 
dose (1ml/cm2) of dichlorvos at concentrations of 10mg/ml and 1mg/ml.  
 
Methods 
For these studies, a total of 27 flow-through diffusion cells were used. 12 flow-
through diffusion cells were used for the 10mg/ml infinite dose study (4 cells 
for each dose in IPA, IPM and PG), and 15 cells were used for the 1mg/ml 
infinite dose study (5 cells for each dose in IPA, IPM and PG). Skin was taken 
from 6 donors in total (3 for each study) to account for interindividual 
variability. Dichlorvos was applied to the skin as an infinite dose (1ml/cm2) and 
dose concentrations of 10mg/ml and 1mg/ml were used. A high dose 
(10mg/ml) in each vehicle was used instead of using saturated doses to 
ascertain the infinite dose of dichlorvos in the 3 application vehicles because 
of the safety issue of handling large quantities of dichlorvos in the laboratory, 
and also due to the cost implications of using large quantities to produce 
saturated solutions in each vehicle. The 1mg/ml dose was used to see if there 
was a linear correlation between dose and absorption. In each study, the dose 
was left in contact with the skin for 24 hours before analysis of receptor fluid 
samples (1ml each) and the remaining skin surface dose by GC-MS.  
 
Results 
Figure 4.1 shows the cumulative absorption profile of dichlorvos applied to 
dermatomed human breast skin as an infinite dose (10mg/ml) in three 
vehicles. As can be seen from this figure, the greatest absorption of dichlorvos 
was from exposure in IPA, with 75% of the applied dose being absorbed after 
4. Results 
94 
24 hours. Absorption was greatest over the first 3 hours of exposure, 
however, absorption tailed off rapidly from this point up to 24 hours. The lag 
time for dichlorvos applied in IPA was 0.6 ± 0.1 hours. The absorption profiles 
of dichlorvos applied in IPM and PG were in keeping with an infinite dosing 
regime, as absorption continued to increase throughout the 24 hour exposure 
period. Approximately 27% of the applied dose in PG was recovered from 
receptor fluid samples after 24 hours, whereas 12% of the applied dose in 
IPM was absorbed after the same exposure time.  
 
A similar absorption profile was observed for the 1mg/ml infinite dose (figure 
4.2) as for the 10mg/ml dose, with absorption of dichlorvos from the IPA 
vehicle being greater than from the IPM and PG vehicles. Following 24 hour 
exposure, 688 ± 18µg/cm2 had been absorbed from the IPA vehicle, (68% of 
the applied dose). The 10 fold difference in concentration between these 2 
infinite dose studies yielded an approximately 10 fold difference in absorption 
from the IPA vehicle. There was also an approximately 10 fold reduction in 
maximum flux of dichlorvos between the two studies, with the apparent flux 
when applied at 10mg/ml in IPA being 1346 ± 298µg/cm2/h, and 132 ± 
28µg/cm2/h when applied at 1mg/ml in IPA respectively.  Absorption from IPA 
was fastest over the initial 3 hours of exposure before tailing off up to 24 hours 
after exposure despite infinite dosing.  Although absorption from PG was 
greater than from IPM for the 10mg/ml dose (figure 4.1), this result was found 
to be reversed following exposure to the 1mg/ml dose. However, absorption 
from IPM and PG continued to increase throughout the exposure period.  
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Fig.4.1. 24 hour cumulative absorption profile of an infinite dose of dichlorvos 
(10mg/ml) in IPA, IPM and PG. Values for dichlorvos applied in IPA, IPM and PG were 
mean ± SEM for 4 cells (12 cells in total, 3 donors) . Skin sections were mounted in flow 
through diffusion cells with an exposed area of 0.64cm2. Dichlorvos was applied to the skin 
surface as an infinite dose (1ml/cm2) at a concentration of 10mg/ml.  
 
 
 
Dose 
Flux 
(µg/cm2/h) 
Kp x 10-3 
(cm/h) Lag Time (h) 
Linear 
range 
Dichlorvos in IPA 10mg/ml 1346 ± 298** 1334 ± 220** 0.6 ± 0.1 1-3 
Dichlorvos in IPM 10mg/ml 66.4 ± 12.1 69.3 ± 18.1 2.6 ± 0.8* 4-24 
Dichlorvos in PG 10mg/ml 108 ± 19.7*  110 ± 20.2* 3.2 ± 1.1* 14-24 
 
Table 5. Observed steady state absorption rates, partition coefficients and lag 
times of dichlorvos applied to the skin as an infinite dose at a concentration of 
10mg/ml. A single asterisk denotes that a figure is significantly different from the lowest 
figure in the same column. A double asterisk denotes that the figure is significantly different 
from the remaning two figures in the same column (p<0.05 with one way ANOVA).  
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Fig 4.2. 24 hour cumulative absorption profile of an infinite dose of dichlorvos 
(1mg/ml) in IPA, IPM and PG. Values for dichlorvos applied in IPA, IPM and PG were 
means ± SEM for 5 cells (15 cells in total, 3 donors). Skin sections were mounted in flow 
through diffusion cells with an exposed area of 0.64cm2. Dichlorvos was applied to the skin 
surface as an infinite dose (1ml/cm2) at a concentration of 1mg/ml.  
 
 
 
Dose 
Flux 
(µg/cm2/h) 
Kp x 10-3 
(cm/h) 
Lag Time 
(h) 
Linear 
range 
Dichlorvos in IPA 
(1mg/ml) 132.4 ± 28.7** 132 ± 25.1** 0.4 ± 0.2 1-3 
Dichlorvos in IPM 
(1mg/ml) 5.8 ± 1.3 5.5 ± 1.1 2.3 ± 0.6* 6-24 
Dichlorvos in PG (1mg/ml) 3.8 ± 0.9 4.1 ± 1.1 2.9 ± 0.7* 3-24 
 
Table 6. Observed steady state absorption rates, partition coefficients and lag 
times of dichlorvos applied to the skin surface in an infinite dose at a 
concentration of 1mg/ml. A single asterisk denotes that a figure is significantly different 
from the lowest figure in the same column. A double asterisk denotes that a figure is 
significantly different from the remaining two figures in the same column (p<0.05 with one 
way ANOVA). 
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4.3.2: 24 hour exposure of dermatomed human breast skin to a finite 
dose of dichlorvos in 3 vehicles. 
 
 
Methods  
For the finite dose studies using dichlorvos, a total of 24 flow-through diffusion 
cells were used, allowing 8 cells per treatment (in IPA, IPM and PG). Skin 
sections were taken from 5 separate donors to account for interindividual 
variability. Each skin sample was dosed with a finite amount (10µl/cm2) of 
dichlorvos in each vehicle at a concentration of 5µg/cm2. Each dose was left 
in contact with the skin surface for 24 hours before terminal procedures were 
carried out to determine the dermal distribution of dichlorvos. Sample analysis 
was carried out using GC-MS. The data shown is pooled from experiments 
performed in duplicate.  
 
Results 
The cumulative absorption profile of dichlorvos applied as a finite dose in 
three vehicles can be seen in figure 4.3. From this, it can be seen that 
absorption of dichlorvos was greatest when applied to the skin surface in IPA. 
The absorption profile of dichlorvos applied in IPA was fastest over the initial 3 
hours of exposure, before declining from this point up to 24 hours. Despite the 
decrease in absorption after 3 hours of exposure, 38% of the applied dose 
was absorbed from the IPA vehicle after 24 hours. The absorption profiles of 
dichlorvos applied in IPM and PG were similar, with absorption increasing up 
to 8 hours after exposure, with the rate of absorption slowing markedly after 
this point up to 24 hours.  Absorption from the PG vehicle was greater than 
from the IPM vehicle, with 36% of the applied dose in PG, and 31% of the 
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applied dose in IPM absorbed after 24 hour exposure respectively. Although 
the cumulative absorption profiles of dichlorvos applied in PG and IPM were 
very different from the profile of dichlorvos applied in IPA, the total amount of 
dichlorvos absorbed after 24 hours was not statistically significant between 
vehicles.    
 
The dose distribution of dichlorvos after 24 hour exposure in IPA, IPM and PG 
vehicles is shown in figure 4.4. It can be seen that a larger proportion of the 
applied dose in IPA was found to have evaporated from the skin surface 
(13.8%), compared with IPM (9.9%) and PG (4.4%). The greatest amount of 
dichlorvos recovered from the skin surface after 24 hour exposure came from 
the PG vehicle, with 34.7% of the dose remaining on the skin surface, 
compared with 19.8% from IPM and 16.6% from IPA. The amount of 
dichlorvos recovered from the skin surface when applied in PG was 
significantly different from the amount recovered from the skin surface when 
applied in IPA or IPM (p>0.05 with one-way ANOVA).  
 
Despite comparable amounts of dichlorvos being recovered from the stratum 
corneum tape strips from all three vehicles (1.2% from IPA, 2.6% from IPM 
and PG respectively), the amount  recovered from within the skin after 24 hour 
exposure varied greatly between application vehicles. Significantly more 
dichlorvos was recovered from within the skin membrane after 24 hour 
exposure when applied in the IPM vehicle (20.1%) compared with 7.1% 
following application in the IPM vehicle, and 1.6% from the IPA vehicle 
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Fig.4.3. 24 hour cumulative absorption profile of dichlorvos applied as a finite 
dose (10µl/cm2) in IPA, IPM and PG. Values for dichlorvos applied in IPA, IPM and 
PG were means ± SEM for 8 cells (24 cells in total, 5 donors). Skin sections were mounted 
in flow through diffusion cells with an exposed area of 0.64cm2. Dichlorvos was applied to 
the skin surface as a finite dose (10µl/cm2) at a concentration of 5µg/cm2.  
 
 
 
 
 
Dose 
Flux 
(ng/cm2/h) 
Kp x 10-3 
(cm/h) Lag Time (h) 
Linear 
range 
Dichlorvos in IPA 
(5µg/cm2) 
983.1 ± 
121.2** 812 ± 104** 0.6 ± 0.2 1-3 
Dichlorvos in IPM 
(5µg/cm2) 
330.4 ± 
65.5* 297 ± 55.1* 0.6 ± 0.1 1-8 
Dichlorvos in PG (5µg/cm2) 
163.4 ± 
32.7 157 ± 30.2 0.4 ± 0.1 2-8 
 
Table 7. Observed steady state absorption rates, partition coefficients and lag 
times for dichlorvos applied as a finite dose in IPA, IPM and PG. A single asterisk 
next to a figure denotes that a figure is significantly different from the lowest figure in the 
same column. A double asterisk indicates that a figure is significantly different from both 
remaining figures in the same column (p<0.05 with one way ANOVA).  
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Fig.4.4.Dose distribution of dichlorvos applied as a finite dose to dermatomed 
human breast skin. Values are means ± SEM for 8 cells for each vehicle (24 cells in total, 
5 donors). ‘Carbon filter’ corresponds to the evaporated dose recovered after 24 hour 
exposure, ‘unabsorbed’ is the dose remaining on the skin surface after 24 hours,’ tape strip’ 
is the amount of dichlorvos recovered from the stratum corneum tape strips after 24 hours 
(no more than 15 strips per skin sample), ‘skin’ is the dose recovered from within the skin 
membrane after tape stripping, and the absorbed dose accounts for the total amount 
recovered from the receptor fluid after 24 hour exposure. The total recovery is the sum of all 
the compartments.  
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4.3.3: 24 hour exposure of dermatomed human breast skin to a finite 
dose of 14C-labelled chlorpyrifos in 3 vehicles 
 
Methods 
For these studies, a total of 27 flow-through diffusion cells were used, with 
skin taken from 6 different human breast skin donors. Overall, there were 9 
cells per treatment (Chlorpyrifos in IPA, chlorpyrifos in IPM, and chlorpyrifos in 
PG). Chlorpyrifos was applied to the skin surface as a finite dose (10µl/cm2), 
at the same concentration in each vehicle (500ng/cm2), containing 
approximately 100,000 DPM/cell of radiolabelled chlorpyrifos. The dose was 
left in contact with the skin for 24 hours, at which point terminal procedures 
were undertaken to analyse the dermal distribution of chlorpyrifos after 24 
hour exposure.  Sample analysis was carried out using liquid scintillation 
counting.  
 
Results 
The cumulative absorption profile of chlorpyrifos applied as a finite dose in 
IPA, IPM and PG is shown in figure 4.5. It can be seen that chlorpyrifos 
absorption was greatest following 24 hour exposure to a finite dose in PG, 
with 19.4% of the applied dose recovered from the receptor fluid compared 
with 10.3% from the IPA vehicle and 1.9% from the IPM vehicle.  Despite 
more chlorpyrifos being absorbed from the PG vehicle after 24 hour exposure, 
chlorpyrifos absorption took longer to reach steady state than from either IPM 
or IPA vehicles, with an observed lag time of 8.6 ± 1.8h, compared with 5.9 ± 
1.3h from the IPA vehicle, and 0.3 ± 0.1h from IPM respectively. Although 
chlorpyrifos applied in IPM gave the shortest apparent lag time, the amount 
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absorbed after 24 hours was significantly lower than from IPA and PG. 
Despite finite dosing, absorption or chlorpyrifos through the skin continued to 
increase steadily over the 24 hour exposure period. 
 
The dose distribution of chlorpyrifos after 24 hour exposure can is shown in 
figure 4.6. It can be seen that the largest proportion of applied dose was 
recovered from the skin surface after 24 hour exposure. The greatest amount 
of chlorpyrifos was recovered from the skin surface following exposure in IPM 
(68.2%), followed by 57% from IPA and 40.7% from PG. The amount 
recovered from the skin surface from the PG vehicle was significantly lower 
than from the other two vehicles following 1-way ANOVA (p>0.05). Following 
24 hour exposure, a large proportion of the applied dose was recovered from 
the stratum corneum when applied in all 3 vehicles, with 15% of the applied 
dose in PG recovered from the stratum corneum tape strips, 13.5% from the 
IPA vehicle, and 10.5% being recovered from stratum corneum tape strips 
after exposure in IPM respectively. The greatest amount of chlorpyrifos 
recovered from within the skin membranes after 24 hour exposure was 
observed following application of chlorpyrifos in PG (17%), with 8% recovered 
following application in IPA, and 7% of the applied dose was recovered from 
within the skin membranes following application of chlorpyrifos in IPM. 
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Fig.4.5. 24 hour cumulative absorption profile of chlorpyrifos applied as a finite 
dose (10µl/cm2) in IPA, IPM and PG. Values for chlorpyrifos applied in IPA, IPM and 
PG were means ± SEM for 9 cells (27 cells in total, from 6 donors). Skin sections were 
mounted in flow through diffusion cells with an exposed area of 0.64cm2. Chlorpyrifos was 
applied to the skin surface as a finite dose (10µl/cm2) at a concentration of 500ng/cm2.  
 
 
 
Dose Flux (ng/cm2/h) Kp x 10-3 (cm/h) Lag Time (h) 
Linear 
range 
Chlorpyrifos in IPA 
(500ng/cm2) 3.1 ± 1.2* 2.6 ± 1.1 5.9 ± 1.6* 8-21 
Chlorpyrifos in IPM 
(500ng/cm2) 0.4 ± 0.1 3.9 ± 1.2 0.2 ± 0.04 0-24 
Chlorpyrifos in PG 
(500ng/cm2) 6.3 ± 1.8* 5.7 ± 1.4* 8.6 ± 2.1* 13-24 
 
Table 8. Observed steady state absorption rates, partition coefficients and lag 
times for chlorpyrifos applied as a finite dose in IPA, IPM and PG. A single 
asterisk next to a figure indicates that a figure is significantly different from the lowest figure 
in the same column. A double asterisk indicates that a figure is significantly different from 
both remaining figures in the same column (P<0.05 with one way ANOVA).  
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 Fig.4.6. Dose distribution of chlorpyrifos applied as a finite dose to 
dermatomed human breast skin. Values are means ± SEM for 9 cells for each vehicle 
(27 cells in total, 6 donors). ‘Carbon filter’ corresponds to the evaporated dose recovered 
after 24 hour exposure, ‘unabsorbed’ is the dose remaining on the skin surface after 24 
hours,’ tape strip’ is the amount of chlorpyrifos recovered from the stratum corneum tape 
strips after 24 hours (no more than 15 strips per skin sample), ‘skin’ is the dose recovered 
from within the skin membrane after tape stripping, and the absorbed dose accounts for the 
total amount recovered from the receptor fluid after 24 hour exposure. The total recovery is 
the sum of all the compartments.  
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4.3.4: 24hr exposure of ST pig abdomen skin to a finite dose (20µl) of 
neat phorate (23mg/cell) and dilute phorate in IPA (25µg/cell) 
 
Methods 
For this study, 16 static diffusion cells were used (exposed surface area, 
2.54cm2), taking skin from 4 pig skin donors to account for interindividual 
variability. Half of the skin samples were exposed to neat phorate and the 
remaining cells were exposed to dilute phorate in IPA. A finite dose (20µl) was 
applied to the skin surface with an exposed area of 2.54cm2. The dose was 
left in contact with the skin for 24 hours, after which terminal procedures were 
performed in order to analyse the dermal distribution of phorate. Sample 
analysis was carried out using GC-MS at dstl, Porton Down.  
 
Results 
Absorption of neat phorate continued to increase steadily over the 24 hour 
exposure period despite finite dosing (20µl), although the absorption rate was 
fastest over the initial 6 hours of exposure.  The lag time for neat phorate 
through ST pig abdomen skin was 4.4 ± 1.1h.  However, despite the increase 
in absorption over 24hrs (figure 4.7), less than 1% of the applied dose of 
phorate was absorbed 24hrs after initial exposure to the skin (figure 4.8).  
 
The 24 hour cumulative absorption profile of dilute phorate in IPA is very 
similar to that of neat phorate in that absorption increases over 24hrs despite 
finite dosing (Figure 4.9).  However, there are some important differences. 
The lag time for absorption of dilute phorate in IPA (1.4h ± 0.4) was much 
shorter than for neat phorate. It is also important to note that even though 
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more phorate was absorbed from neat than from dilute in terms of the actual 
amount recovered in the receptor fluid, as a percentage of what was applied 
to the skin surface, far more was absorbed from the dilute dose. Less than 1% 
of the applied dose of neat phorate was absorbed a 24hrs compared with 
approximately 18% of the applied dose of dilute phorate in IPA (figures 4.8 
and 4.10). 
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Fig 4.7. 24 hour cumulative absorption profile of neat phorate (23mg/cell 
(9.05mg/cm2)) applied as a finite dose to ST pig abdomen skin. Values are means 
± SEM of 8 static diffusion cells (4 donors). Skin sections were mounted in static diffusion 
cells with an exposed area of 2.54cm2.  The dose applied to the skin surface was 20µl/cell. 
Lag time (4.4 ± 1.1h) was calculated from 3-6 hours after exposure. 
 
 
 
Dose Flux (ng/cm2/h) 
Kp x 10-3 
(cm/h) Lag Time (h) 
Linear 
range 
Neat phorate 
(finite dose) 3.9 ± 0.3 3.5 ± 2.1 4.4 ± 1 3-6 
 
Table 9. Observed steady state absorption rate, partition coefficient and lag 
time for neat phorate applied to pig abdomen skin in vitro 
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Fig 4.8. Dose distribution of neat phorate (23mg/cell) applied as a finite dose to 
ST pig abdomen skin. Values are means ± SEM for 8 static diffusion cells (4 donors). 
‘Unabsorbed’ corresponds to the percentage of the applied dose recovered from the skin 
surface, ‘skin digest’ is the percentage of applied dose recovered from within the skin, the 
‘absorbed’ dose is the percentage of neat HD recovered from the receptor fluid after 24 hour 
exposure. 
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Fig 4.9.24 hour cumulative absorption profile of dilute phorate in IPA 
(25µg/cell (9.84µg/cm2)) applied as a finite dose to ST pig abdomen skin. Values 
are means ± SEM of 8 static diffusion cells (4 donors). Skin sections were mounted in static 
diffusion cells with an exposed area of 2.54cm2.  The dose applied to the skin surface was 
20µl/cell. Lag time (1.4 ± 0.4h) was calculated from 1-6 hours after exposure. 
 
 
 
Dose 
Flux 
(ng/cm2/h) Kp x 10-3 (cm/h) Lag Time (h) Linear range 
Dilute phorate in IPA 
(finite dose) 372.3 ± 32.9 359 ± 37.4 1.4 ± 0.4 1-6 
 
Table 10. Observed steady state absorption rate, partition coefficient and lag 
time of phorate diluted in IPA, applied to pig abdomen skin in vitro 
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Fig 4.10. Dose distribution of dilute phorate in IPA (25µg/cell) applied as a 
finite dose to ST pig abdomen skin. Values are means ± SEM for 8 static diffusion cells 
(4 donors). ‘Unabsorbed’ corresponds to the percentage of the applied dose recovered from 
the skin surface, ‘skin digest’ is the percentage of applied dose recovered from within the 
skin, the ‘absorbed’ dose is the percentage of neat HD recovered from the receptor fluid 
after 24 hour exposure. 
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4.4: Discussion 
 
 
4.4.1: Infinite dose dichlorvos 
The main purpose of assessing infinite dose exposure is to generate 
maximum absorption rates, partition coefficients and lag times so that the data 
can be used to feed into QSAR predictions, in order to rank the chemicals of 
interest against known marker compounds. Dermal absorption of dichlorvos at 
high doses (1mg/ml and 10mg/ml) was investigated due to the high levels of 
dichlorvos required to produce saturated solutions in the vehicles used. 
Absorption of infinite, saturated solutions of chlorpyrifos were not investigated 
for similar reasons, however, attempts to investigate high doses under infinite 
conditions did not work and so are not included in this thesis.  
 
The cumulative absorption profiles of dichlorvos applied as an infinite dose in 
IPA at both 10mg/ml and 1mg/ml concentrations (figures 4.1 and 4.2) were 
not typical of what would be expected from an infinite dose absorption profile. 
The observed flux was fastest over the first 3 hours of exposure (1346.8 ± 
298.2µg/cm2/h), before slowing markedly up to 24 hours. It is possible that the 
rapid tailing-off in absorption was due to the depletion of IPA from the skin 
surface, despite infinite dosing. IPA is a highly volatile solvent, and so it is 
possible that as it evaporated from the skin surface, the surface concentration 
of dichlorvos may have been increased, leading to an increase in flux. As a 
result of the volatility of IPA, steady state absorption was not achieved and so 
true infinite dose conditions were not achieved.  Despite dichlorvos being 
added to the skin surface as an infinite dose in IPA, IPM and PG at 2 
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concentrations (10mg/ml and 1mg/ml), it was not possible to ascertain the 
‘true’ maximum flux of dichlorvos in the 3 vehicles tested because, in order to 
do this, the chemical should be saturated in its application vehicle. Also, due 
to the properties of the 3 vehicles used, the solubility of dichlorvos was 
different in each vehicle, and so the thermodynamic activity of dichlorvos in 
each vehicle was not the same.  As dichlorvos is a lipophilic compound, it will 
be closer to saturation in the most hydrophilic solvent (PG), as it is less 
soluble in PG than in IPA or IPM, which are more lipophilic.  
 
The 10 fold difference in dose concentration of dichlorvos in IPA did however 
yield an approximately 10 fold difference in the observed flux (1346µg/cm2/h 
and 132µg/cm2/h for 10mg and 1mg/ml doses respectively), meaning that 
meaning that there was a linear flux-concentration relationship. 
 
4.4.2: Finite exposure to dichlorvos and chlorpyrifos 
As expected due to the different chemical properties of the two 
organophosphates used, the cumulative absorption profiles of dichlorvos 
(figure 4.3), and chlorpyrifos (figure .4.5) were very different when applied to 
the skin surface in IPA, IPM and PG. The cumulative absorption profile of 
dichlorvos applied as a finite dose in IPA (figure.4.3) was similar to the profile 
observed from the infinite dose studies using dichlorvos in IPA (figure 4.1 and 
4.2). From the infinite dose studies, it can be seen that the amount of 
dichlorvos absorbed after 24 hours was far greater than from the other two 
vehicles, however, when applied as a finite dose at a low concentration in  the 
same vehicles, there was no significant difference in the amount of dichlorvos 
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absorbed between the three vehicles used (figure 4.3). This was unexpected 
and it is possible that the greater volume of IPA on the skin surface for the 
infinite dose studies allowed absorption to continue at a faster rate for longer 
than when applied as a finite dose. Therefore, the rapid evaporation of IPA 
from the skin surface from the finite dose may have prevented absorption by 
allowing dichlorvos to evaporate. This is supported by the dose distribution in 
figure 4.4, where more dichlorvos had evaporated from the IPA vehicle than 
from either IPM or PG. 
 
It was expected that absorption of dichlorvos from a finite exposure would be 
greatest from the PG vehicle, as this would have had greatest thermodynamic 
activity. However, it was observed that absorption was marginally greater from 
the IPA vehicle than from IPM or PG after 24 hours. It is possible that this 
could also be due to the volatility of IPA. Although the observed flux of 
dichlorvos in IPA (983 ± 121ng/cm2/h) was approximately 3 times greater than 
the observed flux of dichlorvos in IPM (330 ± 65ng/cm2/h), and 6 times greater 
than dichlorvos in PG (163 ± 32ng/cm2/h), the time over which the maximum 
absorption rate could be calculated was far shorter (2 hours) when applied in 
IPA. Flux rates from the remaining vehicles were calculated over much longer 
periods, as IPM and PG are less volatile and maintain contact with the skin for 
longer, allowing more absorption to occur over a longer period of time. The 
volatile nature of IPA means that maximum flux can only be measured over a 
short period of time, and so this makes accurate calculation of steady state 
flux virtually impossible.  
 
4. Results 
114 
From the dose distribution shown in figure 4.4, it can be seen that a much 
greater proportion of the applied dose was recovered from within the skin 
when applied in IPM and PG. Therefore, it may be possible that further 
absorption from these 2 vehicles could be possible beyond the 24 hour 
exposure period, and that this could surpass the amount absorbed from IPA, 
as only a small proportion of the applied dose was recovered from the stratum 
corneum tape strips and within the skin membranes.  
 
The greatest absorption of chlorpyrifos following 24 hour exposure to the skin 
came from the PG vehicle (figure 4.5). This was expected due to chlorpyrifos 
having a greater thermodynamic activity in PG than in either IPA or IPM due 
to the hydrophilic nature of PG. Absorption continued to increase over 24 
hours from all three vehicles despite finite dosing. This was unusual, 
particularly for IPA given its volatility and rapid evaporation from the skin 
surface. However, chlorpyrifos is a more lipophilic chemical than dichlorvos, 
and so it is possible that when this was applied to the skin surface in the 
moderately amphipathic IPA, that chlorpyrifos partitioned more readily into the 
skin and from here, could penetrate slowly through the dermis and into the 
receptor fluid. This appears to be the case when looking at the dose 
distribution in figure 4.6, as the amount of chlorpyrifos recovered from within 
the stratum corneum tape strips and skin membrane combined exceeded 20% 
of the applied dose in IPA. The amount of chlorpyrifos recovered from the 
tape strips and skin membranes from IPM and PG also exceeded 20% of the 
applied dose This reservoir may explain the increase in absorption from IPM 
and PG over the 24 hour exposure period despite finite dosing. Also, IPM and 
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PG are non volatile and maintain contact with the skin surface for long periods 
of time compared with IPA, therefore allowing absorption through the skin to 
occur steadily over time. 
 
When comparing absorption of dichlorvos and chlorpyrifos, it can be seen that 
absorption of dichlorvos after 24 hour exposure in IPA, IPM and PG was 
approximately twice as great as absorption of chlorpyrifos from finite dose 
conditions. This may be explained by differences in their physicochemical 
properties. Chlorpyrifos is a more lipophilic chemical than dichlorvos, and so 
will preferentially partition into the stratum corneum, particularly when applied 
in IPA and PG. From here, penetration through the more hydrophilic dermis 
into the receptor fluid was much slower. Chlorpyrifos is also a solid at room 
temperature, and so as the solvent vehicles evaporated, a deposit of 
chlorpyrifos was left behind which could not be absorbed. This could explain 
the large proportion of applied dose on the skin surface after 24 hour 
exposure (figure 4.6). Dichlorvos is less lipophilic, and is also a liquid at room 
temperature. Therefore, absorption can be maintained for longer on the skin 
surface even after depletion of the application vehicle from the skin surface.  
 
 
4.4.3: Phorate absorption through pig abdomen skin 
The cumulative absorption profile for neat phorate (figure 4.7) shows that 
absorption increases over the 24hr exposure period despite finite dosing. It 
was expected, despite being applied as a small volume to the skin surface in 
IPA, that phorate would partition readily into the lipophilic upper layers of the 
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skin, and slowly become absorbed, although the majority of the dose that 
penetrates the skin surface may not become ‘systemically’ absorbed, due to  
phorate being a lipophilic liquid (log p = 3.56). Further evidence for this can be 
seen from the distribution graphs for dilute phorate in IPA (figure 4.10), with 
17% of the applied dose of dilute phorate in IPA absorbed following 24 hour 
exposure. The majority of the applied dose of neat phorate was recovered 
from the skin surface following 24hr exposure (84%), suggesting that there 
was little potential for phorate to penetrate the skin beyond the 24hr exposure 
time. However, recovery of the applied dose of dilute phorate was 
comparatively poor (32% recovery for dilute phorate, 85% for neat phorate). 
Unfortunately, no skin distribution data were available due to the poor stability 
of phorate in soluene, the solvent used to dissolve the skin samples. This may 
explain the poor recovery of the dilute phorate. However, due to phorate being 
a lipophilic chemical, it is highly likely that a large proportion of the applied 
dose would be retained within the skin after 24hr exposure, particularly within 
the lipids of the stratum corneum in the upper layers of the skin.   
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24 hour exposure of human and pig 
skin to sulphur mustard (HD) 
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5. 24 hour exposure of human and pig skin to 14C-
radiolabelled sulphur mustard (HD) 
 
5.1: Introduction 
The purpose of this project was to investigate dermal absorption of chemicals 
that could be used as potential surrogates for predicting absorption of more 
harmful, bioactive agents, therefore, it was important to investigate in parallel 
the dermal absorption of bioactive agents where possible, so that the 
absorption profiles of these chemicals could be compared with those of the 
marker and surrogate compounds in order to identify how useful they are for 
predicting absorption.  
 
Following the absorption studies undertaken with the marker compounds and 
the organophosphates dichlorvos and chlorpyrifos it would have been 
informative to study sarin. However this proved impossible. 14C labelled HD 
was available for a study in collaboration with dstl, and was chosen because it 
is a potent vesicating agent, meaning the dermal route is of great importance 
in terms of exposure. HD has previously been studied in terms its potential for 
high level, military exposure due to its use as a chemical warfare agent 
(Chilcott et al. 2000, Chilcott et al. 2001, and Hattersley et al. 2008). It has 
also been extensively reviewed in terms of local HD toxicity and mechanisms 
of action (Balali-Mood and Hefazi 2005, Saladi et al .2005, Shakarjian et al. 
2010). Despite this, little is currently known about HD in terms of low level, 
civilian exposure  
 
5.Results 
119 
HD was applied to the skin surface as a neat, finite dose and also as a finite 
dose diluted in IPA. Neat doses were applied in order to compare the diluted 
doses with a ‘worst case’ scenario in terms of dermal exposure to a finite dose 
of HD and phorate. The diluted dose in IPA was chosen because IPA is the 
most volatile of the vehicles tested in previous studies using marker and 
surrogate compounds, meaning that it more closely mimics exposure to a 
spray or vapour, which may come into contact with the skin during accidental 
or deliberate exposure to individuals on the periphery of chemical release. 
 
5.2: Aims  
The aim of these studies was to generate 24 hour absorption data for dermal 
exposure to low levels of HD with the purpose of comparing the data 
generated with the data obtained from the model and surrogate compounds to 
identify the usefulness of these chemicals for predicting the dermal absorption 
of HD.  
 
5.3: Results 
 
5.3.1: 24hr exposure of full thickness human breast skin to neat 14C-
labelled HD and 14C-labelled HD diluted in IPA 
 
Methods 
For this study, finite doses (20µl/cell) of neat HD (25mg/cell) and HD diluted in 
IPA (1.25mg/cell) (all containing 0.185MBq/cell of radiolabelled HD) were left 
in contact with human breast skin in static diffusion cells (exposed area, 
2.54cm2) for 24 hours (6 cells for each dose). Following this, terminal 
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procedures were performed in order to determine the dermal distribution of 
HD after 24 hour exposure.  
 
Results 
The cumulative absorption profile of neat HD applied to full thickness human 
breast skin can be seen in figure 5.1. As can be seen from this figure, 
exposure to neat HD resulted in slow absorption over the initial 3 hours of 
exposure before an increase in flux up to 20 hours after exposure. This 
produced a lag time of 2.64 ± 0.61 hours. This profile fits a predicted finite 
dose curve as the absorption rate tails off towards the end of the exposure 
period as the applied dose becomes depleted over time.  
 
After 24 hour exposure to neat HD, approximately 25% of the applied dose 
was absorbed through the full thickness human breast skin into the receptor 
fluid (figure 5.2). It can also be seen that only a small percentage (8.2 ± 2.7%) 
of the applied dose was recovered from the skin surface after 24 hour 
exposure when compared with the absorbed dose, and the dose remaining 
within the skin. The majority of the applied dose was recovered from within the 
skin membrane after 24 hours, with 58 ± 8% of the applied dose found in the 
skin. 
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Fig 5.1. 24 hour cumulative absorption profile of neat HD applied as a finite 
dose (10mg/cm2) to full thickness human breast skin. Values for neat HD applied to 
human breast skin were mean ± SEM for 4 static diffusion cells (4 skin donors). Skin 
sections were mounted in static diffusion cells with an exposed area of 2.54cm2. Neat HD 
was applied to the skin surface as a finite dose (20µl/cell).  
 
 
 
Dose Flux (µg/cm2/h) 
Kp x 10-3 
(cm/h) Lag Time (h) 
Linear 
range 
Neat HD (finite dose) 129.1 ± 14.4 126 ± 10.3 2.6 ± 0.6 3-6 
 
Table 11. Observed steady state absorption rate, partition coefficient and lag 
time following 24 hour exposure of full thickness human breast skin to neat 
HD. 
 
 
 
 
5.Results 
122 
0
20
40
60
80
100
120
unabsorbed skin digest absorbed total
compartment
pe
rc
e
n
ta
ge
 
o
f d
o
s
e
 
re
c
o
v
e
re
d 
a
fte
r 
24
 
ho
u
rs
Fig 5.2. Dose distribution of Neat HD applied as a finite dose to full thickness 
human breast skin. Values are mean ± SEM of 4 static diffusion cells (from 4 donors). 
‘Unabsorbed’ corresponds to the percentage of the applied dose recovered from the skin 
surface, ‘skin digest’ is the percentage of applied dose recovered from within the skin, the 
‘absorbed’ dose is the percentage of neat HD recovered from the receptor fluid after 24 hour 
exposure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.Results 
123 
The cumulative absorption profile of HD diluted in IPA through full thickness 
human breast skin can be seen in figure 5.3. The lag time for dilute HD in IPA 
was shorter in when compared with that of neat HD (1.8 ± 0.3 hours for HD in 
IPA, and 2.6 ± 0.6 hours for neat HD). Absorption of dilute HD in IPA was 
fastest over the first 6 hours of exposure, however, absorption continued to 
increase from 6 hours up to 24 hours at a slower rate, despite finite dosing.   
 
The dose distribution of dilute HD in IPA shown in figure 5.3 is similar to the 
distribution profile of neat HD (figure 5.2) in terms of the proportion of the 
applied dose recovered from each compartment after 24 hour exposure. 
Again, the percentage of the applied dose recovered from the skin surface 
was low (7.5 ± 3.2%) when compared to the percentage absorbed (24.2 ± 
6.2%) and the percentage retained within the skin after 24 hours (62.2 ± 
9.8%).    
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Fig 5.3. 24 hour cumulative absorption profile of dilute HD applied in IPA as a 
finite dose (492µg/cm2) to full thickness human breast skin. Values for neat HD 
applied to human breast skin were mean ± SEM for 8 static diffusion cells (4 skin donors). 
Skin sections were mounted in static diffusion cells with an exposed area of 2.54cm2. Dilute 
HD in IPA was applied to the skin surface as a finite dose (20µl/cell). Lag time was 
calculated from 4-6 hours after exposure. 
 
 
 
Dose Flux (µg/cm2/h) 
Kp x 10-3 
(cm/h) Lag Time (h) Linear range 
Dilute HD in IPA (finite 
dose) 11.63 ± 4.03 10.4 ± 3.1 1.8 ± 0.3 4-6 
 
Table 12. Observed steady state absorption rate, partition coefficient and lag 
time following 24 hour exposure of full thickness human breast skin to HD 
diluted in IPA 
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Fig 5.4. Dose distribution of dilute HD in IPA applied as a finite dose to full 
thickness human breast skin. Values are mean ± SEM of 8 static diffusion cells (from 4 
donors). ‘Unabsorbed’ corresponds to the percentage of the applied dose recovered from 
the skin surface, ‘skin digest’ is the percentage of applied dose recovered from within the 
skin, the ‘absorbed’ dose is the percentage of neat HD recovered from the receptor fluid 
after 24 hour exposure. 
 
 
 
5.Results 
126 
5.3.2: 24 hour exposure of full thickness (FT) and split thickness (ST) pig 
abdomen skin to finite doses of neat 14C-radiolabelled HD and 14C-
radiolabelled HD diluted in IPA 
 
Methods 
For these studies, a total of 20 static diffusion cells were used, meaning 5 
cells were available for each treatment: 
1 – Full thickness pig abdomen skin exposed to neat HD 
2 – Split thickness pig abdomen skin exposed to neat HD 
3 – Full thickness pig abdomen skin exposed to dilute HD in IPA 
4 – Split thickness pig abdomen skin exposed to dilute HD in IPA 
 
Neat HD (25.4mg/cell) was applied as a finite dose (20µl) to the skin, and 
dilute HD in IPA (1.25mg/cell) was also applied to the skin surface as a finite 
dose. Each dose contained approximately 0.185MBq/cell of radiolabelled HD. 
After 24 hour exposure, terminal procedures were undertaken to assess the 
dermal distribution of HD.  
 
Results 
The cumulative absorption of neat HD through full thickness and split 
thickness pig abdomen skin following 24 hour exposure is shown in figure 5.5. 
From this figure, it can be seen that absorption of neat HD continued to 
increase through both full thickness and split thickness pig abdomen skin for 
24 hours despite finite dosing.  The amount of HD absorbed through split 
thickness pig skin was significantly greater than through full thickness pig 
abdomen skin, with more than double the amount being absorbed after 24 
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hour exposure. The lag time for absorption through split thickness skin was 
also much shorter than through full thickness pig skin (1.7h ± 0.2 through split 
thickness skin and 4.1 ± 0.6 through full thickness skin).  
 
From the dose distribution profile of neat HD applied to full thickness and split 
thickness pig abdomen skin shown in figure 5.6, it can be seen that a greater 
proportion of the applied dose was recovered from the skin surface with full 
thickness pig skin (16.6 ± 5.2%) compared with split thickness pig skin (8.9 ± 
2.1%). The amount of HD recovered from within the skin after 24 hour 
exposure was also greater in full thickness pig abdomen skin (52.5 ± 6.2%) 
compared with the amount recovered from split thickness pig abdomen skin 
(33.7 ± 4.4%).  
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Fig 5.5 24 hour cumulative absorption profile of neat HD (10mg/cm2) applied as 
a finite dose to full and split thickness pig abdomen skin. Values for neat HD FT 
are mean ± SEM of 5 diffusion cells (5 donors), and values for neat HD ST are means ± 
SEM of 5 cells (5 donors). Skin sections were mounted in static diffusion cells with an 
exposed area of 2.54cm2. The dose applied to the skin surface was 20µl/cell. The lag time 
for neat HD FT was calculated from 4-6 hours, and the lag time for neat HD ST was 
calculated from 3-6 hours 
 
 
 
 
Dose Flux (µg/cm2/h) Kp x 10-3 (cm/h) 
Lag 
Time (h) 
Linear 
range 
neat HD ST pig skin (finite 
dose) 268.4 ± 10.6* 259.1 ± 10.6* 1.7 ± 0.2 2-6 
neat HD FT pig skin (finite 
dose) 82.4 ± 14.7 80.4 ± 10.1 4.1± 0.6* 4-6 
 
Table 13. Observed steady state absorption rates, partition coefficients and lag 
times of HD applied to full and split thickness pig abdomen skin in vitro. A single 
asterisk next to a figure indicates a significant difference (p<0.05 with one way ANOVA).  
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Fig 5.6. Dose distribution of neat HD applied as a finite dose to full and split 
thickness pig abdomen skin. Values for neat HD FT are mean ± SEM of 5 static 
diffusion cells (5 donors), and values for neat HD ST are means ± SEM of 5 static diffusion 
cells (5 donors). ‘Unabsorbed’ corresponds to the percentage of the applied dose recovered 
from the skin surface, ‘skin digest’ is the percentage of applied dose recovered from within 
the skin, the ‘absorbed’ dose is the percentage of neat HD recovered from the receptor fluid 
after 24 hour exposure. 
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The cumulative absorption profile of dilute HD in IPA through full thickness pig 
abdomen skin differs greatly to that of dilute HD through split thickness pig 
abdomen skin (figure 5.7). As can be seen from this figure, absorption through 
full thickness pig skin continues to increase steadily throughout the 24 hour 
exposure period, despite application of a finite dose. However, absorption 
through split thickness pig skin was much faster over the first 6 hours of 
exposure, but then slowed dramatically up to the 24 hour time point. Despite 
this, the amount of HD absorbed through split thickness pig abdomen skin 
was significantly greater than through full thickness pig skin, with more than 
double the amount being absorbed through split thickness pig skin after 24 
hours.  
 
The dose distribution of dilute HD in IPA applied to full and split thickness pig 
abdomen (figure 5.8) follows a similar pattern to the dose distribution of neat 
HD through full and split thickness pig skin (figure 5.6) in the sense that a 
greater proportion of the applied dose was recovered from the skin surface of 
full thickness pig skin (17.3 ± 4.7% from full thickness skin compared with 
10.2 ± 3.5% from split thickness skin),  and also a greater proportion of the 
applied dose was recovered from within full thickness skin compared with split 
thickness skin (56.1 ± 10.2% for full thickness skin and 35.8 ± 7.3% for split 
thickness skin respectively).  
 
 
 
 
5.Results 
131 
0
50
100
150
200
250
300
350
0 5 10 15 20 25 30
Time (h)
c
u
m
u
la
tiv
e
 
a
bs
o
rp
tio
n
 
o
f H
D 
(u
g/
c
m
2)
IPA FT
IPA ST
 
Fig 5.7. 24 hour cumulative absorption profile of dilute HD in IPA (492µg/cm2) 
applied as a finite dose to full and split thickness pig abdomen skin. Values for 
dilute HD in IPA (IPA FT) are mean ± SEM of 5 diffusion cells (5 donors), and values for 
dilute HD in IPA (IPA ST) are means ± SEM of 5 cells (5 donors). Skin sections were 
mounted in static diffusion cells with an exposed area of 2.54cm2.  The dose applied to the 
skin surface was 20µl/cell.  
 
 
 
 
Dose Flux (µg/cm2/h) 
Kp x 10-3 
(cm/h) Lag Time (h) 
Linear 
range 
HD in IPA FT pig skin (finite 
dose) 5.99 ± 0.50 2.1 ± 0.5 2.86 ± 0.67* 4-6 
HD in IPA ST pig skin (finite 
dose) 33.37 ± 3.14* 31.5 ± 3.1* 0.5 ± 0.03 1-6 
 
Table 14. Observed steady state absorption rates, partition coefficients and lag 
times of HD applied to full and split thickness pig abdomen skin in IPA. A single 
asterisk next to a figure indicates a significant difference (p<0.05 with one way ANOVA).  
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Fig 5.8. Dose distribution of dilute HD in IPA (492µg/cm2) applied as a finite 
dose to full and split thickness pig abdomen skin. Values for dilute HD in IPA (IPA 
FT) are mean ± SEM of 5 static diffusion cells (5 donors), and values for dilute HD in IPA 
(IPA ST) are means ± SEM of 5 static diffusion cells (5 donors). ‘Unabsorbed’ corresponds 
to the percentage of the applied dose recovered from the skin surface, ‘skin digest’ is the 
percentage of applied dose recovered from within the skin, the ‘absorbed’ dose is the 
percentage of neat HD recovered from the receptor fluid after 24 hour exposure. 
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5.4: Discussion 
 
Although the 24 hour cumulative absorption profiles of neat HD and dilute HD 
in IPA through full thickness human breast skin were very different (figures 5.1 
and 5.3), the amount of HD absorbed through the skin in terms of percentage 
applied to the skin surface was similar (25.2 ± 4.3% absorbed from neat HD 
and 24.2 ± 6.2% from dilute HD in IPA respectively). The lag time for HD 
applied in IPA (1.8 ± 0.3h) was similar to that of neat HD (2.6 ± 0.6h). 
However, the observed reduction in lag time may be explained by the vehicle 
effect of IPA on HD absorption. HD is a lipophilic compound and so will have a 
greater affinity for the lipids of the stratum corneum than for the IPA vehicle, 
leading to an increase in absorption initially while the vehicle evaporated from 
the skin surface. It can be seen from the cumulative absorption profiles that 
absorption of HD is greater over the first 6 hours of exposure when applied in 
IPA than as a neat dose (as a proportion of the applied dose).  
 
It is important to note from the dermal distribution graphs shown in figures 5.2 
and 5.4 that the majority of the applied dose of neat HD and dilute HD in IPA 
was recovered from within the skin after 24 hour exposure (58 ± 8.6% after 
exposure to neat HD and 62.2 ± 9.8% following exposure to dilute HD in IPA). 
This suggests that HD preferentially partitions within the skin, and is slow to 
be further absorbed. This confirms the presence of a HD skin reservoir from 
which it can elicit local, chronic toxic effects as described by Hattersley et al. 
2008. It is possible that some of the dose remaining within the skin may have 
the potential to become absorbed, however, it has been suggested that at 
least part of the applied dose of HD becomes fixed within the skin and is non-
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extractable, and that this is the cause of the vesication within the skin (Chilcott 
et al. 2000, Hattersley et al. 2008).  It has also been suggested that binding of 
HD to various skin membrane proteins, including actin, annexin A2 and 
keratin 9 may contribute to HD pathology, as these proteins all play an 
important role in maintaining skin membrane structure (Sayer et al. 2009).  
 
The amount of HD absorbed through full thickness pig abdomen skin after 
24hr exposure for both neat HD and dilute HD in IPA was very similar to the 
amount absorbed through full thickness human breast skin. However, 
absorption through split thickness pig abdomen skin was approximately 2 fold 
higher for neat HD and HD applied in IPA than through full thickness skin. 
This suggests that split thickness pig abdomen skin was not as good a model 
for absorption through human skin as full thickness pig abdomen skin. Despite 
this, it is interesting to see that approximately 35% of the applied dose for both 
neat HD and dilute HD were retained within the split thickness pig abdomen 
skin (figures 5.6 and 5.8). Even though a large proportion of the applied dose 
of HD was retained within full thickness human skin (figures 5.2 and 5.4), the 
amount found in split thickness pig abdomen skin after 24hr exposure may 
further suggest that HD can be readily absorbed into the skin and can form a 
‘reservoir’ from which to cause prolonged local toxic effects. It is possible that 
this could also be the case for split thickness human skin as well as for split 
thickness pig abdomen skin.  
 
 
 
 
  
 
 
 
 
 
 
Chapter 6 
 
The effect of clothing and skin 
surface decontamination on dermal 
absorption of organophosphates 
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6. The effect of clothing and skin surface decontamination on 
dermal absorption of organophosphates 
 
6.1: Introduction 
The effect of covering the skin with everyday clothing and decontamination of 
the skin surface following exposure to chemicals was investigated to identify 
how effective they can be at reducing absorption.  The approach was to 
compare dermal absorption of organophosphates following 24 hour exposure 
with that following decontamination and when the skin was protected with 
clothing. 
 
Due to the fact that organophosphates (OPs) are widely used in agriculture, 
the possibility of workers and civilians becoming exposed to these chemicals 
is high. As a result of this, exposure to various OPs from an occupational 
perspective has been widely investigated, with many studies being carried out 
in vivo to assess pesticide worker exposure and the effectiveness of personal 
protective equipment (PPE) for reducing exposure, in particular with respect to 
the protection provided by gloves (Creely and Cherrie, 2001, Rawson et al. 
2001, Nielsen and Andersen, 2001, Cherrie et al. 2004), but also with respect 
to protection provided by PPE worn by workers (Baldi et al. 2006, Marchera et 
al. 2009, Protano et al. 2009). The investigation carried out by Protano et al. 
2009 not only investigated PPE such as rubber boots, Tyvek suits and gloves, 
but also long sleeved cotton shirts and cotton shorts. In this study, it was 
found that PPE gave >97% protection against five different pesticides 
(azinphos-methyl, terbutylazine, alachlor, dimethoate and dicamba), whereas 
cotton clothing gave protection in the range of 84.1% to 92.5%, indicating that 
6. Results 
137 
clothing designed for protective purposes is more effective that cotton clothing 
for reducing exposure to chemicals used in agriculture. Studies undertaken by 
Marchera et al. 2009 investigated the effect of different designs (woven cotton 
design vs water repellent cotton/polyester) of coverall for reducing exposure of 
pesticide applicators, and found that cotton/polyester material gave 
approximately 5.5 times the protection of woven cotton material coveralls. 
However, both types of coverall were deemed to be sufficiently protective 
against exposure for use.  
 
Exposure of the hands to various hazardous chemicals has been extensively 
investigated as exposure to hands has been shown to account for between 
50% and 90% of total body exposure (Karr et al. 1992, Archibald et al. 1995). 
A study by Creely and Cherrie, 2001 showed that internal glove contamination 
occurred frequently (25 out of 30 occasions) when using a permethrin-based 
pesticide based on the use of a novel method for assessing glove protection, 
where cotton gloves were worn underneath, and over the top of protective 
gloves to assess the amount of pesticide that would deposit on the skin 
surface. Despite internal glove contamination occurring so frequently, all 
gloves tested were found to be impermeable after 8 hours of exposure. 
Nielsen and Andersen, 2001 also investigated protective gloves (latex and 
nitrile), as well as the protective nature of nonylphenolethoxylate (NPE), a 
detergent widely used in pesticide formulations, against absorption of 
methiocarb, paclobutrazol and pirimicarb. This study showed that NPE 
decreased absorption of the 3 pesticides, and also that nitrile gloves gave 
better general protection against absorption than latex, although the degree of 
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protection was found to decrease over time (nitrile gave only 18 hours of 
protection against pirimicarb). Nitrile and similar protective material gloves 
have generally been shown to provide greatest resistance against pesticide 
exposure, whereas natural rubber has been found to provide limited protection 
in comparison (Ehntholt et al. 1989, Schwope et al. 1992, and Raheel and 
Dai, 1997).  
 
Despite the extensive research into occupational exposure relating to 
pesticides, very little is known regarding the capability of everyday clothing 
worn by workers or civilians to provide protection against exposure to 
hazardous chemicals. It is a distinct possibility that bystanders may become 
exposed to low levels of chemicals used in agriculture following application to 
crops, and so it is important to identify the level of protection obtained from 
wearing everyday clothing.  Of relevance to this project t is important to be 
able to quantitate the effects of every-day clothing worn by those exposed in 
an incident to protect them. 
 
Studies investigating the effects of decontamination on the dermal absorption 
of chemicals have also primarily focused on military exposure. In relation to 
organophosphate exposure, the most common chemical used to investigate 
the effects of decontamination is the chemical warfare agent VX (Hamilton et 
al. 2004, Bide et al. 2005, Taysse et al. 2007, Bjarnason et al. 2008). The 
majority of decontamination studies have been carried out using animal 
models in vivo, in particular the domestic pig and guinea pig, with the most 
common decontamination procedures being application of Fuller’s Earth or 
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reactive skin decontamination lotion (RSDL). Fuller’s Earth is frequently used 
as it is widely available and cheap to produce. It is generally an effective 
absorbent of a variety of chemical warfare agents; however, it does not 
detoxify agents, and also provides a dust hazard if being used outdoors. As a 
result of this, liquid skin surface decontaminants have become preferable, and 
led to the production of RSDL. The first formulation of RSDL was a solution of 
2, 3 butanedione mono-oximate and diacetyl mono-oxime in MPEG2, and is 
now commercially available, and used by a number of armies worldwide 
(Taysse et al. 2007). It has been commonly found that decontamination of pig 
skin in vivo after exposure to VX is effective at reducing clinical manifestations 
of VX exposure. The study by Hamilton et al. 2004 showed that 
decontamination of pig ear skin with RSDL 15 minutes after exposure resulted 
in arrested development of clinical symptoms of VX poisoning. Fuller’s Earth 
and RSDL have commonly been used as decontaminants for VX exposure 
and have both been shown to prevent cholinesterase inhibition as a result of 
VX exposure (Taysse et al. 2007). These results were supported by 
Bjarnason et al. 2008, who found that decontamination of pig skin with both 
RSDL and Fuller’s Earth 45 minutes after exposure to 5 times the LD50 for 
the domestic pig resulted in 100% survival. However, RSDL was found to be 
more effective at reducing clinical symptoms, as 50% of the surviving pigs 
decontaminated with Fuller’s Earth displayed classical symptoms of VX 
exposure. This study also found that decontamination of the skin surface with 
soapy water following VX exposure was completely ineffectual. However, 
decontamination of guinea pig skin with RSDL following VX exposure was 
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less effective, with only 36% of guinea pigs surviving after only a 1 minute 
exposure to VX (Bide et al. 2005). 
 
There is little in the published literature aimed specifically at civilian exposure, 
with the majority of studies using animal models in vivo, aimed at military 
exposure to chemical warfare agents. Therefore, high level exposures for 
short exposure times have traditionally been used. As a result of this, one of 
the main aims of these studies was to assess the effectiveness of 
decontamination using human skin in vitro, as this is widely regarded as the 
best model for human exposure in vivo, following low level exposure to 
surrogate organophosphate compounds.  
 
 
6.2: Aims and Methods 
The aims of these studies were to generate novel data regarding low level 
exposure of human skin to surrogate compounds in vitro in order to assess 
the ability of everyday clothing (cotton shirt material) to reduce dermal 
absorption of surrogate compounds (dichlorvos and chlorpyrifos), and also to 
identify the effect of decontaminating the skin surface using a simple soap 
solution (5% v/v in water) in relation to skin exposure to surrogate 
compounds. 
 
For the chlorpyrifos studies, 14C-labelled chlorpyrifos (500ng/cm2) was 
applied as a finite dose (10µl/cm2) and for the dichlorvos studies; dichlorvos 
was applied as a finite dose (10µl/cm2) at a concentration of 5µg/cm2. 
Clothing (cotton shirt material, 1cm2) was held in place above the skin surface 
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by screwing in the donor chamber attachment over the piece of shirt material, 
creating an approximately 1mm air gap between the clothing and the skin 
surface (figure 6). 
 
 
 
  
 
 
Fig.6. Schematic diagram of the flow through diffusion cell with clothing 
 
After exposure of clothed skin to 14C-labelled chlorpyrifos (4 hours) and 
dichlorvos (30 minutes), the donor chamber attachment was removed and the 
clothing was removed. Some of the diffusion cells had no clothing, and were 
decontaminated at the same time as the removal of clothing from the 
remaining diffusion cells. Decontamination was carried out by swabbing the 
skin surface with alternate wet and dry tissues (6 swabs in total), with the 
initial wet swab containing 0.5% soap solution (v/v), and the remaining wet 
swabs were carried out using water (to mimic washing with soap and water). 
Some of the cells had clothing removed and were also decontaminated at the 
same time, whereas others had clothing removed and were not 
decontaminated until 24 hours after the initial exposure. All cells were left for 
24 hours before terminal procedures were carried out to determine dermal 
distribution of the test compounds. 
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6.3: Results  
 
6.3.1: 4 hour exposure of dermatomed human breast skin (clothed and 
unclothed) to 14C-labelled chlorpyrifos in IPA and PG  
 
Methods 
For this study, a total of 18 flow-through diffusion cells were used for 2 in vitro 
flow-through diffusion cell experiments. 6 cells were left unclothed, but were 
decontaminated after 4 hour exposure to 14C-labelled chlorpyrifos applied in 
IPA or PG at a concentration of 500ng/cm2 (finite dose, 10µl/cm2). 6 cells were 
clothed, with removal and decontamination of the skin surface after 4 hours, 
and 6 cells were clothed, with removal at 4 hours after exposure, but no 
decontamination of the skin surface was carried out until after 24 hours. 
Samples were analysed by scintillation counting.  
 
Results 
The 24 hour cumulative absorption profile in figure 6.1 shows the absorption 
of chlorpyrifos (applied in IPA) following 4 hour exposure to clothed and 
unclothed skin. From this figure, it can be seen that decontamination of the 
unclothed skin surface with 5% soap solution after 4 hour exposure was the 
least effective at reducing dermal absorption of chlorpyrifos, with 11.6 ± 
0.9ng/cm2 being absorbed. The highest flux was also observed following 
exposure to unclothed skin compared with both clothed treatments (0.50 ± 
0.24ng/cm2/h for unclothed, 0.14 ± 0.06ng/cm2/h for clothed 4 hour removal 
and decontamination, and 0.26 ± 0.1ng/cm2/h for clothed, 4 hour removal and 
24 hour decontamination respectively) However, despite removal of the dose 
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from the skin surface after 4 hours, absorption continued to increase steadily 
over 24 hours. 
  
Although a higher flux was observed following removal of clothing at 4 hours 
followed by 24 hour decontamination of the skin surface, the actual amounts 
absorbed through the skin at 24 hours were not significantly different, with 5.2 
± 1.1ng/cm2 absorbed following removal of clothing at 4 hours and 
decontamination at 24 hours, and 4.9 ± 0.9ng/cm2 being absorbed following 
removal of clothing and decontamination at 4 hours respectively. Despite the 
presence of clothing up to 4 hours after exposure, absorption continued to 
increase over 24 hours with or without the decontamination step at 4 hours. 
Even though absorption continued to increase after all 3 treatments, 
absorption was significantly reduced when compared with the amount 
absorbed following 24 hour exposure to a finite dose chlorpyrifos in IPA 
(chapter 4), where 51.9 ± 11.1ng/cm2 was absorbed. This means that an 
approximately 5 fold reduction in absorption was observed following 
decontamination of unclothed skin after 4 hours, and an approximately 10 fold 
reduction in absorption was observed in the presence of clothing (with or 
without decontamination at 4 hours).  
 
The distribution profile (table 16 and figure 6.2) shows that the majority of the 
dose applied to clothed skin was retained within the cotton shirt material after 
4 hour exposure, as 86.1 ± 6.3% was recovered from clothing – 4 hour 
decontamination, and 79.3 ± 4.1% recovered from clothing – 24 hour 
decontamination respectively.  Also, the majority of the applied dose was 
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recovered from the skin surface of unclothed skin following 4 hour 
decontamination (84 ± 5.2% recovered in the skin surface wash). Results 
indicated that significantly more of the applied dose was recovered from the 
tape strips of unclothed skin compared with clothed skin (p<0.05 with one way 
ANOVA). More of the applied dose was also recovered from the skin digests 
and receptor fluid samples (absorbed) following 4 hour decontamination of 
unclothed skin compared with both clothed treatments. However, the 
differences here did not reach significance.  
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Figure 6.1. 24 hour cumulative absorption profile of chlorpyrifos applied in 
IPA to clothed and unclothed skin following 4 hour exposure. Values are mean ± 
SEM of 6 cells per treatment (18 cells in total, taken from 4 skin donors). Skin sections were 
mounted in flow through diffusion cells with an exposed area of 0.64cm2. Chlorpyrifos was 
applied to both clothed and unclothed dermatomed human breast skin surface as a finite 
dose (10µl/cm2) at a concentration of 500ng/cm2. Clothing was removed after 4 hour 
exposure and the skin either decontaminated using 5% (v/v) soap solution at 4 hours or 24 
hours after exposure. Unclothed skin samples were decontaminated after 4 hour exposure.  
 
 
 
 
 
Dose 
Flux 
(ng/cm2/h) 
Kp x 10-3 
(cm/h) Lag Time (h) 
Linear 
range 
Chlorpyrifos in IPA:unclothed - 4 
hour wash  
0.50 ± 
0.24 0.05 ± 0.002 0.58 ± 0.38 1-24 
Chlorpyrifos in IPA:clothed - 4 hour 
removal and decontamination  
0.26 ± 
0.10 0.02 ± 0.01 0.34 ± 0.12 1-9 
Chlorpyrifos in IPA:clothed - 4 hour 
removal , 24 hour decontamination 
0.14 ± 
0.06 0.002 ± 0.001 0.80 ± 0.26 4-14 
 
Table 15. Observed steady state absorption rates, partition coefficients and lag 
times following absorption of chlorpyrifos applied in IPA to clothed and 
unclothed skin, with removal of clothing at 4 hours and decontamination at 4 or 
24 hours 
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Figure 6.2. Dose distribution of chlorpyrifos applied to clothed and unclothed 
skin in IPA. Values are mean ± SEM of 6 cells per treatment (18 cells in total from 4 skin 
donors) over 2 studies. ‘clothing’ relates to the percentage of dose recovered from within the 
clothing after 4 hour exposure, ‘unabsorbed’ is the dose remaining on the skin surface after 
4 or 24 hour exposure, ‘tape strip’ is the dose recovered from the stratum corneum tape 
strips (no more than 15 per cell) after 24 hours, ‘skin digest’ is the percentage of dose 
recovered from within the skin membrane after 24 hours, and the absorbed dose is the 
percentage of the applied dose recovered from the receptor fluid samples after 24 hours.  
 
 
  
Clothing 
(%) 
Unabsorbed 
(%) 
tape strip 
(%) 
skin digest 
(%) 
Absorbed 
(%) 
Total 
(%) 
clothed - 
4h wash 86.1 2.98 0.51 0.86 1.08 91.5 
SEM 6.33 1.02 0.21 0.12 0.33 8.36 
unclothed 
4h wash   84.8* 2.79* 2.85 2.34 92.8 
SEM 
  7.01 0.86 0.94 0.45 9.92 
clothed - 
24h wash 79.3 2.88 0.56 1.59 0.72 85.0 
SEM 4.12 1.32 0.21 0.32 0.11 7.41 
 
Table 16. Table showing figures for the dose distribution of chlorpyrifos 
applied to clothed and unclothed skin in IPA (as shown in figure 6.2 above). 
Figures are expressed as percentage of dose applied to the skin surface. An asterisk (*) 
next to a figure denotes a statistically significant difference (p<0.05 with one way ANOVA).  
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The cumulative absorption profile of chlorpyrifos applied to clothed and 
unclothed skin in PG is shown in figure 6.3. This profile is similar to the profile 
of chlorpyrifos in IPA (figure 6.1), as the greatest absorption was seen when 
chlorpyrifos was applied to unclothed skin, followed by decontamination at 4 
hours (11.2 ± 1.6ng/cm2 absorbed after 24 hours). The lowest level of 
absorption was observed when clothing was removed and the skin surface 
decontaminated after 4 hours, with 1.3 ± 0.2ng/cm2 absorbed at 24 hours. A 
significant difference in absorption was observed between the two clothed 
skin treatments from the PG vehicle, the same was not seen following 
absorption from the IPA vehicle (figure 6.1). Absorption following 4 hour 
exposure to clothed skin followed by 24 hour decontamination led to 
approximately double the amount being absorbed compared with absorption 
through the skin following removal of clothing and skin surface 
decontamination after 4 hours (2.5 ± 0.4ng/cm2 absorbed through clothed skin 
- 24 hour wash, 1.3 ± 0.2ng/cm2 absorbed through clothed skin – 4 hour wash 
respectively) (p<0.05 with one way ANOVA).  
 
Despite a greater amount of chlorpyrifos absorption through the skin following 
removal of clothing at 4 hours with decontamination at 24 hours compared 
with 4 hour clothing removal and decontamination, the lag time for absorption 
was significantly longer following 24 hour decontamination (2.5 ± 0.9h), 
compared with 0.4 ± 0.2h following removal of clothing and decontamination 
at 4 hours.  Although absorption took approximately 5 times longer to reach 
steady state flux without decontamination immediately after removal of 
clothing, the steady state flux was approximately 2 fold greater without 
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decontamination following removal of clothing after 4 hour exposure (table 
16).  
 
The dose distribution at 24 hours after the initial exposure shown in figure 6.4 
and table 17 is similar to the distribution following exposure of clothed and 
unclothed skin to chlorpyrifos in IPA (figure 6.2). Again, the majority of the 
applied dose was retained within the cotton shirt material following 4 hour 
exposure to chlorpyrifos in PG (86.1 ± 8.1 for clothed – 4 hour wash, and 83.3 
± 7.3 for clothed – 24 hour wash). Significantly more chlorpyrifos was 
recovered from the stratum corneum tape strips taken from unclothed skin 
decontaminated after 4 hours following termination of the study at 24 hours 
after the initial exposure (5.9 ± 1.6% of the applied dose in the stratum 
corneum, compared with 0.5 ± 0.2% from clothed – 4 hour wash and 1.5 ± 
0.4% from clothed – 24 hour wash respectively).  A greater percentage of the 
applied dose was also recovered from within the skin membrane at 24 hours 
from the unclothed skin compared with the two clothed skin treatments; 
however, this was not statistically significant.  
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Figure 6.3. 24 hour cumulative absorption profile of chlorpyrifos applied in PG 
to clothed and unclothed skin following 4 hour exposure. Values are means ± SEM 
of 7 cells per treatment (21 cells in total, taken from 5 skin donors) over 2 studies. Skin 
sections were mounted in flow through diffusion cells with an exposed area of 0.64cm2. 
Chlorpyrifos was applied to both clothed and unclothed dermatomed human breast skin 
surface as a finite dose (10µl/cm2) at a concentration of 500ng/cm2. Clothing was removed 
after 4 hour exposure and the skin either decontaminated using 5% (v/v) soap solution at 4 
hours or 24 hours after exposure. Unclothed skin samples were decontaminated after 4 
hour exposure.  
 
 
 
Dose 
Flux 
(ng/cm2/h) 
Kp x 10-3 
(cm/h) 
Lag Time 
(h) 
Linear 
range 
Chlorpyrifos in PG:unclothed - 4 hour 
wash  
0.81 ± 
0.23** 
0.02 ± 
0.01 2.4 ± 0.8* 3-9 
Chlorpyrifos in PG:clothed - 4 hour 
removal and decontamination  
0.14 ± 
0.05 
0.002 ± 
0.001 0.4 ± 0.2 1-10 
Chlorpyrifos in PG:clothed - 4 hour 
removal , 24 hour decontamination 
0.06 ± 
0.02 
0.003 ± 
0.001 2.5 ± 0.9* 6-12 
 
Table 17. Observed steady state absorption rates, partition coefficients and lag 
times of chlorpyrifos applied to clothed and unclothed skin in a PG vehicle. An 
asterisk (*) next to a figure denotes a statistically significant difference from the remaining 
figures in each column (one way ANOVA, p<0.05). A double asterisk denotes that that figure 
is statistically significant from the remaining 2 figures in the column.  
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Figure 6.4. Dose distribution of chlorpyrifos applied to clothed and unclothed 
skin in PG. Values are means ± SEM of 7 cells per treatment (21 cells in total from 5 skin 
donors) over 2 studies. ‘clothing’ relates to the percentage of dose recovered from within the 
clothing after 4 hour exposure, ‘unabsorbed’ is the dose remaining on the skin surface after 
4 or 24 hour exposure, ‘tape strip’ is the dose recovered from the stratum corneum tape 
strips (no more than 15 per cell) after 24 hours, ‘skin digest’ is the percentage of dose 
recovered from within the skin membrane after 24 hours, and the absorbed dose is the 
percentage of the applied dose recovered from the receptor fluid samples after 24 hours.  
 
 
 
 
  
clothing unabsorbed tape strip skin digest absorbed total 
clothed - 4h 
wash 86.1 4.9 0.5 0.9 1.1 93.5 
SEM 8.09 1.12 0.20 0.16 0.09 9.21 
unclothed 4h 
wash   81.01** 5.8** 2.9* 2.2* 92.1 
SEM 
  7.09 1.60 0.85 0.35 8.32 
clothed - 24h 
wash 83.3 5.3 1.4 1.8 0.6 92.5 
SEM 7.32 2.05 0.46 0.63 0.12 7.81 
 
Table 18. Figures for the distribution of chlorpyrifos applied to clothed and 
unclothed human skin in a PG vehicle (as shown in figure 6.4 above). An asterisk 
(*) next to a figure denotes a significant difference with the lowest figure in each column, but 
not both remaining figures. A double asterisk denotes a significant difference with both 
remaining figures in the column (p<0.05 with one way ANOVA).  
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6.3.2: 30 minute exposure of dermatomed human breast skin (clothed 
and unclothed) to dichlorvos in IPA 
 
 
Methods 
For the purposes of this study, 12 flow-through diffusion cells were used 
containing skin from 2 human breast skin donors. The finite dose of dichlorvos 
in IPA (10µl/cm2, concentration - 5µg/cm2) was applied to the skin under 
unclothed conditions, and to the clothing under clothed conditions. After a 30 
minute exposure, the clothing was removed from the skin surface. Of the 12 
cells used, 4 cells had clothing removed and also had the skin surface 
decontaminated using 5% soap solution (v/v),  4 cells had clothing removed 
but without decontamination until 24 hours after exposure, and 4 unclothed 
cells were decontaminated at 30 minutes using 5% soap solution. Following 
removal of clothing and decontamination at 30 minutes, all cells were left for 
24 hours, where terminal procedures were undertaken to assess the dermal 
distribution of dichlorvos applied to the skin. Sample analysis was carried out 
by GC-MS. 
 
Results 
The cumulative absorption of dichlorvos applied to clothed and unclothed 
dermatomed human breast skin in IPA is shown in figure 6.5.  From this 
figure, it can be seen that absorption of dichlorvos applied in IPA was 
significantly greater through unclothed skin compared with clothed skin 
(p<0.05 with one way ANOVA). Despite skin surface decontamination at 30 
minutes after exposure, 501.7 ± 113.5ng/cm2 of dichlorvos was absorbed 
through unclothed skin after 24 hours. This was approximately 10% of the 
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applied dose. The rate of absorption from the IPA vehicle after 
decontamination with 5% soap solution was fastest over the first 2 hours (220 
± 26.3ng/cm2/h, table 19), before rapidly tailing off up to 24 hours. This was 
despite absorption through unclothed skin generating the longest observed 
lag time of all the treatments (0.6 ± 0.3h, compared with 0.3 ± 0.1h for clothed 
– 30 minute decontamination, and 0.2 ± 0.1h for clothed – 24 hour 
decontamination, shown in table 19).   From the two clothing treatments, it can 
also be seen that approximately double the amount of dichlorvos was 
absorbed following removal of clothing at 30 minutes followed by 24 hour skin 
surface decontamination compared with absorption after removal of clothing 
at 30 minutes with decontamination at 30 minutes (129.2 ± 16.6ng/cm2 
through clothed – 24 hour wash, and 63.2 ± 13.6ng/cm2 through clothed – 30 
minute wash) (p<0.05 with one way ANOVA). When compared with 24 hour 
exposure of human breast skin to dichlorvos in IPA (figure 4.3, chapter 4), it 
can be seen that absorption was greatly reduced for all 3 treatments. 
Absorption through unclothed skin decontaminated after 30 minutes was 
reduced by approximately a third when compared with 24 hour exposure, 
whereas absorption through clothed skin was reduced by 15 fold through 
clothed skin with decontamination at 24 hours, and by approximately 30 fold 
through clothed skin with decontamination at 30 minutes after initial exposure.  
 
From the dose distribution graph shown in figure 6.6, it can be seen that the 
majority of the applied dose of dichlorvos was recovered from the cotton shirt 
material following removal of clothing at 30 minutes after exposure (74.3 ± 
8.3% from clothed – 30 minute wash, and 70.8 ± 7.6% from clothed – 24 hour 
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wash respectively). The majority of the applied dose of dichlorvos was also 
recovered from the surface of the unclothed skin following 30 minute 
decontamination (73.4 ± 7.2%). Despite the presence of clothing on some of 
the cells, approximately 15% of the applied dose was still recovered from the 
skin surface swabs following decontamination at both 30 minutes and 24 
hours after the initial exposure. Significantly more of the applied dose of 
dichlorvos was recovered from the stratum corneum tape strips, the skin 
digests and receptor fluid (absorbed) of unclothed skin decontaminated at 30 
minutes after exposure (p<0.05 with one way ANOVA). 
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Figure 6.5. 24 hour cumulative absorption profile of dichlorvos applied in IPA 
to clothed and unclothed skin following 0.5 hour exposure. Values are mean ± 
SEM of 4 cells per treatment (12 cells in total, taken from 2 skin donors). Skin sections were 
mounted in flow through diffusion cells with an exposed area of 0.64cm2. Dichlorvos was 
applied to both clothed and unclothed dermatomed human breast skin surface as a finite 
dose (10µl/cm2) at a concentration of 5µg/cm2. Clothing was removed after 0.5 hour 
exposure and the skin either decontaminated using 5% (v/v) soap solution at 0.5 hours or 
24 hours after exposure. Unclothed skin samples were decontaminated after 0.5 hour 
exposure.  
 
 
 
 
Dose 
Flux 
(ng/cm2/h) 
Kp x 10-3 
(cm/h) 
Lag Time 
(h) 
Linear 
range 
Dichlorvos in IPA: unclothed 
30 min decontamination 
220.0 ± 
26.3** 
214.1 ± 
21.10** 
0.66 ± 
0.26* 1-2 
Dichlorvos in IPA: clothed 30 
min decontamination 5.8 ± 1.2 5.16 ± 1.4 0.31 ± 0.07 0-7 
Dichlorvos in IPA: clothed 24 
hour decontamination 10.8 ± 2.1 10.2 ± 1.8 0.22 ± 0.05 0-6 
 
Table 19. Observed steady state absorption rates, partition coefficients and lag 
times following exposure of clothed and unclothed skin to dichlorvos in IPA. A 
single asterisk denotes that the figure is significantly different from the lowest figure in the 
same column. A double asterisk denotes that that figure is statistically significant compared 
with the remaining two figures in the column. (p<0.05 with one way ANOVA).  
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Figure 6.6. Dose distribution of dichlorvos applied to clothed and unclothed 
skin in IPA. Values are mean ± SEM of 4 cells per treatment (12 cells in total from 2 skin 
donors). ‘clothing’ relates to the percentage of dose recovered from within the clothing after 
0.5 hour exposure, ‘unabsorbed’ is the dose remaining on the skin surface after 0.5 or 24 
hour exposure, ‘tape strip’ is the dose recovered from the stratum corneum tape strips (no 
more than 15 per cell) after 24 hours, ‘skin digest’ is the percentage of dose recovered from 
within the skin membrane after 24 hours, and the absorbed dose is the percentage of the 
applied dose recovered from the receptor fluid samples after 24 hours. 
 
 
  
Clothing 
(%) 
Unabsorbed 
(%) 
tape strip 
(%) Skin (%) 
Absorbed 
(%) 
Total 
(%) 
clothed - 30 min wash 74.3 16.9 3.80** 1.13 1.26 97.9 
SEM 8.37 3.11 1.07 0.11 0.18 10.1 
unclothed - 30 min wash   73.3** 7.97** 3.83** 9.55** 94.7 
SEM 
  7.22 1.03 0.84 2.32 8.32 
clothed - 24hr wash 70.8 14.8 1.08 1.17 2.58 90.5 
SEM 7.66 2.87 0.15 0.18 0.51 9.36 
 
 Table 20. Figures for the distribution of dichlorvos applied to clothed and 
unclothed human skin in an IPA vehicle (as shown in figure 6.6 above). A double 
asterisk denotes that a figure is statistically significant from both of the remaining figures in 
the same column (p<0.05 with one way ANOVA).   
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6.3.3: 30 minute exposure of dermatomed human breast skin (clothed 
and unclothed) to dichlorvos in IPM 
 
Methods 
For this study, 12 flow-through diffusion cells were used, containing human 
breast skin from 2 different donors. A finite dose of dichlorvos in IPM 
(10µl/cm2, concentration at 5µg/cm2) was applied to the skin surface under 
unclothed conditions, and directly to the clothing under clothed conditions. 
Following 30 minute exposure, the 4 unclothed cells were decontaminated 
with 5% soap solution (v/v), 4 clothed cells had clothing removed and the skin 
surfaces were decontaminated immediately using soap solution, and the 
remaining clothed cells had clothing removed but the skin surfaces were not 
decontaminated until 24 hours after exposure. All cells were left in the flow-
through diffusion system for 24 hours at which point, terminal procedures 
were undertaken to assess the dermal distribution of dichlorvos applied to the 
skin. 
 
Results 
The cumulative absorption profile of dichlorvos applied to clothed and 
unclothed skin in IPM was different from the profile shown with dichlorvos 
applied in IPA as can be seen in figure 6.7. Once again, absorption through 
the skin was significantly greater through unclothed skin decontaminated at 30 
minutes, compared with the two clothed treatments (p<0.05 with one way 
ANOVA). Approximately 6.5 ± 2.1% (322.5 ± 63.2ng/cm2) was absorbed 
through unclothed skin at 24 hours following 30 minute skin surface 
decontamination. Absorption through unclothed skin was approximately 6 fold 
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greater than through clothed skin decontaminated at 30 minutes (56.9 ± 
5.2ng/cm2), and approximately 4 fold greater than through clothed skin 
decontaminated at 24 hours (81.83 ± 10.42ng/cm2). The rate of absorption 
through unclothed skin was greater than through skin for either of the clothed 
treatments (19.2 ± 5.6ng/cm2/h through unclothed skin, 3.62 ± 0.81ng/cm2/h 
through clothed skin – 30 minute wash, and 6.4 ± 1.9ng/cm2/h through clothed 
skin – 24 hour wash). The significantly higher absorption and absorption rate 
through unclothed skin was observed despite a marginally longer lag time in 
comparison to the clothed skin treatments (0.35 ± 0.13h for unclothed, 0.14 ± 
0.04h for clothed – 30 minute wash, and 0.24 ± 0.07h for clothed – 24 hour 
wash) (table 21). No significant differences were observed in the amount of 
dichlorvos absorbed through clothed skin decontaminated at 30 minutes, or 
24 hours after initial exposure, although a numerical decrease was observed.  
 
From the dose distribution graph shown in figure 6.8, and the dose distribution 
table (table 22), it can be seen that the majority of the applied dose was either 
recovered from within the clothing (77.2 ± 8.4% for clothed – 30 minute wash, 
73.6 ± 9.3% for clothed – 24 hour wash), or from the skin surface swabs 
following 30 minute decontamination of unclothed skin (83.3 ± 11.6%). It can 
also be seen that approximately 12-14% of the applied dose of dichlorvos was 
recovered from the skin surface of clothed skin following decontamination of 
the skin surface after 30 minutes or 24 hours.  A greater proportion of the 
applied dose was recovered within the stratum corneum tape strips of 
unclothed skin (3.6 ± 0.9%) compared with clothed skin (1.34 ± 0.5% from 
clothed – 30 minute decontamination, and 2.5 ± 1% from clothed – 24 hour 
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decontamination). A greater proportion of the applied dose of dichlorvos was 
also recovered from within the skin membranes of unclothed skin following 30 
minute decontamination (1.57 ± 0.36%) compared with 0.87 ± 0.12% from 
clothed skin decontaminated at 30 minutes, and 1.55 ± 0.44% from clothed 
skin decontaminated at 24 hours. Despite the greater recovery from the tape 
strips and skin membranes from the unclothed treatment compared with the 
two clothed treatments, the results obtained were not statistically significant.  
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Figure 6.7. 24 hour cumulative absorption profile of dichlorvos applied in IPM 
to clothed and unclothed skin following 0.5 hour exposure. Values are mean ± 
SEM of 4 cells per treatment (12 cells in total, taken from 2 skin donors). Skin sections were 
mounted in flow through diffusion cells with an exposed area of 0.64cm2. Dichlorvos was 
applied to both clothed and unclothed dermatomed human breast skin surface as a finite 
dose (10µl/cm2) at a concentration of 5µg/cm2. Clothing was removed after 0.5 hour 
exposure and the skin either decontaminated using 5% (v/v) soap solution at 0.5 hours or 
24 hours after exposure. Unclothed skin samples were decontaminated after 0.5 hour 
exposure.  
 
 
 
 
Dose 
Flux 
(ng/cm2/h) Kp x 10-3 (cm/h) 
Lag Time 
(h) 
Linear 
range 
Dichlorvos in IPM: unclothed 30 
min decontamination 
19.25 ± 
5.62** 20.8 ± 5.32* 
0.35 ± 
0.13* 0-8 
Dichlorvos in IPM: clothed 30 min 
decontamination 3.62 ± 0.81 2.71 ± 0.25 
0.14 ± 
0.04 0-5 
Dichlorvos in IPM: clothed 24 hour 
decontamination 6.42 ± 1.91 6.29 ± 1.12* 
0.24 ± 
0.07 1-8 
 
Table 21. Observed steady state absorption rates, partition coefficients and lag 
times following exposure of clothed and unclothed human skin to dichlorvos in 
IPM. A single asterisk denotes that a figure is statistically significant compared with the 
lowest figure in the same column. A double asterisk denotes that a figure is statistically 
significant from both of the remaining figures in the same column (p<0.05 with one way 
ANOVA).  
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Figure 6.8. Dose distribution of dichlorvos applied to clothed and unclothed 
skin in IPM. Values are mean ± SEM of 4 cells per treatment (12 cells in total from 2 skin 
donors). ‘clothing’ relates to the percentage of dose recovered from within the clothing after 
0.5 hour exposure, ‘unabsorbed’ is the dose remaining on the skin surface after 0.5 or 24 
hour exposure, ‘tape strip’ is the dose recovered from the stratum corneum tape strips (no 
more than 15 per cell) after 24 hours, ‘skin digest’ is the percentage of dose recovered from 
within the skin membrane after 24 hours, and the absorbed dose is the percentage of the 
applied dose recovered from the receptor fluid samples after 24 hours. 
 
 
  
clothing unabsorbed 
tape 
strip skin absorbed total 
clothed - 30 min 
wash 77.23 12.12 1.34 0.87 1.13 92.69 
SEM 8.37 2.11 0.47 0.12 0.28 8.96 
unclothed - 30 min 
wash   83.32** 3.59 1.57 6.44** 94.92 
SEM 
  11.64 0.97 0.36 2.11 9.31 
clothed - 24hr 
wash 73.61 14.32 2.46 1.55 1.62 94.7 
SEM 9.32 2.66 1.03 0.44 0.56 10.31 
 
Table 22. Table of figures for the dermal distribution of dichlorvos applied to 
clothed and unclothed human skin in an IPM vehicle (as shown in figure 6.8 
above). A double asterisk next to a figure denotes that this figure is significantly different 
compared with the remaining two figures in the same column 9p<0.05 with one way 
ANOVA).  
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6.3.4: 30 minute exposure of dermatomed human breast skin (clothed 
and unclothed) to dichlorvos in PG 
 
Methods 
For this study, 12 flow-through diffusion cells were used, containing human 
breast skin from 2 different donors. A finite dose of dichlorvos in PG 
(10µl/cm2, concentration at 5µg/cm2) was applied to the skin surface under 
unclothed conditions, and directly to the clothing under clothed conditions. 
Following 30 minute exposure, the 4 unclothed cells were decontaminated 
with 5% soap solution (v/v), 4 clothed cells had clothing removed and the skin 
surfaces were decontaminated immediately using soap solution, and the 
remaining clothed cells had clothing removed but the skin surfaces were not 
decontaminated until 24 hours after exposure. All cells were left in the flow-
through diffusion system for 24 hours at which point, terminal procedures 
were undertaken to assess the dermal distribution of dichlorvos applied to the 
skin. 
 
Results 
The cumulative absorption profiles shown in figure 6.9 are in keeping with all 
of the absorption profiles of dichlorvos through clothed and unclothed skin 
shown previously throughout this chapter. It can be seen that absorption of 
dichlorvos applied in a PG vehicle was greater through unclothed skin 
decontaminated after 30 minutes  (446.59 ± 51.33ng/cm2) than through 
clothed skin (53.60 ± 7.44ng/cm2 absorbed through clothed skin 
decontaminated at 30 minutes, and 107.64ng/cm2 absorbed through clothed 
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skin decontaminated at 24 hours). The amount of dichlorvos absorbed at 24 
hours was significantly different between all 3 treatments (p<0.05 with one 
way ANOVA). The lag times were short despite the presence of clothing (0.12 
± 0.04h for clothed skin decontaminated at 30 minutes and 0.13 ± 0.02h for 
clothed skin decontaminated at 24 hours after exposure) (table 22). 
Absorption continued to increase up to 24 hours after the initial exposure to 
dichlorvos despite removal of the majority of the applied dose after 30 minutes 
of exposure. Despite this increase, the amounts absorbed through the skin 
were significantly lower compared to the amount absorbed following 24 hour 
exposure of human breast skin to dichlorvos in a PG vehicle (figure 4.3, 
chapter 4). Here, it was shown that 36.2 ± 3.41% of the applied dose was 
absorbed, meaning that a 4–fold reduction in absorption was observed 
through unclothed skin decontaminated at 30 minutes after exposure, an 
approximately 16-fold decrease in absorption through clothed skin 
decontaminated at 24 hours, and a 30-fold reduction in absorption was 
observed through clothed skin decontaminated after a 30 minute exposure.  
 
The dose distribution of dichlorvos applied in a PG vehicle can be seen in 
figure 6.10. Once again, this follows a very similar pattern to the dose 
distribution of dichlorvos in both the IPA and the IPM vehicle, with the majority 
of the applied dose recovered either from within the cotton shirt material (69.1 
± 10.3% from clothed – 30 minute wash, and 62.3 ± 7.61% from clothed – 24 
hour wash), or from the skin surface of unclothed skin decontaminated at 30 
minutes after exposure (68.3 ± 7.32%). Also, between 11 and 15% of the 
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applied dose was recovered from the skin surface after 30 minute and 24 hour 
decontamination, despite the presence of clothing for both treatments.  
 
It can also be seen that the percentage of the applied dose of dichlorvos 
recovered from the stratum corneum tape strips and the skin membranes was 
greater for unclothed skin compared with clothed skin. However, the amount 
of dichlorvos recovered from the tape strips of the stratum corneum from both 
clothed treatments was greater following application in a PG vehicle than from 
either the IPA or IPM vehicles. 3.95 ± 0.66% was recovered from tape strips 
from clothed skin decontaminated at 30 minutes, and 4.22 ± 0.73% was 
recovered from tape strips of clothed skin decontaminated at 24 hours 
respectively.    
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Figure 6.9. 24 hour cumulative absorption profile of dichlorvos applied in PG 
to clothed and unclothed skin following 0.5 hour exposure. Values are means ± 
SEM of 4 cells per treatment (12 cells in total, taken from 2 skin donors). Skin sections were 
mounted in flow through diffusion cells with an exposed area of 0.64cm2. Dichlorvos was 
applied to both clothed and unclothed dermatomed human breast skin surface as a finite 
dose (10µl/cm2) at a concentration of 5µg/cm2. Clothing was removed after 0.5 hour 
exposure and the skin either decontaminated using 5% (v/v) soap solution at 0.5 hours or 
24 hours after exposure. Unclothed skin samples were decontaminated after 0.5 hour 
exposure. 
 
 
 
 
Dose 
Flux 
(ng/cm2/h) 
Kp x 10-3 
(cm/h) Lag Time (h) Linear range 
Dichlorvos in PG: unclothed 30 
min decontamination 30.1 ± 7.33** 27.6 ± 6.2** 0.28 ± 0.11* 0-5 
Dichlorvos in PG: clothed 30 min 
decontamination 3.77 ± 0.91 3.8 ± 1.2 0.12 ± 0.04 0-8 
Dichlorvos in PG: clothed 24 hour 
decontamination 7.12 ± 2.10 6.36 ± 1.9 0.13 ± 0.02 0-8 
 
Table 23. Observed steady state absorption rates, partition coefficients and lag 
times of dichlorvos applied to the skin surface in a PG vehicle. A single asterisk 
next to a figure denotes that this figure is statistically significant from the lowest figure in the 
same column. A double asterisk denotes that a figure is significantly different from the 
remaning two figures in the same column (p<0.05 with one way ANOVA).  
6. Results 
165 
0
20
40
60
80
100
120
clothing unabsorbed tape strip skin absorbed total
compartment
pe
rc
en
ta
ge
 
o
f a
pp
lie
d 
do
se
 
re
co
v
er
ed
clothed - 30
min wash
unclothed -
30 min wash
clothed - 24hr
wash
 
Figure 6.10. Dose distribution of dichlorvos applied to clothed and unclothed 
skin in PG. Values are means ± SEM of 4 cells per treatment (12 cells in total from 2 skin 
donors). ‘clothing’ relates to the percentage of dose recovered from within the clothing after 
0.5 hour exposure, ‘unabsorbed’ is the dose remaining on the skin surface after 0.5 or 24 
hour exposure, ‘tape strip’ is the dose recovered from the stratum corneum tape strips (no 
more than 15 per cell) after 24 hours, ‘skin digest’ is the percentage of dose recovered from 
within the skin membrane after 24 hours, and the absorbed dose is the percentage of the 
applied dose recovered from the receptor fluid samples after 24 hours. 
 
 
 
  
clothing unabsorbed 
tape 
strip skin absorbed total 
clothed - 30 min wash 69.1 11.3 3.95 1.42 1.23 86.9 
SEM 10.30 1.86 0.66 0.07 0.21 11.24 
unclothed - 30 min 
wash   68.3** 8.62* 3.69** 8.92** 89.5 
SEM 
  7.32 2.35 0.97 2.14 7.66 
clothed - 24hr wash 62.3 15.9 4.22 1.92 2.14 86.5 
SEM 7.61 3.65 0.67 0.52 0.84 8.32 
 
Table 24. Table of figures for the dermal distribution of dichlorvos applied to 
clothed and unclothed human skin in a PG vehicle (as shown in figure 6.10 
above). A single asterisk next to a figure denotes that a figure is significantly different from 
the lowest figure in the same column. A double asterisk next to a figure denotes that a figure 
is significantly different from the remaining two figures in the same column (p<0.05 with one 
way ANOVA).  
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6.4: Discussion 
 
 
6.4.1: Chlorpyrifos 
The time of 4 hours for removal of clothing and decontamination of the skin 
surface following exposure to chlorpyrifos was chosen based on the lag times 
of chlorpyrifos applied in IPA (5.91 ± 1.36h) and PG (8.4 ± 2.9h) following 24 
hour exposure. This time point would allow some absorption to occur prior to 
steady state absorption being reached, and also provided a reasonable time 
frame in which an individual may remove decontaminated clothing in a real life 
scenario.   
 
Decontamination of chlorpyrifos from the surface of unclothed skin at 4 hours 
was the least effective method for reducing dermal absorption measured at 24 
hours after exposure. This was expected; as it was hypothesised that 
everyday cotton shirt material would provide more of a barrier to absorption 
than decontamination with 5% soap solution alone. Two clothing treatments 
were used, removal of clothing at 4 hours after exposure supplemented with 
decontamination of the skin surface at 4 hours, and removal of clothing at 4 
hours after exposure with washing of the skin surface at 24 hours. There was 
no difference in the amount of chlorpyrifos absorbed at 24 hours between the 
two clothing treatments when applied to the skin in IPA, however, a significant 
reduction in absorption was seen when removal of clothing at 4 hours was 
supplemented with skin surface decontamination at 4 hours when chlorpyrifos 
was applied in a PG vehicle. It was expected that decontamination of the skin 
surface and removal of clothing carried out at the same time would help to 
reduce absorption as it would be a more thorough decontamination 
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procedure. It is possible that the skin surface decontamination may not have 
been as necessary when removing the dose applied in the IPA vehicle due to 
the volatility of the vehicle. This would mean that less of the applied dose 
would soak through the clothing and reach the skin surface to become 
available for dermal absorption.  
 
As expected, the clothing retained the majority of the applied dose applied in 
IPA and PG; however, the amount recovered from the skin surface following 
removal of the clothing following application in the IPA vehicle was 
approximately half of the amount of chlorpyrifos recovered from the skin 
surface following application in PG. It is possible that the non-volatile PG 
vehicle may have kept the cotton shirt material wet for longer than when 
applied in IPA, and therefore may have resulted in longer contact with the skin 
surface to allow deposition of chlorpyrifos on the skin surface.  
 
Despite absorption being significantly higher following application of 
chlorpyrifos in both IPA and PG to unclothed skin decontaminated at 4 hours 
compared with the two clothed skin treatments, all 3 of the decontamination 
regimes were effective at reducing absorption compared with 24 hour 
exposure to the chlorpyrifos in IPA and PG (chapter 4). Absorption of 
chlorpyrifos applied as a finite dose in IPA, and left in contact with the skin for 
24 hours resulted in absorption of 10.38 ± 2.60% of the dose, and 19.55 ± 
2.36% of the applied dose in PG was absorbed at 24 hours. Absorption of 
chlorpyrifos was greatest through unclothed skin when applied in both IPA 
(2.34 ± 0.46%), and PG (2.24 ± 0.35%). Although the amount of chlorpyrifos 
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absorbed through unclothed skin decontaminated at 4 hours was similar 
between vehicles, the reduction in absorption from the PG vehicle was far 
greater than from the IPA vehicle following decontamination at 4 hours, when 
compared with 24 hour exposure. Absorption from the IPA vehicle following 
decontamination of unclothed skin at 4 hours was reduced by approximately 5 
fold, whereas absorption from the PG vehicle was reduced by approximately 9 
fold. It is possible that the greater reduction in absorption through clothed skin 
from the PG vehicle compared with 24 hour exposure is likely to be due to the 
physicochemical properties of PG. As PG has been shown to enhance 
penetration through the skin, it is possible that the presence of clothing greatly 
reduces the ability of PG to perturb the lipid formation of the stratum corneum, 
and so the difference in absorption would be greater when compared with 
absorption from the IPA vehicle, which evaporates rapidly from the skin 
surface.  
 
6.4.2: Dichlorvos 
The lag times observed following 24 hour exposure to dichlorvos in IPA, IPM 
and PG were shorter than for exposure to chlorpyrifos in the same vehicles, 
and so the clothing removal and decontamination time was altered to 30 
minutes after exposure for dichlorvos.  It was decided that the 
decontamination times would be set around the time at which dichlorvos had 
been seen to reach steady state flux, to identify how removal of the dose at 
this point would affect absorption.  
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Similar results to the chlorpyrifos data were obtained following 30 minute 
exposure of clothed and unclothed skin to dichlorvos in IPA, IPM and PG 
vehicles. As expected, absorption was found to be significantly higher 
following decontamination of unclothed skin at 30 minutes after exposure 
when compared with absorption through clothed skin regardless of the 
application vehicle. It was expected that absorption would be greatest from 
the PG vehicle as this was the most hydrophilic of the vehicles used, however, 
the greatest absorption was observed following exposure of unclothed skin to 
dichlorvos in the IPA vehicle. It is possible that the rapid evaporation of IPA 
may have caused an increase in concentration of dichlorvos on the skin 
surface and resulted in faster absorption within the first 2 hours of exposure. 
Due to skin surface decontamination being carried out using an aqueous soap 
solution, it is likely that removal of the dose in PG would be more successful 
than removal with IPA and IPM, as PG is a hydrophilic solvent.  
 
Despite the amount of dichlorvos absorbed being greater through unclothed 
skin following decontamination at 30 minutes after application in IPA, the 
actual reduction in absorption compared with 24 hour exposure to dichlorvos 
in IPA, IPM and PG was similar for all vehicles. An approximately 4 fold 
reduction in absorption from IPA and PG was seen following skin 
decontamination at 30 minutes, and an approximately 5 fold reduction was 
observed following exposure of unclothed skin to dichlorvos in IPM. This 
suggests that decontamination of the skin with an aqueous soap solution was 
successful regardless of the application vehicle used.  
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These studies indicate that removal of contaminated clothing and skin surface 
decontamination within 4 hours of exposure to chlorpyrifos, and within 30 
minutes of exposure to dichlorvos can significantly reduce the amount of 
chemical being absorbed through the skin. From a real life exposure 
perspective, an approximate 4 hour window of opportunity to significantly 
reduce absorption following exposure to chlorpyrifos gives a greater 
opportunity to reduce any potential toxic effects resulting from systemic 
absorption. However, due to the rapid absorption of dichlorvos into the skin, 
particularly from the IPA vehicle, decontamination of the skin surface would 
potentially have to occur immediately after exposure in order to prevent 
significant absorption of dichlorvos occurring.  
 
These studies indicate that, although everyday clothing is not primarily 
designed for protective purposes, it could potentially help to reduce chemical 
to skin contact. This in turn may be vitally important in reducing local and 
systemic toxic effects that can occur as a result of dermal absorption.  
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7. Effect of clothing and decontamination on dermal absorption of neat 
14C-labelled HD and dilute 14C-labelled HD in IPA.  
 
 
7.1: Introduction 
 
Following the 24 hour absorption studies carried out at Dstl using neat HD, 
and diluted HD in IPA; further studies were conducted to investigate how 
effective everyday clothing (cotton shirt material) was at reducing dermal 
absorption of neat HD and dilute HD in IPA under similar conditions. 
Comparison was also made with the effect of clothing on dermal absorption of 
surrogate compounds 
 
Previous studies have investigated the effect of decontamination using fuller’s 
earth (used in laboratories to clean up spillages of HD), Ambergard (a 
decontaminating agent used in military exposure scenarios), and BDH spillage 
granules in response to exposure to neat HD (Chilcott et al. 2001). This study 
also investigated the differences in absorption and decontamination between 
human breast, and pig ear skin. Other studies have also investigated the 
effect of barrier creams at reducing absorption of neat HD through human skin 
in vitro (Chilcott et al. 2002), and also through pig skin in vivo and in vitro 
(Chilcott et al. 2007). These studies have all been undertaken from the 
perspective of military personnel becoming exposed to high levels of HD. The 
influence of clothing on HD absorption has been investigated previously using 
man-in-simulant testing (MIST) as reported by Duncan and Gudgin Dickson, 
2003. Individuals were exposed to methyl salicylate, as an HD surrogate, 
whilst wearing military protective equipment, Data was compared with 
archived data for military exposure to HD (Gudgin Dickson, 2008). 
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At present, there is little published data regarding the protective qualities of 
‘everyday’ clothing against HD absorption. In particular, with reference to low 
level exposure of civilians on the periphery of a chemical release. Historically, 
HD has been used as a chemical warfare agent, and existing knowledge on 
HD skin exposure, and protection against it, has primarily focused on military 
scenarios. As a result of this, it was decided that it would be useful to 
generate novel data for low level exposure to HD (neat and diluted in a 
solvent vehicle (IPA)) of clothed human skin in vitro using ‘everyday’ cotton 
shirt material  
 
 
7.2: Results 
 
 
7.2.1: 1hour exposure of clothed full thickness (FT) human breast skin to 
neat HD 
 
 
Methods 
For this study, 12 static diffusion cells were used. The static diffusion cells 
used had an exposed surface area of 2.54cm2. All skin samples were covered 
with a small piece of cotton shirt material onto which the dose was applied. 
Half of the cells dosed with 25.4mg/cell of neat HD, and the remaining 6 cells 
were dosed with 1.25mg/cell of dilute HD in IPA applied as a finite dose 
(20µl). Each dose contained approximately 0.185MBq or radiolabelled HD per 
static cell. The cotton shirt material was placed on top of the skin on a 1mm x 
1mm steel washer to create a 1mm air gap to simulate how clothing would be 
worn in a real life scenario. The clothing was removed from all cells after 1 
hour exposure. For half of the cells, clothing was removed and the skin 
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surface was decontaminated using 5% soap solution immediately after 
removal of clothing. For the remaining cells, clothing was removed after 1 
hour, with decontamination of the skin surface being carried out at the end of 
the experiment (24 hours).  
 
Results 
From figure 7.1, it can be seen that removal of clothing and skin 
decontamination at 1 hour reduced the cumulative absorption of neat HD 
compared with just removal of clothing at 1 hour. A similar outcome was 
observed when HD diluted in IPA was used instead of neat HD (figure 7.3). 
Neat HD absorbed to  the receptor fluid continued to increase over 24 hours 
despite the fact that the clothing upon which the dose was applied was 
removed after 1 hour exposure, and that the dose was finite (20µl). However, 
although absorption from both clothing treatments continued to increase, the 
amount absorbed following dose deposition on clothing (cotton shirt) was 
significantly reduced when compared with 24 hour exposure. Following 24 
hour exposure to neat HD, 25.3 ± 5.2% of the applied dose was recovered 
from the receptor fluid, and 58.3 ± 6.5% of the applied dose was recovered 
from within the skin membrane following digestion in soluene.  
 
The dose distribution graph for neat HD (figure 7.2) shows that the majority of 
the applied dose of neat HD was retained within the clothing after 1 hour 
exposure.  Following application to clothed skin, absorption was significantly 
reduced when compared with the percentage of applied dose absorbed after 
24 hour exposure to neat HD (8.4 ± 2.9% absorbed for 1 hour removal with 24 
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hour decontamination, and 5.9 ± 1.7% absorbed following 1 hour removal of 
clothing and 1 hour decontamination respectively). The presence of clothing 
on the skin surface also reduced the amount of HD recovered from within the 
skin membrane from 58.3 ± 6.5%, to 18.6 ± 4.1% following skin surface 
decontamination at 1 hour, and 6.1 ± 3.2% following decontamination at 24 
hours.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7. Results 
176 
-500
0
500
1000
1500
2000
2500
3000
3500
0 5 10 15 20 25
time (h)
cu
m
u
la
tiv
e 
ab
so
rp
tio
n
 
o
f H
D
 
(ug
/c
m
2)
FT early removal
and
decontamination
FT early removal
and 24hr
decontamination
FT 24hr
exposure
 
Figure 7.1. 24 hour cumulative absorption profile of neat HD (10mg/cm2) 
applied to clothed, full thickness human breast skin. Values were means ± SEM of 
3 cells (3 skin donors) for each of the clothing treatments (6 static diffusion cells in total). 
Clothing was removed at 1 hour after exposure to HD in both treatments, but skin surface 
decontamination was carried out at either 1 hour or 24 hours. Skin was mounted in static 
diffusion cells with an exposed area of 2.54cm2. HD was applied at a concentration of 
10mg/cm2 in a finite dose (20µl). 
 
 
 
 
Dose 
Flux 
(ng/cm2/h) 
Kp x 10-3 
(cm/h) Lag Time (h) 
Linear 
range 
full thickness, 1hr removal and 
decontamination 23.3 ± 6.33 23.9 ± 7.3 1.91 ± 0.57 3-6 
full thickness, 1hr removal and 
24hr decontamination 39.0 ± 9.52 41.1 ± 9.3 0.32 ± 0.10 2-6 
full thickness, 24hr exposure  
129 ± 
19.6** 
127 ± 
20.1** 1.77 ± 0.52 3-6 
 
Table 25. Observed steady state absorption rates, partition coefficients and lag 
times of neat HD applied to clothed and unclothed full thickness human breast 
skin in vitro. A double asterisk next to a figure indicates that a figure is significantly 
different from the remaining 2 figures in the same column (p<0.05 with one way ANOVA).  
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Figure 7.2. Dose distribution at 24 hours following 1 hour exposure of clothed 
full thickness human breast skin to neat HD (10mg/cm2). Absorbed represents the 
percentage dose recovered from receptor fluid samples either after 1hour removal and 
decon or 1hr removal with 24hour decon, clothing represents the percentage of applied 
dose recovered from the clothing after 1hour exposure, unabsorbed was the percentage 
dose removed from the skin surface after either 1hour decon or 24 hour decon, and skin 
digest represents the percentage recovered from within the skin at 24 hours following 1hr 
removal and decon or 1hr removal with 24 hour decon respectively. 
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7.2.2: 1 hour exposure of clothed, full thickness human breast skin to 
dilute 14C-labelled HD in IPA (492µg/cm2)  
 
The cumulative absorption profile of dilute HD in IPA (figure 7.3) shows that 
removal of contaminated clothing (cotton shirt material) from the skin surface 
after 1 hour followed by immediate decontamination reduced the cumulative 
absorption of HD by approximately 20µg/cm2 when compared with removal of 
clothing alone (with decontamination at the end of the experiment at 24 
hours).  Absorption continued to increase up to 24 hours, despite the 
presence of clothing above the skin for 1 hour after dosing. However, as can 
be seen from this figure, absorption was reduced by approximately 50% 
following removal of clothing with immediate skin surface decontamination 
compared with 24 hour exposure. Absorption following removal of clothing 
with immediate decontamination was lower than with 24 hour 
decontamination, despite having a shorter apparent lag time (0.49 ± 0.11h, 
compared with 1.14 ± 0.55) (table 26). A lower apparent maximum flux was 
also observed following removal of clothing and decontamination at 1 hour 
compared with removal of clothing alone (3.82 ± 0.89 µg/cmµ2/h, compared 
with 5.62 ± 1.13µg/cm2/h respectively) (table 26). However, the overall 
reduction in absorption compared with 24 hour exposure was not statistically 
significant, despite there being a significantly greater observed maximum flux 
following 24 hour exposure to neat HD compared with the flux observed 
following 1 hour removal of clothing with immediate decontamination (table 
28).  
 
The dose distribution of dilute HD in IPA (figure 7.4) shows a very similar 
pattern to the dose distribution for neat HD. Here, the clothing had also 
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retained the majority of the applied dose after 1 hour exposure. Approximately 
11% of the applied dose was recovered from the skin surface after removal of 
clothing and decontamination at 1hour. This is much more than what was 
recovered from the skin surface at 24 hours (2.5%). Despite this difference, 
the amount of HD retained within the skin was similar for both treatments 
(approximately 7%). However, this represents a significant reduction in skin 
retention of HD compared with 24 hour exposure to dilute HD in IPA, where 
61.2 ± 8.8% of the dose was found within the skin after 24 hour exposure 
(p<0.05 with one way ANOVA). Absorption of dilute HD in IPA was 
approximately double compared with absorption of neat HD in terms of 
percentage of dose applied to the skin surface.  
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Figure 7.3. 24 hour cumulative absorption profile of dilute HD in IPA 
(492µg/cm2) applied to clothed, full thickness human breast skin. Values were 
means ± SEM of 3 cells (3 skin donors) for each of the clothing treatments (6 static diffusion 
cells in total). Clothing was removed at 1 hour after exposure to HD in both treatments, but 
skin surface decontamination was carried out at either 1 hour or 24 hours. Skin was 
mounted in static diffusion cells with an exposed area of 2.54cm2. HD was applied at a 
concentration of 10mg/cm2 in a finite dose (20µl). 
 
 
 
 
 
 
Dose 
Flux 
(ng/cm2/h) 
Kp x 10-3 
(cm/h) 
Lag Time 
(h) 
Linear 
range 
full thickness, 1hr removal 
and decontamination 3.82 ± 0.89 3.74 ± 1.1 0.49 ± 0.11 0-6 
full thickness, 1hr removal 
and 24hr decontamination 5.62 ± 1.13 5.5 ± 1.2 1.03 ± 0.37 2-5 
full thickness, 24hr exposure  9.35 ± 2.74* 9.1 ± 3.5 
1.14 ± 
0.55* 2-5 
 
Table 26. Observed steady state absorption rates, partition coefficients and lag 
times of dilute HD in IPA following application to clothed and unclothed full 
thickness human breast skin in vitro. A single asterisk next to a figure indicates that it 
is significantly different from the lowest figure in the same column.  
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Figure 7.4. Dose distribution at 24 hours following 1hour exposure of clothed 
full thickness human breast skin to dilute HD in IPA (492µg/cm2). Absorbed 
represents the percentage dose recovered from receptor fluid samples either after 1hour 
removal and decon or 1hr removal with 24hour decon, clothing represents the percentage of 
applied dose recovered from the clothing after 1hour exposure, unabsorbed was the 
percentage dose removed from the skin surface after either 1hour decon or 24 hour decon, 
and skin digest represents the percentage recovered from within the skin at 24 hours 
following 1hr removal and decon or 1hr removal with 24 hour decon respectively. 
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7.3: Discussion 
 
The purpose of these studies was to investigate the effectiveness of everyday 
clothing (cotton shirt) at reducing dermal absorption of neat HD and dilute HD 
through human breast skin which was used full thickness in static diffusion 
cells. Dermal absorption of neat HD was reduced by cotton shirt clothing 
compared to unclothed skin, suggesting that ‘every day’ clothing can provide a 
significant barrier to dermal absorption of chemicals. Absorption of neat HD 
following removal of clothing and skin surface decontamination at 1 hour was 
reduced compared with removal of clothing only although the difference was 
not significant. 
 
It is clear that removal or clothing supplemented with immediate skin surface 
decontamination can help to further reduce the amount of HD being absorbed 
into the skin. This is supported by the lower absorption of HD through the skin 
following immediate decontamination after removal of clothing compared with 
removal of clothing alone. Although this was not a statistically significant 
reduction, it is a numerical one and this could potentially be important with 
regard to decontamination procedures in real life scenarios. 
 
Removal of clothing with immediate decontamination resulted in more of the 
applied dose being recovered from the skin surface compared with the 
amount recovered from the skin surface with removal of clothing alone. This 
suggests that a significant proportion of the applied dose can still come into 
contact with the skin despite the presence of clothing, and even though 
clothing was only in contact with the skin for 1 hour after exposure. This may 
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suggest that, from a real life exposure perspective, skin surface 
decontamination and removal of clothing as soon as possible following 
exposure to a chemical is advantageous for minimising the amount of 
chemical coming into contact with the skin, and also the amount of time in 
which the chemical has to penetrate through the stratum corneum.   
 
 
Similar results were obtained when clothed; full thickness human breast skin 
was exposed to dilute HD in IPA Absorption was approximately halved 
following removal of clothing and decontamination at 1 hour compared with 
the amount of HD absorbed following 24 hour exposure, and by approximately 
a third  when clothing was removed at one hour without decontamination. The 
amount of HD recovered from the skin surface following 1 hour 
decontamination after removal of clothing was also significantly greater than 
following 24 hour decontamination. This adds further evidence to the proposal 
that removal of clothing supplemented with skin surface decontamination as 
early as possible after exposure can help to reduce absorption of HD through 
the skin. Despite the presence of clothing and a short exposure time, the 
amount of HD absorbed through the skin was still high. This may be an effect 
of the application vehicle, with IPA leading to greater penetration of HD into 
the stratum corneum, particularly with occlusion from the clothing above the 
skin surface.  
 
Following exposure of clothed, full thickness human breast skin to both neat 
HD, and HD diluted in IPA, it can be seen that ‘everyday’ cotton shirt material 
provides an effective barrier to absorption despite not being designed 
specifically for protective purposes. The amount of HD retained within the 
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clothing at 1 hour following exposure ranged from 62-69% of the applied dose. 
From a real life exposure perspective, this suggests that if contaminated 
clothing is removed from the skin surface as soon as possible after exposure, 
then the amount of chemical reaching the skin surface, and also the amount 
being absorbed through the skin can be significantly reduced. This is 
important to consider for chemicals like HD, which elicits its major toxic effects 
locally within the skin, but also for chemicals which exert their effect 
systemically.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Chapter 8 
 
Predictions of dermal absorption 
using a mathematical model 
 
 
 
 
 
 
 
 
8. Results 
186 
8. Predictions of dermal absorption using a mathematical 
model 
 
 
8.1: Introduction 
 
It is important to investigate dermal absorption of chemicals from a 
toxicological risk assessment perspective in order to estimate the amount of a 
chemical which may become internally available following exposure to the 
skin. As shown in previous chapters, in vitro dermal absorption studies can be 
undertaken to predict in vivo exposure. Also, many in vivo experiments have 
been undertaken using animal models to predict exposure outcomes for 
human exposure in vivo. However, cost implications, as well as the desire to 
reduce the number of animals used in dermal absorption studies, are limiting 
factors when implementing the in vivo approach. In vitro experiments also 
have flaws, particularly as individual experiments implement highly specific 
parameters for absorption of a particular chemical. This means that data 
obtained may not reflect the outcomes under different exposure settings. 
 
As of the end of mid-2007, new European Union legislation on the registering 
of chemicals was agreed, known as REACH (Registration, Evaluation, 
Authorisation and Restriction of Chemicals). This states that over 50,000 
known chemicals will need to be evaluated for environmental and 
occupational safety regarding the way they are produced, used and disposed 
of by the end of 2017. These issues have stimulated this area of research, 
and have led to a variety of pharmacokinetic models being established to 
predict dermal absorption of chemicals, to attempt to reduce the time and 
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financial costs needed to rank chemicals for risk assessment purposes 
(European Commission, Joint Research Centre website).  
 
QSAR models have traditionally been used to quantify the relationship 
between the chemical structure and the pharmacological activity of a 
chemical. Most available QSAR models predict only the permeability 
coefficient (Kp) of a chemical from an infinite dose, under steady state 
conditions. An extensive overview of most of the available QSAR models has 
been published recently (Bouwman et al. 2008). This review came to the 
conclusion that none of the available QSARs were suitable for accurate risk 
assessment of chemical absorption through skin. The permeability coefficient 
of a chemical across the skin is expressed as cm/h, and from this parameter, 
the steady state flux can be calculated under infinite dose conditions. Under 
these conditions, the dose concentration of a chemical on the skin surface 
does not reduce markedly over time, however, for ‘real life’ exposure 
scenarios, finite dose conditions are more likely to occur. Many ‘in silico’ 
methods do not take the depletion in dose concentration across the skin into 
account, and so generally lead to poor prediction of dermal absorption. 
 
For the purposes of this chapter, a novel pharmacokinetic model has been 
implemented, using infinite and finite dose parameters from the experimental 
data obtained in order to identify whether predicted outcomes correlate well 
with experimental outcomes from finite dose studies. The model used for this 
purpose was described by Buist et al. 2010. This model was developed to 
predict cumulative absorption from finite dose conditions based on the 
permeability coefficients, lag times and the stratum corneum/water partition 
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coefficients (Ksc/w) obtained from infinite dose data. This model incorporates a 
distribution factor, which accounts for the depletion of the surface dose 
concentration after distribution of the test chemical into the stratum corneum, 
and so may lead to more accurate prediction of dermal absorption. 
Cumulative absorption was predicted using the following equation: 
 
      Mt = M0(1-ef(-KpA (t-tlag)/V))     (1) 
 
 
Here, Mt is the cumulative amount of chemical absorbed at time t, M0 is the 
amount of chemical applied to the skin surface at time 0 (µg), f is the 
distribution factor, Kp is the permeability coefficient (cm/h), A is the application 
area (cm2), tlag is the experimental lag time (h) (under infinite dose 
conditions) and V is the volume applied to the skin surface (ml).  Without the 
distribution factor (f), the model would assume that the dose concentration 
remained unchanged during absorption, until the entire dose was exhausted 
by the absorption process. 
 
The distribution factor was calculated using the following equation: 
 
 
F = VDL/ (VDL + KSC, V * VSC) 
      VDH/ (VDH + KSC, V * VSC) 
(2) 
 
 
Here, VDL and VDH are applied volumes (µl) for finite and infinite dose 
conditions respectively, KSC, V is the stratum corneum: vehicle partitioning 
coefficient, and VSC is the volume of stratum corneum (1.23µl for an exposed 
area of 0.64cm2).   
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For aqueous vehicles, the value for KSC, V can be calculated using a QSAR. 
For the purposes of the data set obtained from the experiments in this project, 
non aqueous vehicles were used for application of chemicals to the skin. 
Therefore, the following equation was used to calculate KSC, V  for any vehicle: 
 
 
KSC, V = [tlag*6Kp]/h    (3) 
 
 
 
Here, h is the distance through the stratum corneum (20µm).  
 
The amount of chemical present in the stratum corneum can be predicted 
using the following equation: 
 
 
MSC = (M0-MP) * (1-f)              (4) 
 
 
 
Here, MSC is the amount of chemical present in the stratum corneum, M0 is 
the amount applied to the skin surface (µg), and MP is the cumulative amount 
absorbed in the receptor fluid (this was determined using the equation 1). 
 
The experimental data obtained from human breast skin exposure to infinite 
dose and finite doses of the chemicals outlined in chapters 3 and 4 was used 
to correlate with the pharmacokinetic model described by Buist et al. 2010, in 
order to establish comparisons between experimental data and predicted 
outcomes. Data taken from infinite dose exposure experiments (experimental 
lag time, permeability coefficient (KP), and stratum corneum: vehicle partition 
coefficient (KSC, W)) was used to predict the experimental outcome based on a 
finite dose exposure. The experimental data shown in each cumulative 
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absorption graph is from a finite dose exposure. The data used to input into 
the Buist model is shown in table 27 below.  
 
application dose 
dose 
concentration 
finite dose 
applied 
volume  (µl) 
infinite dose 
experimental 
lag (h) 
Partition 
coefficient Ksc,w 
Caffeine in IPA 10mg/ml 6.4 2.4 hours 0.0427cm/h 307 
Caffeine in PG 12mg/ml 6.4 1.7 hours 0.0168 cm/h 85.7 
Benzoic acid in 
IPA 35mg/ml 6.4 2.3 hours 0.0014 cm/h 9.66 
Benzoic acid in 
PG 24mg/ml 6.4 9.1 hours 0.0011 cm/h 30 
Dichlorvos in IPA 500µg/ml 6.4 0.6 hours 0.133 cm/h 240 
Dichlorvos in IPM 500µg/ml 6.4 2.6 hours 0.0693 cm/h 541 
Dichlorvos in PG 500µg/ml 6.4 3.2 hours 0.110 cm/h 1060 
 
Table 27. Table of infinite dose data used to predict finite dose absorption based 
on the Buist pharmacokinetic model. A shorter lag time for caffeine in IPA was used 
here compared to the data shown in chapter 3 (12.1 hours). The shorter lag time of 2.4 hours 
was selected based on the early linear phase of the cumulative absorption graph, as the later 
increase in absorption may have been due to evaporation of the application vehicle.  
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8.2: Results 
 
8.2.1: Caffeine applied in IPA and PG 
The cumulative absorption profile of caffeine applied as a finite dose in IPA 
can be seen in figure 8.1, with the predicted outcome also shown based on 
the partition coefficient calculated from equation 3, using the KP and lag time 
measured under infinite dose conditions (table 27). The results show that the 
model described by Buist et al over predicted absorption compared with 
experimental data, despite the assumption that no absorption occurred before 
the lag time. Absorption at 24 hours showed an approximately 4 fold over 
estimate of absorption compared with experimental data. Absorption of 
caffeine applied in IPA was faster over early time points, and then tailed off up 
to 24 hours. As a result of this, the predicted outcome prior to the lag time (2.4 
hours) does not correlate well with the experimental data.  
 
Caffeine applied as a finite dose in PG gave an unusual cumulative absorption 
profile, with slow initial absorption, followed by an increase at later time points 
(19-24 hours). As a result of this, the predicted cumulative absorption 
significantly over estimated absorption of caffeine applied as a finite dose in 
PG (approximately 7 fold higher than the experimental value).  
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Fig 8.1. Cumulative absorption graph comparing predicted outcomes for a finite 
exposure with experimental data obtained from exposure of skin to finite dose of 
caffeine in IPA. Predictions were made based on the partition coefficient (Kp), and lag time 
measured under infinite dose conditions, with correction for distribution into the stratum 
corneum.   
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Fig 8.2. Cumulative absorption graph comparing predicted outcomes for a finite 
exposure with experimental data obtained from exposure of skin to finite dose of 
caffeine in PG. Predictions were made based on the partition coefficient (Kp), and lag time 
measured under infinite dose conditions, with correction for distribution into the stratum 
corneum.   
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8.2.2: Benzoic acid applied in IPA and PG 
 
 
As can be seen from the cumulative absorption profile in figure 8.3, the 
predicted absorption of benzoic acid applied as a finite dose in IPA more 
closely followed the experimental values than for caffeine. The predicted and 
experimental values after 7 hours of exposure were similar (predicted value = 
86µg/cm2, experimental value = 83µg/cm2). However, after this time point, the 
predicted values continued to over estimate absorption, with predicted 
absorption being approximately double that of the experimental values at 24 
hours.  
 
In contrast to the previous predictions leading to an over estimate of 
absorption,  the predicted absorption of benzoic acid from a finite dose in PG 
led to an underestimation compared with the experimental value, despite the 
long lag time (9.1 hours) (figure 8.4). Benzoic acid applied as a finite dose in 
PG was initially slow to be absorbed, until reaching steady state absorption 
between 8 and 14 hours after exposure, before tailing off up to 24 hours. The 
experimental value was approximately double that of the predicted value at 24 
hours. 
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Fig 8.3. Cumulative absorption graph comparing predicted outcomes for a finite 
exposure with experimental data obtained from exposure of skin to finite dose of 
benzoic acid in IPA. Predictions were made based on the partition coefficient (Kp), and lag 
time measured under infinite dose conditions, with correction for distribution into the stratum 
corneum.   
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Fig 8.4. Cumulative absorption graph comparing predicted outcomes for a finite 
exposure with experimental data obtained from exposure of skin to finite dose of 
benzoic acid in PG. Predictions were made based on the partition coefficient (Kp), and lag 
time measured under infinite dose conditions, with correction for distribution into the stratum 
corneum.   
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8.2.3: Dichlorvos applied in IPA, IPM and PG 
 
As can be seen from the predicted cumulative absorption values shown in 
figures 8.5, 8.6 and 8.7 (for IPA, IPM and PG respectively), the predicted 
model for cumulative absorption of dichlorvos from all three vehicles 
significantly over predicted absorption compared with the experimental values 
obtained from finite dose studies for dichlorvos applied in IPA, IPM and PG, 
with absorption being over predicted by approximately 2-fold after 24 hours. 
The predicted cumulative absorption profile of dichlorvos in IPA and IPM were 
similar in terms of the shape of the profile curve. The predicted cumulative 
absorption of dichlorvos in IPA closely matched the experimental values for 
the first 2-3 hours, but then absorption tailed off rapidly and the difference 
between predicted and experimental values became greater.  
 
A short lag time (0.6 hours) was observed when dichlorvos was applied in 
IPM, with absorption reaching a steady state in the early time points (1-8 
hours) before tailing off up to 24 hours. Absorption of dichlorvos from PG was 
also approximately linear from 2-8 hours after exposure, with a lag time of 3.2 
hours. The predicted values for absorption from all three vehicles showed 
rapid absorption over the initial time points after the experimental lag time, 
with absorption tailing off up to 24 hours.  
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Fig 8.5. Cumulative absorption graph comparing predicted outcomes for a finite 
exposure with experimental data obtained from exposure of skin to finite dose of 
dichlorvos in IPA. Predictions were made based on the partition coefficient (Kp), and lag 
time measured under infinite dose conditions, with correction for distribution into the stratum 
corneum.   
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Fig 8.6. Cumulative absorption graph comparing predicted outcomes for a finite 
exposure with experimental data obtained from exposure of skin to finite dose of 
dichlorvos in IPM. Predictions were made based on the partition coefficient (Kp), and lag 
time measured under infinite dose conditions, with correction for distribution into the stratum 
corneum.   
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Fig 8.7. Cumulative absorption graph comparing predicted outcomes for a finite 
exposure with experimental data obtained from exposure of skin to finite dose of 
dichlorvos in PG. Predictions were made based on the partition coefficient (Kp), and lag 
time measured under infinite dose conditions, with correction for distribution into the stratum 
corneum.   
 
 
 
 
 
8. Results 
198 
8.3: Discussion 
 
 
The results show that the model described by Buist et al. does not correlate 
well with the finite dose experimental data obtained during this project. Very 
few predictive models are available that attempt to predict absorption from 
non aqueous vehicles. The majority of models focus on absorption from 
aqueous vehicles due to the lack of availability of KSC, W values. One of the 
main problems with the Buist predictive model is that it does not recognise 
any absorption before the experimental lag time. However, the lag time is 
calculated based on the extrapolation of the linear portion of the cumulative 
absorption curve to the x-axis, and is therefore not represented by the amount 
of time taken for a chemical to partition into the skin. During in vivo and in vitro 
studies, a chemical applied to the skin will undergo some absorption prior to 
the measured lag time. As a result of this, the model described by Buist et 
al.2010 will almost certainly be a poor predictor of absorption, particularly 
during early time points. With the exception of benzoic acid applied in IPA, this 
is certainly true of the data shown in this chapter.  
 
It is also possible that the lag times may not be accurately calculated, 
particularly with the dichlorvos studies where the dose concentration on the 
skin surface was not saturated (meaning that true infinite dose conditions 
were not obtained). It is also unlikely that calculating the lag time by 
extrapolating the line of best fit through the linear portion of the cumulative 
absorption curve to the x-axis may not be an accurate measure of the ‘true’ 
lag time.  Inaccuracies in measurement of experimental lag time will lead to 
error in the calculation of KSC, W values.  
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Also, the model tends to predict that all compounds that are absorbed through 
the skin under finite conditions will fit a classical finite dose cumulative 
absorption curve (fast absorption during early time points followed by tailing 
off up to 24 hours). However, the experimental data used in these predictions 
show that this is not always the case. For instance, the cumulative absorption 
profile of caffeine applied to the skin as a finite dose in PG began with a slow 
absorption rate over the initial 10 hours of exposure, followed by an increase 
in absorption rate up to 24 hours. Therefore, it is likely that chemicals which 
do not fit this particular profile will not fit well with the predictive model. The 
best fit observed from the experimental data came from benzoic acid in IPA, 
which gave an expected finite dose cumulative absorption curve, however, 
absorption was still over predicted by approximately double at 24 hours.  
 
However, it is clear from the data shown in this chapter that the predicted 
absorption more closely matched the experimental data when using a 
chemical that more readily partitions into the stratum corneum (dichlorvos), 
compared with experimental data obtained using a chemical which is less able 
to penetrate into the stratum corneum (caffeine). This is shown in particular 
from the predicted absorption of dichlorvos from IPA, as predicted absorption 
closely matched observed absorption over early time points. It is possible that 
better predictions for absorption of chemicals that readily penetrate the 
stratum corneum are due to the Buist model taking into consideration 
partitioning into the stratum corneum, and not absorption through the skin as a 
whole. It is possible that if predictions were made to identify the amount of a 
test chemical within the skin at a given time point, that the amount penetrated 
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and the amount absorbed combined may more closely match the amount 
absorbed based on the predictive model described by Buist et al.  
 
There are complex interactions between chemicals and the vehicles in which 
they are applied to the skin surface, and to take this into consideration, as well 
as the complexities of skin structure, make it extremely difficult to produce 
mathematical models which will be suitable for risk assessment for dermal 
exposure to chemicals. It could be argued that in order to validate 
mathematical models, experimental data will need to be produced in parallel, 
and so the argument for using mathematical models as a cost effective tool for 
compliance with the REACH programme may not be entirely valid. However, 
models that reliably over predict absorption may possibly be useful for a ‘worst 
case scenario’ for dermal exposure to chemicals.  
 
Further work on mathematical models of dermal absorption is clearly needed 
if the predicted data is to be trusted without having to validate it by producing 
experimental data. 
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9. General Discussion 
9.1: Discussion and conclusion 
The main aim of this project was to increase the understanding of the dermal 
absorption of chemical agents in man and to assess the influence of different 
exposure scenarios, including application vehicle, and the influence of 
everyday clothing with decontamination on the dermal absorption of a series 
of chemicals, including marker chemicals, organophosphates and HD. To do 
this, skin mounted in static and flow through diffusion cells was used to 
provide information in vitro and to extrapolate these results to dermal 
absorption of chemicals in vivo. It has previously been shown that in vitro 
studies with human skin predict absorption in vivo under similar exposure 
conditions for a range of model compounds (Williams et al. 2006).  
 
9.1.1: Choice of Surrogate compounds for chemical agents and vehicle 
effects on dermal absorption 
Initially, caffeine and benzoic acid were used for in vitro diffusion studies as 
model compounds as they represent a range of physico chemical properties, 
and the influence of vehicle on their dermal absorption was assessed (chapter 
3). These chemicals were used as they had been extensively studied in the 
laboratory in Newcastle as reference compounds in dermal absorption 
studies. Including these compounds as references allowed ranking of 
absorption studies with organophosphates, which could be considered 
chemical agents in their own right as well as surrogates for nerve agents, and 
with a chemical agent (HD). The main purpose of conducting the in vitro finite 
dose exposure experiments outlined in this project was to understand the 
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absorption profile of a range of chemicals and to use this data to predict 
absorption in vivo for specific exposure scenarios.  
 
Caffeine  (applied to the surface of dermatomed human breast skin as a finite 
(10µl/cm2), saturated dose in IPA (10mg/ml) or in PG (12mg/ml) resulted in 
approximately 16µg/cm2 of caffeine absorbed at 24 hours after exposure, 
despite differences between the two absorption profiles. This was despite a 
longer lag time being observed following application of caffeine in PG, and 
also a greater observed maximum flux being observed for caffeine in IPA 
(3.3µg/cm2/h). However, as steady state absorption was not achieved for 
caffeine absorption from the IPA vehicle (when applied as an infinite dose), it 
was difficult to make comparisons based on observed maximum absorption 
rates.  
 
Absorption of benzoic acid through dermatomed human breast skin was much 
greater than caffeine when applied as a saturated, finite dose (concentration 
of 12mg/ml in IPA and IPM). Initial absorption was faster when applied in IPA; 
however, the total amount of benzoic acid absorbed from both vehicles was 
similar after 24 hours (approximately 115µg/cm2). Absorption of benzoic acid 
was expected to be greater through the skin than for caffeine, due to the more 
lipophilic nature of benzoic acid and its interaction with both IPA and PG 
vehicles. IPA is amphipathic, and PG is a hydrophilic solvent, therefore, 
benzoic acid partitioned into the stratum corneum more readily than caffeine 
applied to the skin in the same two vehicles.  
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It was impossible to ascertain a true maximum absorption rate for either 
caffeine or benzoic acid applied in IPA as an infinite dose due to the volatility 
of the vehicle. Despite being applied as an infinite saturated dose (1ml/cm2), 
the vehicle volume depleted rapidly from the skin surface, and so steady state 
absorption was never achieved. Absorption of both chemicals from PG 
however, did achieve and maintain a steady state as PG is much less volatile, 
and so steady state absorption was maintained over 24 hours.  
 
 Having defined the absorption profiles of caffeine and benzoic acid, dermal 
absorption studies were undertaken using the organophosphates chlorpyrifos, 
dichlorvos and phorate. Organophosphates are an accidental exposure threat 
to civilians and so it is important to generate absorption data for these 
chemicals. By comparison of their physicochemical properties with nerve 
agents it may be possible to extrapolate these dermal absorption results to 
nerve agents with which it was not possible to work in this project.  
 
Application of dichlorvos to dermatomed human skin in 3 vehicles (IPA, IPM 
and PG) at the same absolute concentration resulted in differing cumulative 
absorption profiles. Absorption from the IPA vehicle was fastest over the first 
few hours, and resulted in the fastest observed absorption rate. This was 
likely to be due to rapid evaporation of the IPA vehicle from the skin surface 
leading to a transient increase in skin surface concentration of dichlorvos. The 
greatest absorption of dichlorvos from IPA occurred over the first 3 hours of 
exposure, suggesting that in vivo, an early wash-off (within the first hour) 
would be necessary to prevent significant dermal absorption. Despite 
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differences in the cumulative absorption profiles between vehicles, the overall 
amount of dichlorvos absorbed from each vehicle over a 24 hour period was 
not significantly different. However, the observed maximum absorption rate of 
dichlorvos from the IPM and PG vehicles was lower than from IPA, and so 
from a decontamination perspective, may present a wider window of 
opportunity to successfully remove the majority of the chemical in contact with 
the skin.  
 
The same three vehicles were used to investigate the dermal absorption of 
chlorpyrifos. Application of chlorpyrifos to the skin surface in the PG vehicle 
resulted in a two-fold increase in absorption compared with chlorpyrifos in 
IPA, and a ten-fold increase in absorption compared with chlorpyrifos in IPM. 
The observed difference in absorption of chlorpyrifos is likely to be due to the 
different physicochemical properties of the solvent vehicles. Chlorpyrifos is a 
lipophilic chemical, and so it had a greater thermodynamic activity in the 
hydrophilic PG vehicle than in IPA or IPM. This resulted in a steeper 
thermodynamic gradient across the skin and led to greater absorption of 
chlorpyrifos through the skin. The least absorption of chlorpyrifos was 
observed from the IPM vehicle, as this was the most lipophilic of the solvent 
vehicles used. Despite greater absorption resulting from application of 
chlorpyrifos in PG and IPA compared with IPM, long lag times were also 
observed following use of these vehicles. This suggests that wash-off from the 
skin surface up to 6 hours after exposure to chlorpyrifos is likely to 
significantly reduce the amount reaching systemic circulation in vivo. Overall, 
dermal absorption of dichlorvos was greater than chlorpyrifos from all 
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application vehicles. Absorption of dichlorvos ranged from approximately 30-
40% of the applied dose from the 3 vehicles, whereas absorption of 
chlorpyrifos ranged from approximately 5-20% when applied in the same 
vehicles to the skin surface. However, a greater proportion of the applied dose 
of chlorpyrifos was retained within the skin (skin digests and tape strips, 
approximately 25-30% of the dose) compared with dichlorvos (10-20% 
retained in the skin) when applied as a finite dose in the 3 different vehicles. It 
is possible that chlorpyrifos may have the potential to be further absorbed 
from within the skin by slowly penetrating through the stratum corneum and 
epidermis to the more hydrophilic regions of the skin where it can become 
systemically available. From a civilian exposure perspective, there may be 
more potential for removal of a larger proportion of the dose of chlorpyrifos 
from the skin surface than dichlorvos, as chlorpyrifos was slower to penetrate 
the skin and resulted in a greater proportion of the dose remaining 
unabsorbed on the skin surface when compared with dichlorvos applied in all 
vehicles (chapter 4). However, chlorpyrifos showed a greater propensity to be 
retained in the upper layers of the skin and so could lead to further systemic 
absorption in an in vivo scenario, it is also possible that decontamination of 
the skin surface may result in a ‘wash-in effect’, causing further absorption of 
chlorpyrifos that may be re-solubilised within the decontaminant. However, a 
previous study by Hattersley et al. 2008 investigating the skin reservoir of HD 
showed that it is possible to extract non-bound HD from within the stratum 
corneum by using acetonitrile.  
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A small study investigating the influence of vehicle on absorption of phorate 
through dermatomed pig abdomen skin showed that the proportion of the 
applied dose of phorate absorbed was increased when applied to the skin in 
IPA compared with application of neat phorate. No data were obtained for 
dermal distribution of either neat phorate of phorate diluted in IPA, however, 
based on the properties of phorate and the proportion of the applied dose 
recovered from the receptor fluid after 24 hours, it is likely that a significant 
proportion of the applied dose of phorate would have been retained within the 
skin, in particular in the stratum corneum due to the lipophilic nature of 
phorate. The enhanced absorption of phorate from the IPA vehicle was 
probably due to the vehicle properties, taking into account the volatility of IPA 
leading to a rapid increase in skin surface concentration of phorate, and also 
the fact that IPA is mildly lipophilic and so phorate would readily partition into 
the lipophilic stratum corneum from the IPA vehicle. Application of phorate in 
IPA also resulted in a reduced observed lag time compared with neat phorate, 
and so from a skin surface decontamination perspective, there would 
potentially be less time to remove the majority of the applied dose from the 
skin surface in the event of a lipophilic chemical being administered in a mildly 
lipophilic/hydrophilic vehicle. However, it is important to note that even though 
a larger percentage of the applied dose of phorate applied in IPA was 
absorbed compared with neat phorate; the actual amount reaching the 
receptor fluid was greater from the neat dose.  
 
HD was investigated because exposure to this chemical could be a civilian 
threat and it was available to study with collaboration with Dstl. HD has been 
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extensively researched in dermal absorption studies (Chilcott et al. 2000, 
Chilcott et al. 2001, and Hattersley et al. 2008), and the primary route of 
exposure to HD is through the skin. IPA was chosen for finite exposure due to 
its volatility, meaning that application of a finite dose would more closely 
mimic in vitro what may happen as a result of exposure to low levels of HD in 
droplet form in vivo. It is likely that civilian exposure to chemicals in the 
atmosphere will be to small volumes, and so small dose volumes (10µl/cm2) 
were applied to the skin surface. This is the largest volume that can be 
applied to unclothed skin without the chemical falling off the skin surface 
(OECD, 2004, Wilkinson et al. 2010). However, in the presence of clothing it 
may be possible to load greater volumes of chemicals which may be retained 
in the clothing above the skin surface.  
 
Absorption of HD through full thickness human skin after 24 hours was similar 
when applied as neat HD or as a dilution in IPA when expressed as a 
percentage of the dose applied to the skin (approximately 25%). The 
observed flux rate for neat HD through full thickness human breast skin (129.1 
± 14.4µg/cm2h) was in keeping with the literature (71-294µg/cm2/h, Chilcott et 
al .2000). The concentration of HD used in IPA in this project was lower than 
the dose used in previous published studies and an order of magnitude lower 
than for neat HD. The observed lag time for HD in IPA was shorter than for 
neat HD, this was likely to be as a result of HD readily partitioning into the skin 
from the amphipathic IPA vehicle. From a skin decontamination perspective, it 
is likely that HD applied in a moderately lipophilic/hydrophilic solvent vehicle, 
such as IPA will penetrate more efficiently into the skin as a result of an 
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increase in thermodynamic activity of HD in the IPA vehicle, and result in a 
shorter window of opportunity to remove a significant amount of HD from the 
skin surface. However, this does not mean that a greater amount of chemical 
will reach systemic circulation in an in vivo scenario from a vehicle compared 
with a neat chemical. It is possible that even though a shorter window of 
opportunity for removal of a chemical from the skin surface may be observed 
from a dilute dose, the local and systemic toxic effects that may occur as a 
result of dermal exposure are likely to be worse from a neat chemical with low 
level absorption compared with a low dose with a higher level of absorption. 
Prediction of the degree of absorption of HD into the systemic circulation is 
further complicated by binding of HD to proteins and other molecules in the 
stratum corneum and viable skin, due to the high reactivity of HD with 
functional groups found in proteins and other biomolecules. 
 
 A large proportion of HD was measured within the skin after 24 hours when 
applied as neat HD and diluted in IPA. This was expected as sulphur mustard 
has been shown to form a reservoir within the skin from which it can elicit its 
local toxic effects (Hattersley et al. 2008).  
 
The amount of HD remaining in full thickness skin in vitro is likely to be an 
overestimate of what would be expected to be retained in the skin in vivo, 
particularly with the constant migration of cells from the basal to epidermal 
membranes and desquamation of the stratum corneum. As suggested by 
Hattersley et al .2008, some of the dose retained in the skin becomes 
irreversibly bound to proteins within the stratum corneum, and can no longer 
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be extracted from the skin, although some of the retained dose can still 
become available for further penetration through the skin.  
 
Comparisons were also made between full and split thickness pig abdomen 
skin, as pig skin has previously been suggested as a good model for human 
exposure to HD (Chilcott et al. 2001). HD was applied to full and split 
thickness pig skin as a neat solution, and also diluted in IPA to enable 
comparisons to be made with the data obtained from human skin exposure.  
As expected, absorption of HD (both neat and diluted) was greater through 
split thickness skin than full thickness skin (chapter 5). The data obtained from 
full thickness pig skin exposure to HD suggest that full thickness pig skin is a 
good model for exposure to full thickness human breast skin.  The similarity in 
absorption in terms of percentage of applied dose between neat HD and HD 
diluted in IPA, suggests that the application vehicle had little impact on the 
proportion of HD absorbed through either full or split thickness pig skin. This is 
in keeping with the data obtained from exposure of HD to full thickness skin.  
 
Due to time constraints during the work placement at Dstl, only HD in IPA was 
compared with absorption of neat HD through human skin. From the data 
obtained in this project, the absorption profile that most closely matched that 
of HD through human skin was that of benzoic acid. Similar results were 
obtained when comparing finite dose exposures of benzoic acid and HD in an 
IPA vehicle. Both benzoic acid and HD are lipophilic compounds (benzoic acid 
Log p, 1.87, HD Log p, 2.41) that were retained within the skin following 24 
hour dermal absorption (benzoic acid, approximately 55% measured in 
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stratum corneum, HD, 60% in the skin digest). However, it is impossible to 
identify the exact location of HD within the skin, as no tape stripping was 
carried out to remove the stratum corneum in the HD studies, although it is 
likely that HD would be retained within the stratum corneum due to its 
lipophilicity and reactivity with proteins in the stratum corneum. 
 
 As a proportion of the dose applied to the skin surface, similar amounts of 
benzoic acid and HD applied in IPA were absorbed through the skin, and 
comparable kinetic parameters were observed (absorption rates; benzoic 
acid, 18.5µg/cm2/h, HD, 11.6µg/cm2/h, Kp; benzoic acid 17.2cm/h, HD, 
10.4cm/h).  
 
A smaller proportion of the applied dose of both dichlorvos and chlorpyrifos 
was measured within the skin after 24 hour exposure (approximately 5-35%) 
when applied in IPA, compared with HD (60%). This is likely to be due to the 
retention of HD within the skin as a result of a proportion of the applied dose 
being bound to proteins and other structures within the skin (Hattersley et al. 
2008). Measurement of chemical within the skin was not seen to the same 
extent with dichlorvos or chlorpyrifos, despite chlorpyrifos being a more 
lipophilic compound than HD (chlorpyrifos Log p: 4.96, HD Log p: 2.41). This 
reflects the importance of HD binding to skin, an effect which cannot be 
predicted from measuring the dermal absorption of surrogate compounds with 
similar molecular size and lipophilicity. It may be that less toxic analogues of 
HD which also exhibit similar reactivity, such as chloroethyl ethyl sulphide 
(CEES) may be useful in predicting HD binding within the skin. However, 
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despite the lack of distribution data from the phorate study, it may be possible 
that phorate may have had an affinity for the stratum corneum and could 
potentially form a reservoir in the skin in a similar way to HD. Further work is 
needed to identify the absorption profile of phorate through human skin for 
comparison with HD absorption and distribution within the skin.     
 
As dichlorvos and chlorpyrifos are organophosphate compounds with different 
physicochemical properties (table 28 below), it is possible that they may be 
suitable surrogate compounds for other organophosphate chemicals, (e.g. 
sarin). In previous studies, methyl salicylate has been shown to be a useful 
surrogate compound for HD absorption through pig skin in terms of absorption 
kinetics (Riviere et al. 2001), and so this may be a useful chemical to use as a 
surrogate for human exposure to HD. However, due to HD being a more 
reactive chemical in terms of skin exposure than methyl salicylate (Riviere et 
al. 2001, Chilcott et al. 2000), it is likely that methyl salicylate may not be as 
useful for modelling for the distribution of HD within the skin as it is for 
modelling for HD kinetic parameters.  
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Table 28. Table showing the physicochemical properties of chemicals used in this 
project and similar chemicals 
 
 
 
It is difficult to draw true comparisons between the dermal absorption of 
chemicals due to the variation in the concentration applied, and also because 
of the differences in solubility of chemicals in the vehicles used. For valid 
comparisons, it is important that chemical concentrations within vehicles 
should be matched based on solubility. For instance, a lipophilic chemical in a 
hydrophilic vehicle will have a lower solubility than a hydrophilic chemical in a 
hydrophilic vehicle. If these chemicals were applied to the skin surface at the 
same concentration, the thermodynamic activity of the lipophilic chemical 
would be greater than that of the hydrophilic chemical, which is likely to result 
in greater absorption of the lipophilic chemical through the skin. However, if 
the chemicals were dissolved in the same vehicle as saturated solutions, then 
the thermodynamic gradient would be the same for the two chemicals across 
Compound Log P Molecular Weight 
Vapour Pressure 
(at 25˚C) 
Caffeine -0.07 194.19 15 (at 89˚C) 
        
Benzoic Acid 1.87 122.12 7.00E-04 
        
Chlorpyrifos 4.96 350.59 2.03E-05 
        
Dichlorvos 1.47 220.98 0.0158 
        
Phorate 3.56 260.38 6.38E-04 
        
Sulphur Mustard 2.41 159.08 0.1059 
        
Methyl Salicylate 2.55 152.15 3.43E-02 
        
Sarin 0.3 140.1 2.1 
        
VX 2.09 267.38 7.00E-04 
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the skin, and would allow for more accurate comparison of dermal absorption 
of two chemicals applied to the skin in the same vehicle.   
 
It is possible that differences in thermodynamic activity between vehicles and 
chemicals used may have influenced dermal absorption due to the range of 
chemicals used, and the differences in physicochemical properties seen 
between chemicals (table 28). This is demonstrated by comparison of the 
absorption profiles of chlorpyrifos applied as a finite dose in IPA, IPM and PG 
in chapter 4, where absorption of chlorpyrifos was greatly enhanced when 
applied in PG compared with IPA or IPM. This is likely to be an effect of 
thermodynamic activity, although the increase in absorption cannot be solely 
attributed to thermodynamic activity, as PG has been shown previously to 
enhance dermal absorption (Duracher et al. 2009). 
 
9.1.2: The influence of everyday clothing and skin decontamination on 
the dermal absorption of chemicals in vitro 
Due to the likelihood that civilians who become exposed to chemicals will not 
be wearing personal protective equipment, but are likely to be wearing normal 
clothing, experiments were undertaken to investigate the protective qualities 
of everyday clothing against dermal chemical absorption. In general, 
occupational chemical handlers should wear protective clothing that has been 
specifically designed to limit skin exposure to chemicals. However, workers in 
some parts of the world do not have, or do not use personal protective 
equipment, and as a result will be prone to greater exposure to hazardous 
chemicals. Civilians exposed to an accidental release will be wearing clothing 
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that may offer variable protection related to its nature.  Therefore it is 
important to quantify the level of protection that normal clothing may provide 
against dermal exposure. To do this, a thin cotton shirt was used to cover skin 
to undertake in vitro flow through and static diffusion cell studies.  In parallel to 
this, skin surface decontamination with a 5% soap solution was also assessed 
as a supplement to removal of contaminated clothing.  
 
Everyday cotton shirt material retained between 80 and 90% of the applied 
dose of chlorpyrifos (in IPA and PG) when removed from the skin after 4 
hours. Absorption of chlorpyrifos from the IPA vehicle through clothed skin at 
24 hours was reduced approximately 10-fold compared with 24-hour exposure 
of unclothed skin to chlorpyrifos, whereas absorption of chlorpyrifos from the 
PG vehicle through clothed skin was reduced by approximately 20-fold 
compared with 24-hour exposure to unclothed skin. The effectiveness of 
everyday clothing was even greater at reducing dermal absorption of 
dichlorvos from IPA, IPM and PG vehicles. Approximately 65% to 75% of the 
applied dose of dichlorvos for all vehicles was retained within the clothing after 
30-minute exposure. Absorption at 24 hours was reduced from 38% after 24-
hour exposure to dichlorvos in IPA, to 2.6% of the applied dose in the 
presence of clothing in contact with the skin for 30 minutes after exposure. 
Similar reductions were also observed following application of dichlorvos in 
IPM and PG to clothed skin.  
 
Everyday clothing had less of a protective effect against absorption of HD 
compared with chlorpyrifos and dichlorvos. Exposure of unclothed, full 
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thickness human skin to neat HD resulted in approximately 25% of the applied 
dose being absorbed; however, when neat HD was applied to clothed skin, 
absorption at 24 hours was between 6% and 8.5% of the applied dose, 
despite removal of the contaminated clothing after 1 hour. This represents a 
3-4-fold reduction in absorption compared with 24-hour exposure. Absorption 
of HD diluted in IPA through clothed full thickness human skin was reduced by 
approximately 2 fold compared with 24-hour exposure to unclothed skin. 
Despite the lower reduction in absorption of HD through clothed skin 
compared with chlorpyrifos and dichlorvos, the clothing contaminated with HD 
left in contact with the skin for 1 hour still retained between 60% and 70% of 
the applied dose.  
 
A previous study investigating the protective qualities of cotton shirt in vivo 
has shown that cotton shirt material provides between 84.1% and 92.5% 
protection against dermal exposure to agricultural pesticides based on actual 
dermal exposure expressed as a percentage of actual exposure combined 
with potential dermal exposure, which is defined as the total amount in contact 
with the skin and clothing combined (Protano et al. 2009). Unpublished work 
carried out in the Newcastle laboratory has also shown the protective qualities 
of a variety of clothing types (polyester, denim and cotton) against absorption 
of butoxyethanol through minipig skin (Wilkinson et al. 2010). All clothing 
types in this study significantly reduced systemic absorption through minipig 
skin in vitro with removal of clothing at 0.5 hours after exposure, although 
polyester was found to retain markedly less of the applied dose compared 
with cotton shirt material.  
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The results obtained from the in vitro studies undertaken in this project 
support the in vivo findings by Pretano et al. 2009 and the preliminary results 
obtained in the Newcastle laboratory that everyday clothing provides a degree 
of protection against chemical absorption through skin, despite the primary 
function of everyday clothing not being for protective purposes. It is clear that 
everyday clothing can potentially provide a sufficient barrier to significantly 
reduce initial dermal exposure if removed within 4 hours of exposure. Early 
removal of contaminated clothing also reduces the possibility of the 
contaminant (which may be retained in the clothing) from becoming 
resuspended in rainwater or sweat if left in contact with the skin. It is important 
to note that the clothing studies undertaken used a 1mm air gap between the 
skin surface and the clothing. This was done to represent the situation in vivo 
and to enable removal of the clothing during absorption studies without 
perturbing the skin, which would have been unavoidable if the clothing were 
sealed under the donor chamber. It is probable that more tight-fitting clothing 
without an air gap may result in greater transfer of chemicals from 
contaminated clothing to the skin, though it should also be mentioned that 
application of the dose solution resulted in intimate contact of the clothing with 
the skin, despite the air gap.  
 
The results obtained also suggest that removal of clothing followed by 
immediate decontamination removed more of the chemical from the skin than 
removal of clothing alone. The ability to remove chemicals from the skin 
surface is likely to depend on the ability of the chemical or vehicle to interact 
with the skin, for instance, if a corrosive chemical came into contact with the 
9.General Discussion 
218 
skin, the same degree of protection from skin exposure will not be provided by 
everyday clothing, and any damage to the skin caused by chemical irritation 
may lead to a decrease in the effectiveness of skin surface decontamination 
regimes.  
 
Despite there being no significant differences in absorption between removal 
of clothing with immediate decontamination, and removal of clothing with 24 
hour decontamination for all chemicals studied, it would be beneficial from the 
perspective of civilian exposure to an accidental chemical release that both 
removal of clothing and skin surface decontamination should be carried out to 
remove as much of the chemical in contact with the skin as soon as possible 
after exposure. This may help to reduce any potential local or systemic toxic 
effects that may occur as a result of dermal exposure to chemicals, and would 
certainly be preferable in the case of vesicants such as HD, which can have 
delayed effects.  From a practical perspective in the event of civilian chemical 
exposure this would be hoped to be less than four hours, but there will be 
inevitable delay in removal of chemicals from the skin after exposure. It is 
encouraging that the time of removal of the chemical from the skin surface 
following disrobing does not significantly impact on systemic absorption with 
clothed skin; this suggests that once clothing was removed, medical 
countermeasures could be administered before immediate decontamination 
without a significant increase in the risk of harm from dermal absorption. One 
concern however, is that the presence of clothing over the skin may have an 
occlusive effect for in vivo or in vitro exposure scenarios, and result in 
proportionately greater absorption of chemical permeating through clothing to 
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the skin surface. These results show that despite the 1mm air-gap between 
the clothing and the skin surface, a small proportion of the applied dose of 
each chemical used was still recovered from the skin surface despite early 
removal of clothing. This is due to the contaminated clothing temporarily 
adhering to the skin and resulting in transfer of the chemical to the skin 
surface. However, compared with unclothed skin, the amount of chemical 
recovered from the skin surface and the amount penetrated was significantly 
reduced with the presence of clothing. It is encouraging from a 
decontamination perspective that there was some of the applied dose 
remaining on the skin surface after removal of the clothing, suggesting that 
there is little promotion of absorption as a result of occlusion by clothing. 
Extrapolating this to an in vivo scenario, it is likely that the potential occlusive 
effects of clothing to enhance chemical penetration is limited, and is far 
outweighed by the protective capabilities given by the presence of clothing for 
the chemicals used in these studies.  
 
9.1.3: Predictive modelling of chemical absorption 
Due to the limitations in carrying out appropriate in vitro studies with skin for 
all potential exposure chemicals, it would be of use to be able to make an 
initial prediction of dermal absorption for a chemical based on its 
physicochemical properties and the nature of the skin contamination using a 
predictive model. The model described by Buist et al. 2010 was selected for 
this study as this is one of the few mathematical models which attempts to 
predict finite exposures from different vehicles. The Buist model does not 
predict absorption on the basis of physicochemical parameters, but on the 
9.General Discussion 
220 
basis of input parameters determined from experimental procedures or from 
other models.  However the Buist model did not produce good predictions for 
absorption of caffeine and benzoic acid applied in IPA or PG, or dichlorvos 
applied to the skin in IPA, IPM or PG compared with experimental data. In 
most cases, absorption was vastly overestimated at later time points although 
it reasonably well predicted the early phase of absorption after the lag phase, 
with the exception of benzoic acid in PG, where the experimental outcome 
was almost twice that of the predicted outcome. However, it is likely that the 
under-prediction was due to the long observed experimental lag time, as the 
model described by Buist et al. 2010 assumes no absorption of chemicals into 
the systemic circulation prior to the lag time.  
 
Due to the complexities of dermal absorption of chemicals, and the interaction 
of chemicals with the vehicles in which they are applied, it is extremely difficult 
to produce a model that can accurately predict experimental, or ‘real life’ 
outcomes for a wide range of chemicals. The difficulty in predicting exposure 
outcomes is underlined by the variety of mathematical models that have been 
produced and which are not particularly accurate. Many of these models have 
been reviewed (Bouwman et al. 2008).  
 
It is important to develop a reliable mathematical model of dermal absorption 
to reduce the numbers of in vitro or in vivo experimental data needed to define 
the risk of dermal exposure to a wide range of chemicals. However, at 
present, there are few mathematical models that can predict absorption of a 
variety of compounds from real life exposure scenarios and, as is always the 
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case it is necessary to validate the model predictions by undertaking 
experiments to assess dermal absorption of chemicals, as this study has 
illustrated.  
 
9.2: Conclusion 
These studies have shown that the vehicle in which a chemical is applied to 
the skin can have a significant impact on the dermal absorption and dermal 
kinetics of a chemical. Chemical interactions with the vehicle in which it is 
applied to the skin is an important factor affecting dermal absorption and must 
be taken into consideration when using in vitro data to predict in vivo exposure 
scenarios. These studies indicate that benzoic acid can potentially model for 
HD absorption under similar exposure scenarios; however, the 
organophosphate compounds used in this project are shown to be poor for 
predicting dermal absorption of HD. Dichlorvos and chlorpyrifos are 
hazardous compounds for dermal exposure in their own right, and so the 
generation of novel dermal exposure data on these compounds can be useful 
for extrapolating to specific in vivo exposure scenarios. It is possible to use in 
vitro absorption data to predict absorption of other organophosphate 
chemicals with similar physicochemical properties.  
 
It can also be seen from these studies that everyday civilian clothing can 
provide significant protection against dermal absorption in vitro. This may be 
important from a civilian exposure perspective, as limiting the amount of 
chemical in contact with the skin could significantly reduce the local and 
systemic toxic effects caused by chemical exposure.  
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